AFFYMETRIX_3PRIME_IVT_ID	Gene Name	Species	BBID	GOTERM_CC_FAT	BIOCARTA	GOTERM_MF_FAT	SMART	COG_ONTOLOGY	SP_PIR_KEYWORDS	KEGG_PATHWAY	INTERPRO	UP_SEQ_FEATURE	OMIM_DISEASE	GOTERM_BP_FAT	PIR_SUPERFAMILY
37166_at	3-hydroxyanthranilate 3,4-dioxygenase	Homo sapiens		GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005829~cytosol,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,		GO:0000334~3-hydroxyanthranilate 3,4-dioxygenase activity,GO:0005506~iron ion binding,GO:0008198~ferrous iron binding,GO:0009055~electron carrier activity,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0019825~oxygen binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,			3d-structure,alternative splicing,complete proteome,cytoplasm,dioxygenase,iron,metal-binding,oxidoreductase,polymorphism,pyridine nucleotide biosynthesis,	hsa00380:Tryptophan metabolism,	IPR010329:3-hydroxyanthranilic acid dioxygenase,IPR016700:3-hydroxyanthranilate 3, 4-dioxygenase, metazoan,	binding site:Dioxygen,binding site:Substrate,chain:3-hydroxyanthranilate 3,4-dioxygenase,helix,metal ion-binding site:Iron; catalytic,sequence variant,splice variant,strand,turn,		GO:0006732~coenzyme metabolic process,GO:0006733~oxidoreduction coenzyme metabolic process,GO:0006766~vitamin metabolic process,GO:0006767~water-soluble vitamin metabolic process,GO:0006769~nicotinamide metabolic process,GO:0009108~coenzyme biosynthetic process,GO:0009110~vitamin biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009820~alkaloid metabolic process,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010043~response to zinc ion,GO:0016053~organic acid biosynthetic process,GO:0019362~pyridine nucleotide metabolic process,GO:0019363~pyridine nucleotide biosynthetic process,GO:0019674~NAD metabolic process,GO:0019725~cellular homeostasis,GO:0019748~secondary metabolic process,GO:0019805~quinolinate biosynthetic process,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0042364~water-soluble vitamin biosynthetic process,GO:0042592~homeostatic process,GO:0043603~cellular amide metabolic process,GO:0043648~dicarboxylic acid metabolic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046394~carboxylic acid biosynthetic process,GO:0046496~nicotinamide nucleotide metabolic process,GO:0046686~response to cadmium ion,GO:0046874~quinolinate metabolic process,GO:0051186~cofactor metabolic process,GO:0051188~cofactor biosynthetic process,GO:0055114~oxidation reduction,GO:0060249~anatomical structure homeostasis,GO:0070050~neuron maintenance,	PIRSF017681:3-hydroxyanthranilate 3,4-dioxygenase, animal type,PIRSF017681:3hydroanth_dOase_animal,
34467_g_at	5-hydroxytryptamine (serotonin) receptor 4	Homo sapiens		GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,		GO:0004935~adrenoceptor activity,GO:0004993~serotonin receptor activity,GO:0008227~amine receptor activity,			alternative splicing,cell membrane,complete proteome,disulfide bond,endosome,G protein-coupled receptor,g-protein coupled receptor,glycoprotein,lipoprotein,membrane,neurotransmitter receptor,palmitate,polymorphism,receptor,transducer,transmembrane,transmembrane protein,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,	IPR000276:7TM GPCR, rhodopsin-like,IPR001520:5-Hydroxytryptamine 4 receptor,IPR017452:GPCR, rhodopsin-like superfamily,	chain:5-hydroxytryptamine receptor 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,GO:0007242~intracellular signaling cascade,GO:0019932~second-messenger-mediated signaling,GO:0019935~cyclic-nucleotide-mediated signaling,	PIRSF038635:5-hydroxytryptamine receptor 4,PIRSF800006:rhodopsin-like G protein-coupled receptors,
41703_r_at	A kinase (PRKA) anchor protein 7	Homo sapiens		GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,		GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0051018~protein kinase A binding,			alternative splicing,cell membrane,complete proteome,cytoplasm,kinase,lipoprotein,membrane,myristate,palmitate,polymorphism,		IPR019510:Protein kinase A anchor protein, nuclear localisation signal domain,IPR019511:Protein kinase A anchor protein, RI-RII subunit-binding domain,	chain:A-kinase anchor protein 7 isoform gamma,chain:A-kinase anchor protein 7 isoforms alpha and beta,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,region of interest:Required for apical membrane localization,region of interest:Required for membrane localization,region of interest:RII-binding,sequence variant,splice variant,		GO:0006811~ion transport,GO:0007242~intracellular signaling cascade,GO:0008104~protein localization,	
40350_at	ADAM metallopeptidase domain 23	Homo sapiens		GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,		GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0032403~protein complex binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,	SM00050:DISIN,SM00181:EGF,SM00608:ACR,		alternative splicing,cell adhesion,cell membrane,cleavage on pair of basic residues,complete proteome,disulfide bond,egf-like domain,glycoprotein,hydrolase,integrin,membrane,metal-binding,metalloprotease,phosphoprotein,Protease,Secreted,signal,transmembrane,		IPR000742:EGF-like, type 3,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006210:EGF-like,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like region, conserved site,IPR013111:EGF, extracellular,IPR018358:Disintegrin, conserved site,	chain:Disintegrin and metalloproteinase domain- containing protein 23,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:May bind the integrin receptor,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0022610~biological adhesion,	
1575_at	ATP-binding cassette, sub-family B (MDR/TAP), member 1	Homo sapiens		GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031224~intrinsic to membrane,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,	h_mrpPathway:Multi-Drug Resistance Factors,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0008559~xenobiotic-transporting ATPase activity,GO:0015238~drug transporter activity,GO:0015239~multidrug transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042910~xenobiotic transporter activity,GO:0043492~ATPase activity, coupled to movement of substances,	SM00382:AAA,	Defense mechanisms,	ATP,atp-binding,complete proteome,duplication,glycoprotein,hydrolase,membrane,nucleotide binding,nucleotide-binding,P-loop,phosphoprotein,polymorphism,repeat,transmembrane,transmembrane protein,transport,	hsa02010:ABC transporters,	IPR001140:ABC transporter, transmembrane region,IPR003439:ABC transporter-like,IPR003593:ATPase, AAA+ type, core,IPR017871:ABC transporter, conserved site,IPR017940:ABC transporter integral membrane type 1,	chain:Multidrug resistance protein 1,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,topological domain:Cytoplasmic,transmembrane region,	Colchicine resistance,Inflammatory bowel disease 13, susceptibility to,	GO:0042493~response to drug,GO:0055085~transmembrane transport,	PIRSF002773:multidrug resistance protein,
40294_at	ATP-binding cassette, sub-family B (MDR/TAP), member 9	Homo sapiens		GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005773~vacuole,GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0043190~ATP-binding cassette (ABC) transporter complex,		GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043492~ATPase activity, coupled to movement of substances,	SM00382:AAA,		alternative splicing,atp-binding,complete proteome,endoplasmic reticulum,lysosome,membrane,nucleotide-binding,peptide transport,phosphoprotein,polymorphism,protein transport,signal,transmembrane,transport,	hsa02010:ABC transporters,hsa04142:Lysosome,	IPR001140:ABC transporter, transmembrane region,IPR003439:ABC transporter-like,IPR003593:ATPase, AAA+ type, core,IPR017871:ABC transporter, conserved site,IPR017940:ABC transporter integral membrane type 1,	chain:ATP-binding cassette sub-family B member 9,compositionally biased region:Poly-Glu,domain:ABC transmembrane type-1,domain:ABC transporter,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,splice variant,transmembrane region,		GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0008104~protein localization,GO:0015031~protein transport,GO:0015833~peptide transport,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0045184~establishment of protein localization,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0055085~transmembrane transport,	
32439_at	ATPase, H+/K+ exchanging, beta polypeptide	Homo sapiens		GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,		GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0008900~hydrogen:potassium-exchanging ATPase activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,			complete proteome,disulfide bond,glycoprotein,Hydrogen ion transport,hydrolase,ion transport,membrane,potassium,potassium transport,Signal-anchor,transmembrane,transmembrane protein,transport,	hsa00190:Oxidative phosphorylation,	IPR000402:ATPase, P-type cation exchange, beta subunit,	chain:Potassium-transporting ATPase subunit beta,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0002237~response to molecule of bacterial origin,GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006818~hydrogen transport,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0009617~response to bacterium,GO:0009719~response to endogenous stimulus,GO:0010033~response to organic substance,GO:0010243~response to organic nitrogen,GO:0015672~monovalent inorganic cation transport,GO:0015992~proton transport,GO:0030001~metal ion transport,GO:0032496~response to lipopolysaccharide,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046034~ATP metabolic process,	PIRSF005757:Na(+)/K(+)-exchanging ATPase beta-3 chain,
39469_s_at	ATPase, aminophospholipid transporter-like, class I, type 8A, member 2	Homo sapiens		GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,		GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005319~lipid transporter activity,GO:0005524~ATP binding,GO:0005548~phospholipid transporter activity,GO:0015247~aminophospholipid transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,			alternative splicing,atp-binding,complete proteome,hydrolase,magnesium,membrane,metal-binding,nucleotide-binding,phosphoprotein,polymorphism,transmembrane,		IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter,IPR006539:ATPase, P-type, phospholipid-translocating, flippase,IPR008250:ATPase, P-type, ATPase-associated region,IPR018303:ATPase, P-type phosphorylation site,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IB,metal ion-binding site:Magnesium,modified residue,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006869~lipid transport,GO:0008285~negative regulation of cell proliferation,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0010876~lipid localization,GO:0015914~phospholipid transport,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0044271~nitrogen compound biosynthetic process,GO:0046034~ATP metabolic process,	
33685_at	ATPase, class I, type 8B, member 3	Homo sapiens		GO:0000267~cell fraction,GO:0000299~integral to membrane of membrane fraction,GO:0001669~acrosomal vesicle,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,		GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005319~lipid transporter activity,GO:0005524~ATP binding,GO:0005548~phospholipid transporter activity,GO:0015247~aminophospholipid transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,			alternative splicing,atp-binding,complete proteome,hydrolase,magnesium,membrane,metal-binding,nucleotide-binding,phosphoprotein,polymorphism,transmembrane,		IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter,IPR006539:ATPase, P-type, phospholipid-translocating, flippase,IPR008250:ATPase, P-type, ATPase-associated region,IPR013200:HAD superfamily hydrolase-like, type 3,IPR018247:EF-HAND 1,IPR018303:ATPase, P-type phosphorylation site,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IK,metal ion-binding site:Magnesium,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006869~lipid transport,GO:0007338~single fertilization,GO:0007339~binding of sperm to zona pellucida,GO:0008037~cell recognition,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0009566~fertilization,GO:0009988~cell-cell recognition,GO:0010876~lipid localization,GO:0015914~phospholipid transport,GO:0016044~membrane organization,GO:0019953~sexual reproduction,GO:0034204~lipid translocation,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0035036~sperm-egg recognition,GO:0044271~nitrogen compound biosynthetic process,GO:0045332~phospholipid translocation,GO:0046034~ATP metabolic process,GO:0048610~reproductive cellular process,	
33027_at	ArfGAP with GTPase domain, ankyrin repeat and PH domain 4; ArfGAP with GTPase domain, ankyrin repeat and PH domain 6	Homo sapiens				GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0008060~ARF GTPase activator activity,GO:0008270~zinc ion binding,GO:0030695~GTPase regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,	SM00105:ArfGap,SM00233:PH,SM00248:ANK,		ank repeat,complete proteome,GTPase activation,metal-binding,polymorphism,repeat,zinc,zinc-finger,		IPR001164:Arf GTPase activating protein,IPR001849:Pleckstrin homology,IPR002110:Ankyrin,IPR011993:Pleckstrin homology-type,	chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 4,chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6,domain:Arf-GAP,domain:PH,repeat:ANK 1,repeat:ANK 2,sequence variant,zinc finger region:C4-type,		GO:0032012~regulation of ARF protein signal transduction,GO:0032312~regulation of ARF GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0043087~regulation of GTPase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,	
1910_s_at	B-cell CLL/lymphoma 2	Homo sapiens	127.Mito-stress,152.altered_synaptic_signalling-neurodegenerative_disorders,38.Cell_cycle_arrest_and_apoptosis_ceramide,46.P13K_PTEN,83.Growth_factors_Survival_factors_Mitogens,86.Apoptosis_Nematode&_Vert,99.NF-kB_activation,	GO:0000159~protein phosphatase type 2A complex,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005635~nuclear envelope,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005792~microsome,GO:0005829~cytosol,GO:0005955~calcineurin complex,GO:0008287~protein serine/threonine phosphatase complex,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0019867~outer membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031965~nuclear membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0042598~vesicular fraction,GO:0043209~myelin sheath,GO:0044429~mitochondrial part,GO:0044432~endoplasmic reticulum part,	h_badPathway:Regulation of BAD phosphorylation,h_ceramidePathway:Ceramide Signaling Pathway,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_hsp27Pathway:Stress Induction of HSP Regulation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il7Pathway:IL-7 Signal Transduction,h_keratinocytePathway:Keratinocyte Differentiation,h_melanocytepathway:Melanocyte Development and Pigmentation Pathway,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_p53Pathway:p53 Signaling Pathway,h_prionPathway:Prion Pathway,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,	GO:0002020~protease binding,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0051400~BH domain binding,GO:0051434~BH3 domain binding,GO:0070513~death domain binding,	SM00265:BH4,SM00337:BCL,		3d-structure,alternative splicing,Apoptosis,chromosomal rearrangement,complete proteome,disease mutation,endoplasmic reticulum,membrane,mitochondrion,mitochondrion outer membrane,nucleus,phosphoprotein,polymorphism,Proto-oncogene,transmembrane,	hsa04210:Apoptosis,hsa04510:Focal adhesion,hsa04722:Neurotrophin signaling pathway,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05215:Prostate cancer,hsa05222:Small cell lung cancer,	IPR000712:Apoptosis regulator Bcl-2, BH,IPR002475:BCL2-like apoptosis inhibitor,IPR003093:Apoptosis regulator Bcl-2 protein, BH4,IPR004725:Apoptosis regulator Bcl-X protein,IPR013278:Apoptosis regulator, Bcl-2,	chain:Apoptosis regulator Bcl-2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,short sequence motif:BH4,site:Cleavage; by caspase-3,splice variant,strand,transmembrane region,turn,	Leukemia/lymphoma, B-cell, 2,	GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000302~response to reactive oxygen species,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001101~response to acid,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001541~ovarian follicle development,GO:0001558~regulation of cell growth,GO:0001655~urogenital system development,GO:0001656~metanephros development,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001662~behavioral fear response,GO:0001666~response to hypoxia,GO:0001763~morphogenesis of a branching structure,GO:0001775~cell activation,GO:0001776~leukocyte homeostasis,GO:0001782~B cell homeostasis,GO:0001822~kidney development,GO:0001836~release of cytochrome c from mitochondria,GO:0001894~tissue homeostasis,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0001942~hair follicle development,GO:0001952~regulation of cell-matrix adhesion,GO:0002009~morphogenesis of an epithelium,GO:0002209~behavioral defense response,GO:0002244~hemopoietic progenitor cell differentiation,GO:0002252~immune effector process,GO:0002260~lymphocyte homeostasis,GO:0002320~lymphoid progenitor cell differentiation,GO:0002326~B cell lineage commitment,GO:0002360~T cell lineage commitment,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0003006~reproductive developmental process,GO:0003014~renal system process,GO:0006468~protein amino acid phosphorylation,GO:0006470~protein amino acid dephosphorylation,GO:0006582~melanin metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0006808~regulation of nitrogen utilization,GO:0006839~mitochondrial transport,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0006952~defense response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0007006~mitochondrial membrane organization,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007044~cell-substrate junction assembly,GO:0007049~cell cycle,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007292~female gamete generation,GO:0007346~regulation of mitotic cell cycle,GO:0007398~ectoderm development,GO:0007409~axonogenesis,GO:0007423~sensory organ development,GO:0007548~sex differentiation,GO:0007565~female pregnancy,GO:0007568~aging,GO:0007569~cell aging,GO:0007584~response to nutrient,GO:0007610~behavior,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0008406~gonad development,GO:0008544~epidermis development,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0008633~activation of pro-apoptotic gene products,GO:0008637~apoptotic mitochondrial changes,GO:0009266~response to temperature stimulus,GO:0009314~response to radiation,GO:0009408~response to heat,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009611~response to wounding,GO:0009615~response to virus,GO:0009628~response to abiotic stimulus,GO:0009636~response to toxin,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009791~post-embryonic development,GO:0009991~response to extracellular stimulus,GO:0009994~oocyte differentiation,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010039~response to iron ion,GO:0010044~response to aluminum ion,GO:0010212~response to ionizing radiation,GO:0010224~response to UV-B,GO:0010332~response to gamma radiation,GO:0010522~regulation of calcium ion transport into cytosol,GO:0010523~negative regulation of calcium ion transport into cytosol,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010720~positive regulation of cell development,GO:0010810~regulation of cell-substrate adhesion,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010959~regulation of metal ion transport,GO:0012501~programmed cell death,GO:0014031~mesenchymal cell development,GO:0014041~regulation of neuron maturation,GO:0014042~positive regulation of neuron maturation,GO:0014070~response to organic cyclic substance,GO:0014074~response to purine,GO:0014910~regulation of smooth muscle cell migration,GO:0014911~positive regulation of smooth muscle cell migration,GO:0016044~membrane organization,GO:0016049~cell growth,GO:0016050~vesicle organization,GO:0016202~regulation of striated muscle tissue development,GO:0016265~death,GO:0016310~phosphorylation,GO:0016311~dephosphorylation,GO:0016337~cell-cell adhesion,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018209~peptidyl-serine modification,GO:0018210~peptidyl-threonine modification,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0019748~secondary metabolic process,GO:0019953~sexual reproduction,GO:0021548~pons development,GO:0021747~cochlear nucleus development,GO:0022037~metencephalon development,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0022404~molting cycle process,GO:0022405~hair cycle process,GO:0022602~ovulation cycle process,GO:0022610~biological adhesion,GO:0022612~gland morphogenesis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030029~actin filament-based process,GO:0030030~cell projection organization,GO:0030036~actin cytoskeleton organization,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030155~regulation of cell adhesion,GO:0030182~neuron differentiation,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0030278~regulation of ossification,GO:0030279~negative regulation of ossification,GO:0030308~negative regulation of cell growth,GO:0030318~melanocyte differentiation,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0030902~hindbrain development,GO:0031000~response to caffeine,GO:0031069~hair follicle morphogenesis,GO:0031099~regeneration,GO:0031102~neuron projection regeneration,GO:0031103~axon regeneration,GO:0031175~neuron projection development,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031589~cell-substrate adhesion,GO:0031647~regulation of protein stability,GO:0031667~response to nutrient levels,GO:0031960~response to corticosteroid stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032504~multicellular organism reproduction,GO:0032535~regulation of cellular component size,GO:0032835~glomerulus development,GO:0032844~regulation of homeostatic process,GO:0032845~negative regulation of homeostatic process,GO:0032847~regulation of cellular pH reduction,GO:0032848~negative regulation of cellular pH reduction,GO:0032880~regulation of protein localization,GO:0032943~mononuclear cell proliferation,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033032~regulation of myeloid cell apoptosis,GO:0033033~negative regulation of myeloid cell apoptosis,GO:0033059~cellular pigmentation,GO:0033077~T cell differentiation in the thymus,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033273~response to vitamin,GO:0033554~cellular response to stress,GO:0033555~multicellular organismal response to stress,GO:0033688~regulation of osteoblast proliferation,GO:0033689~negative regulation of osteoblast proliferation,GO:0034097~response to cytokine stimulus,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0035094~response to nicotine,GO:0035239~tube morphogenesis,GO:0035265~organ growth,GO:0035295~tube development,GO:0040007~growth,GO:0040008~regulation of growth,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0040014~regulation of multicellular organism growth,GO:0040017~positive regulation of locomotion,GO:0040018~positive regulation of multicellular organism growth,GO:0042100~B cell proliferation,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0042303~molting cycle,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042391~regulation of membrane potential,GO:0042440~pigment metabolic process,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0042592~homeostatic process,GO:0042596~fear response,GO:0042633~hair cycle,GO:0042698~ovulation cycle,GO:0042981~regulation of apoptosis,GO:0043029~T cell homeostasis,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043269~regulation of ion transport,GO:0043271~negative regulation of ion transport,GO:0043279~response to alkaloid,GO:0043368~positive T cell selection,GO:0043369~CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,GO:0043374~CD8-positive, alpha-beta T cell differentiation,GO:0043375~CD8-positive, alpha-beta T cell lineage commitment,GO:0043393~regulation of protein binding,GO:0043434~response to peptide hormone stimulus,GO:0043473~pigmentation,GO:0043496~regulation of protein homodimerization activity,GO:0043497~regulation of protein heterodimerization activity,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0043583~ear development,GO:0043627~response to estrogen stimulus,GO:0044093~positive regulation of molecular function,GO:0045058~T cell selection,GO:0045069~regulation of viral genome replication,GO:0045137~development of primary sexual characteristics,GO:0045165~cell fate commitment,GO:0045321~leukocyte activation,GO:0045471~response to ethanol,GO:0045597~positive regulation of cell differentiation,GO:0045634~regulation of melanocyte differentiation,GO:0045636~positive regulation of melanocyte differentiation,GO:0045664~regulation of neuron differentiation,GO:0045786~negative regulation of cell cycle,GO:0045792~negative regulation of cell size,GO:0045844~positive regulation of striated muscle development,GO:0045926~negative regulation of growth,GO:0045927~positive regulation of growth,GO:0045930~negative regulation of mitotic cell cycle,GO:0045937~positive regulation of phosphate metabolic process,GO:0046545~development of primary female sexual characteristics,GO:0046546~development of primary male sexual characteristics,GO:0046631~alpha-beta T cell activation,GO:0046632~alpha-beta T cell differentiation,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0046660~female sex differentiation,GO:0046661~male sex differentiation,GO:0046668~regulation of retinal cell programmed cell death,GO:0046671~negative regulation of retinal cell programmed cell death,GO:0046688~response to copper ion,GO:0046902~regulation of mitochondrial membrane permeability,GO:0046907~intracellular transport,GO:0048041~focal adhesion formation,GO:0048066~pigmentation during development,GO:0048070~regulation of pigmentation during development,GO:0048087~positive regulation of pigmentation during development,GO:0048477~oogenesis,GO:0048511~rhythmic process,GO:0048534~hemopoietic or lymphoid organ development,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048545~response to steroid hormone stimulus,GO:0048546~digestive tract morphogenesis,GO:0048547~gut morphogenesis,GO:0048565~gut development,GO:0048589~developmental growth,GO:0048599~oocyte development,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0048634~regulation of muscle development,GO:0048636~positive regulation of muscle development,GO:0048641~regulation of skeletal muscle tissue development,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048678~response to axon injury,GO:0048729~tissue morphogenesis,GO:0048730~epidermis morphogenesis,GO:0048732~gland development,GO:0048742~regulation of skeletal muscle fiber development,GO:0048743~positive regulation of skeletal muscle fiber development,GO:0048753~pigment granule organization,GO:0048754~branching morphogenesis of a tube,GO:0048762~mesenchymal cell differentiation,GO:0048812~neuron projection morphogenesis,GO:0048857~neural nucleus development,GO:0048858~cell projection morphogenesis,GO:0048871~multicellular organismal homeostasis,GO:0048872~homeostasis of number of cells,GO:0048873~homeostasis of number of cells within a tissue,GO:0048878~chemical homeostasis,GO:0050767~regulation of neurogenesis,GO:0050792~regulation of viral reproduction,GO:0050801~ion homeostasis,GO:0050931~pigment cell differentiation,GO:0050932~regulation of pigment cell differentiation,GO:0050942~positive regulation of pigment cell differentiation,GO:0051051~negative regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051098~regulation of binding,GO:0051147~regulation of muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051247~positive regulation of protein metabolic process,GO:0051270~regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051384~response to glucocorticoid stimulus,GO:0051385~response to mineralocorticoid stimulus,GO:0051402~neuron apoptosis,GO:0051412~response to corticosterone stimulus,GO:0051593~response to folic acid,GO:0051607~defense response to virus,GO:0051726~regulation of cell cycle,GO:0051789~response to protein stimulus,GO:0051881~regulation of mitochondrial membrane potential,GO:0051899~membrane depolarization,GO:0051900~regulation of mitochondrial depolarization,GO:0051902~negative regulation of mitochondrial depolarization,GO:0051924~regulation of calcium ion transport,GO:0051926~negative regulation of calcium ion transport,GO:0051960~regulation of nervous system development,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0055123~digestive system development,GO:0060249~anatomical structure homeostasis,GO:0060284~regulation of cell development,GO:0060348~bone development,GO:0060429~epithelium development,GO:0060485~mesenchyme development,GO:0060548~negative regulation of cell death,GO:0060562~epithelial tube morphogenesis,GO:0060675~ureteric bud morphogenesis,GO:0070059~apoptosis in response to endoplasmic reticulum stress,GO:0070482~response to oxygen levels,GO:0070661~leukocyte proliferation,	
822_s_at	CASP2 and RIPK1 domain containing adaptor with death domain	Homo sapiens			h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_stressPathway:TNF/Stress Related Signaling,h_tnfr1Pathway:TNFR1 Signaling Pathway,	GO:0002020~protease binding,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0030674~protein binding, bridging,GO:0030693~caspase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0070513~death domain binding,	SM00005:DEATH,SM00114:CARD,		3d-structure,Apoptosis,complete proteome,		IPR000488:Death,IPR001315:Caspase Recruitment,IPR002398:Peptidase C14, caspase precursor p45,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR011029:DEATH-like,	chain:Death domain-containing protein CRADD,domain:CARD,domain:Death,helix,strand,turn,	Many sequence variants affecting diversity of adult human height,	GO:0006508~proteolysis,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,	PIRSF037760:death domain-containing protein CRADD,
35595_at	CGRP receptor component	Homo sapiens		GO:0005886~plasma membrane,GO:0009360~DNA polymerase III complex,GO:0009898~internal side of plasma membrane,GO:0042575~DNA polymerase complex,GO:0044459~plasma membrane part,		GO:0000166~nucleotide binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0004948~calcitonin receptor activity,GO:0016779~nucleotidyltransferase activity,GO:0034062~RNA polymerase activity,	SM00657:RPOL4c,		alternative splicing,Antiviral defense,cell membrane,complete proteome,dna-directed rna polymerase,immune response,innate immunity,membrane,nucleus,phosphoprotein,receptor,Transcription,		IPR006590:RNA polymerase II, Rpb4, core,IPR019000:RNA polymerase III, subunit C17,	chain:DNA-directed RNA polymerase III subunit RPC9,modified residue,splice variant,		GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006383~transcription from RNA polymerase III promoter,GO:0006887~exocytosis,GO:0007338~single fertilization,GO:0007340~acrosome reaction,GO:0009566~fertilization,GO:0016192~vesicle-mediated transport,GO:0017156~calcium ion-dependent exocytosis,GO:0019953~sexual reproduction,GO:0032774~RNA biosynthetic process,GO:0032940~secretion by cell,GO:0046903~secretion,GO:0048610~reproductive cellular process,	PIRSF022700:PIRSF022700,
37814_g_at	DEAD (Asp-Glu-Ala-Asp) box polypeptide 51	Homo sapiens		GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,		GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003723~RNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0070035~purine NTP-dependent helicase activity,	SM00487:DEXDc,SM00490:HELICc,		atp-binding,complete proteome,helicase,hydrolase,nucleotide-binding,nucleus,phosphoprotein,polymorphism,ribosome biogenesis,rna-binding,rrna processing,		IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:DNA/RNA helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:DEAD-like helicase, N-terminal,IPR014021:Helicase, superfamily 1 and 2, ATP-binding,	chain:ATP-dependent RNA helicase DDX51,compositionally biased region:Arg-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,		GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0016072~rRNA metabolic process,GO:0022613~ribonucleoprotein complex biogenesis,GO:0034470~ncRNA processing,GO:0034660~ncRNA metabolic process,GO:0042254~ribosome biogenesis,	
936_s_at	DNA segment on chromosome 4 (unique) 234 expressed sequence	Homo sapiens		GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,		GO:0050780~dopamine receptor binding,			complete proteome,golgi apparatus,membrane,Signal-anchor,transmembrane,		IPR009431:D1 dopamine receptor-interacting, calcyon,	chain:Neuron-specific protein family member 1,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,		GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007212~dopamine receptor signaling pathway,	PIRSF002383:Calcyon,PIRSF002383:neuron specific protein/calcyon,
32148_at	FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)	Homo sapiens		GO:0005856~cytoskeleton,GO:0019898~extrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,		GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0008092~cytoskeletal protein binding,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,	SM00233:PH,SM00295:B41,SM00325:RhoGEF,		alternative splicing,complete proteome,guanine-nucleotide releasing factor,phosphoprotein,polymorphism,repeat,		IPR000219:Dbl homology (DH) domain,IPR000299:FERM domain,IPR000798:Ezrin/radixin/moesin ERM,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR001849:Pleckstrin homology,IPR011993:Pleckstrin homology-type,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR014847:FERM adjacent (FA),IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,IPR019750:Band 4.1 subgroup,	chain:FERM, RhoGEF and pleckstrin domain- containing protein 1,compositionally biased region:Poly-Glu,domain:DH,domain:FERM,domain:PH 1,domain:PH 2,modified residue,sequence conflict,sequence variant,splice variant,		GO:0035023~regulation of Rho protein signal transduction,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,	
33293_at	Fas apoptotic inhibitory molecule 2	Homo sapiens		GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,					Apoptosis,cell junction,cell membrane,complete proteome,glycoprotein,membrane,phosphoprotein,postsynaptic cell membrane,synapse,transmembrane,		IPR006214:Uncharacterised protein family UPF0005,	chain:Fas apoptotic inhibitory molecule 2,compositionally biased region:Poly-Ser,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,transmembrane region,	Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity,	GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0008219~cell death,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0060548~negative regulation of cell death,	
38103_at	GRB10 interacting GYF protein 2	Homo sapiens					SM00444:GYF,		alternative splicing,complete proteome,disease mutation,parkinson disease,phosphoprotein,polymorphism,		IPR003169:GYF,	chain:PERQ amino acid-rich with GYF domain- containing protein 2,compositionally biased region:Arg-rich,compositionally biased region:Gln-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,domain:GYF,modified residue,region of interest:Required for GRB10-binding,sequence conflict,sequence variant,splice variant,	Parkinson disease 11,		
39698_at	HOP homeobox	Homo sapiens			h_hopPathway:Hop Pathway in Cardiac Development,	GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,	SM00389:HOX,		alternative splicing,complete proteome,developmental protein,Homeobox,nucleus,Proto-oncogene,repressor,Transcription,transcription regulation,		IPR001356:Homeobox,IPR012287:Homeodomain-related,IPR017970:Homeobox, conserved site,	chain:Homeodomain-only protein,DNA-binding region:Homeobox; atypical,sequence conflict,splice variant,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001824~blastocyst development,GO:0001825~blastocyst formation,GO:0001829~trophectodermal cell differentiation,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032101~regulation of response to external stimulus,GO:0035295~tube development,GO:0040008~regulation of growth,GO:0043009~chordate embryonic development,GO:0043415~positive regulation of skeletal muscle regeneration,GO:0043416~regulation of skeletal muscle regeneration,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045927~positive regulation of growth,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048286~lung alveolus development,GO:0048638~regulation of developmental growth,GO:0048639~positive regulation of developmental growth,GO:0051094~positive regulation of developmental process,GO:0051147~regulation of muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0060541~respiratory system development,	
34618_at	Indian hedgehog homolog (Drosophila)	Homo sapiens		GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,		GO:0005113~patched binding,GO:0005496~steroid binding,GO:0008233~peptidase activity,GO:0008289~lipid binding,GO:0015485~cholesterol binding,GO:0032934~sterol binding,	SM00305:HintC,SM00306:HintN,		autocatalytic cleavage,cell membrane,complete proteome,developmental protein,disease mutation,glycoprotein,hydrolase,lipoprotein,membrane,palmitate,Protease,Secreted,signal,	hsa04340:Hedgehog signaling pathway,	IPR000320:Hedgehog amino-terminal signaling region,IPR001657:Peptidase C46, hedgehog protein,IPR001767:Peptidase C46, hedgehog protein, hint region,IPR003586:Hedgehog/intein hint domain, C-terminal,IPR003587:Hedgehog/intein hint, N-terminal,IPR006141:Intein splicing site,	chain:Indian hedgehog protein,chain:Indian hedgehog protein C-product,chain:Indian hedgehog protein N-product,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:Cholesterol glycine ester,lipid moiety-binding region:N-palmitoyl cysteine,sequence conflict,sequence variant,signal peptide,site:Cleavage; by autolysis,site:Essential for auto-cleavage,site:Involved in auto-cleavage,site:Involved in cholesterol transfer,	Acrocapitofemoral dysplasia,Brachydactyly, type A1,Genome-wide association analysis identifies 20 loci that influence adult height,Many sequence variants affecting diversity of adult human height,	GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001569~patterning of blood vessels,GO:0001649~osteoblast differentiation,GO:0001763~morphogenesis of a branching structure,GO:0001944~vasculature development,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006508~proteolysis,GO:0007267~cell-cell signaling,GO:0007389~pattern specification process,GO:0007565~female pregnancy,GO:0008284~positive regulation of cell proliferation,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0010033~response to organic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0010941~regulation of cell death,GO:0016485~protein processing,GO:0016539~intein-mediated protein splicing,GO:0021700~developmental maturation,GO:0030908~protein splicing,GO:0031016~pancreas development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032330~regulation of chondrocyte differentiation,GO:0032332~positive regulation of chondrocyte differentiation,GO:0032355~response to estradiol stimulus,GO:0032504~multicellular organism reproduction,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043627~response to estrogen stimulus,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048514~blood vessel morphogenesis,GO:0048545~response to steroid hormone stimulus,GO:0048609~reproductive process in a multicellular organism,GO:0048754~branching morphogenesis of a tube,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051094~positive regulation of developmental process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051604~protein maturation,GO:0060135~maternal process involved in female pregnancy,GO:0060348~bone development,GO:0060548~negative regulation of cell death,	PIRSF009400:hedgehog protein,PIRSF009400:Peptidase_C46,
1645_at	KiSS-1 metastasis-suppressor	Homo sapiens		GO:0005576~extracellular region,					amidation,cleavage on pair of basic residues,complete proteome,direct protein sequencing,phosphoprotein,polymorphism,Secreted,signal,			chain:Metastasis-suppressor KiSS-1,modified residue,peptide:Kisspeptin-10,peptide:Kisspeptin-13,peptide:Kisspeptin-14,peptide:Metastin,region of interest:Essential for receptor binding and receptor activation,sequence conflict,sequence variant,signal peptide,site:Cleavage; by MMP2 and MMP9,		GO:0007010~cytoskeleton organization,	
38128_at	N-acetyltransferase 8 (GCN5-related, putative); N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene)	Homo sapiens		GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,		GO:0008080~N-acetyltransferase activity,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,			Acyltransferase,complete proteome,developmental protein,gastrulation,membrane,polymorphism,transferase,transmembrane,		IPR000182:GCN5-related N-acetyltransferase,IPR016181:Acyl-CoA N-acyltransferase,	chain:Probable N-acetyltransferase 8,chain:Probable N-acetyltransferase 8B,domain:N-acetyltransferase,sequence conflict,sequence variant,transmembrane region,		GO:0001702~gastrulation with mouth forming second,GO:0007369~gastrulation,GO:0042493~response to drug,GO:0048598~embryonic morphogenesis,	PIRSF027824:PIRSF027824,
40058_s_at	PDZ and LIM domain 5	Homo sapiens		GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0030018~Z disc,GO:0031674~I band,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043292~contractile fiber,GO:0044449~contractile fiber part,		GO:0003779~actin binding,GO:0005080~protein kinase C binding,GO:0008092~cytoskeletal protein binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0042805~actinin binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0047485~protein N-terminus binding,	SM00132:LIM,SM00228:PDZ,		3d-structure,acetylation,complete proteome,direct protein sequencing,LIM domain,metal-binding,phosphoprotein,polymorphism,repeat,zinc,		IPR001478:PDZ/DHR/GLGF,IPR001781:Zinc finger, LIM-type,	chain:PDZ and LIM domain protein 5,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:PDZ,helix,modified residue,sequence variant,strand,turn,			
33922_at	PR domain containing 2, with ZNF domain	Homo sapiens		GO:0005794~Golgi apparatus,		GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008170~N-methyltransferase activity,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0030528~transcription regulator activity,GO:0042054~histone methyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,	SM00317:SET,SM00355:ZnF_C2H2,		3d-structure,activator,alternative initiation,alternative splicing,complete proteome,dna-binding,metal-binding,methyltransferase,nucleus,phosphoprotein,polymorphism,repeat,s-adenosyl-l-methionine,Transcription,transcription regulation,transferase,zinc,zinc finger,zinc-finger,		IPR001214:SET,IPR007087:Zinc finger, C2H2-type,IPR009170:Predicted retinoblastoma binding protein (RIZ),IPR015880:Zinc finger, C2H2-like,	chain:PR domain zinc finger protein 2,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:SET,helix,modified residue,mutagenesis site,region of interest:Retinoblastoma protein binding,sequence conflict,sequence variant,short sequence motif:SH3-binding,splice variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7; atypical,zinc finger region:C2H2-type 8; atypical,		GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,	PIRSF002395:retinoblastoma binding protein (RIZ),PIRSF002395:RIZ_SET,
35069_at	PRAME family member 2	Homo sapiens							complete proteome,leucine-rich repeat,polymorphism,repeat,			chain:PRAME family member 2,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,sequence variant,			PIRSF038286:preferentially expressed antigen of melanoma (PRAME) family protein,
33371_s_at	RAB31, member RAS oncogene family	Homo sapiens		GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,		GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,	SM00175:RAB,		3d-structure,cell membrane,complete proteome,GTP binding,gtp-binding,lipoprotein,membrane,nucleotide binding,nucleotide-binding,P-loop,phosphoprotein,prenylation,	hsa04144:Endocytosis,	IPR001806:Ras GTPase,IPR003579:Ras small GTPase, Rab type,IPR005225:Small GTP-binding protein,IPR013753:Ras,IPR015594:Rab22-related,	chain:Ras-related protein Rab-31,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence conflict,short sequence motif:Effector region,strand,turn,		GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0008104~protein localization,GO:0015031~protein transport,GO:0045184~establishment of protein localization,	
966_at967_g_at	RAD54-like (S. cerevisiae)	Homo sapiens				GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,	SM00487:DEXDc,SM00490:HELICc,		atp-binding,complete proteome,disease mutation,DNA damage,dna repair,dna-binding,helicase,hydrolase,nucleotide-binding,nucleus,polymorphism,Proto-oncogene,	hsa03440:Homologous recombination,	IPR000330:SNF2-related,IPR001650:DNA/RNA helicase, C-terminal,IPR014001:DEAD-like helicase, N-terminal,IPR014021:Helicase, superfamily 1 and 2, ATP-binding,	chain:DNA repair and recombination protein RAD54-like,domain:Helicase ATP-binding,domain:Helicase C-terminal,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEGH box,	Breast cancer, invasive intraductal,Colon adenocarcinoma,Lymphoma, non-Hodgkin,	GO:0000279~M phase,GO:0000724~double-strand break repair via homologous recombination,GO:0000725~recombinational repair,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007126~meiosis,GO:0009314~response to radiation,GO:0009628~response to abiotic stimulus,GO:0010212~response to ionizing radiation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0033554~cellular response to stress,GO:0042493~response to drug,GO:0051276~chromosome organization,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,	
33080_s_at	RAP1 GTPase activating protein	Homo sapiens		GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0019898~extrinsic to membrane,		GO:0003924~GTPase activity,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,	SM00390:GoLoco,		3d-structure,acetylation,alternative splicing,complete proteome,golgi apparatus,GTPase activation,membrane,phosphoprotein,polymorphism,		IPR000331:Rap/ran-GAP,IPR003109:GoLoco motif,	chain:Rap1 GTPase-activating protein 1,domain:GoLoco,domain:Rap-GAP,helix,modified residue,sequence variant,splice variant,strand,turn,	Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes,	GO:0051056~regulation of small GTPase mediated signal transduction,	PIRSF019623:Rap1 GTPase-activating protein,
606_at	Rho family GTPase 2	Homo sapiens		GO:0005768~endosome,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,		GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0047485~protein N-terminus binding,	SM00174:RHO,		complete proteome,cytoplasmic vesicle,gtp-binding,lipoprotein,membrane,methylation,nucleotide-binding,prenylation,		IPR001806:Ras GTPase,IPR003578:Ras small GTPase, Rho type,IPR005225:Small GTP-binding protein,IPR013753:Ras,	chain:Rho-related GTP-binding protein RhoN,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,		GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,	PIRSF037169:small GTPase, Rho type,
39908_at	TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa	Homo sapiens		GO:0000118~histone deacetylase complex,GO:0000123~histone acetyltransferase complex,GO:0005654~nucleoplasm,GO:0016585~chromatin remodeling complex,GO:0030914~STAGA complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0070461~SAGA-type complex,		GO:0003677~DNA binding,GO:0003702~RNA polymerase II transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity,GO:0008080~N-acetyltransferase activity,GO:0008134~transcription factor binding,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,	SM00803:TAF,	Transcription,	complete proteome,direct protein sequencing,nucleus,phosphoprotein,Transcription,transcription regulation,	hsa03022:Basal transcription factors,	IPR004823:TATA box binding protein associated factor (TAF),IPR009072:Histone-fold,IPR011442:Protein of unknown function DUF1546,	chain:TAF6-like RNA polymerase II p300/CBP- associated factor-associated factor 65 kDa subunit 6L,modified residue,		GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006473~protein amino acid acetylation,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016573~histone acetylation,GO:0032774~RNA biosynthetic process,GO:0043543~protein amino acid acylation,GO:0043933~macromolecular complex subunit organization,GO:0043966~histone H3 acetylation,GO:0045449~regulation of transcription,GO:0051090~regulation of transcription factor activity,GO:0051098~regulation of binding,GO:0051101~regulation of DNA binding,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,	
34702_f_at	TPTE pseudogene	Homo sapiens									IPR006058:2Fe-2S ferredoxin, iron-sulphur binding site,				
32680_at	TRAF2 and NCK interacting kinase	Homo sapiens				GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005083~small GTPase regulator activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030695~GTPase regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0060589~nucleoside-triphosphatase regulator activity,	SM00036:CNH,SM00220:S_TKc,		alternative splicing,atp-binding,complete proteome,cytoplasm,kinase,nucleotide-binding,nucleus,phosphoprotein,polymorphism,serine/threonine-protein kinase,transferase,wnt signaling pathway,		IPR000719:Protein kinase, core,IPR001180:Citron-like,IPR002290:Serine/threonine protein kinase,IPR008271:Serine/threonine protein kinase, active site,IPR017441:Protein kinase, ATP binding site,IPR017442:Serine/threonine protein kinase-related,	active site:Proton acceptor,binding site:ATP,chain:Traf2 and NCK-interacting protein kinase,domain:CNH,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,	A Genome-Wide Association Study of Schizophrenia Using Brain Activation as a Quantitative Phenotype,	GO:0000165~MAPKKK cascade,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0016310~phosphorylation,GO:0031098~stress-activated protein kinase signaling pathway,GO:0033554~cellular response to stress,	
35213_at	WW domain binding protein 4 (formin binding protein 21)	Homo sapiens		GO:0005654~nucleoplasm,GO:0005681~spliceosome,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,		GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,	SM00451:ZnF_U1,SM00456:WW,		3d-structure,complete proteome,metal-binding,mrna processing,mrna splicing,nucleus,polymorphism,repeat,Spliceosome,zinc,zinc-finger,		IPR000690:Zinc finger, C2H2-type matrin,IPR001202:WW/Rsp5/WWP,IPR003604:Zinc finger, U1-type,IPR013085:Zinc finger, U1-C type,	chain:WW domain-binding protein 4,compositionally biased region:Lys-rich,domain:WW 1,domain:WW 2,mutagenesis site,sequence variant,strand,zinc finger region:Matrin-type,		GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,	
40089_at	Williams Beuren syndrome chromosome region 22	Homo sapiens							alternative splicing,complete proteome,methyltransferase,nucleus,transferase,williams-beuren syndrome,	hsa00150:Androgen and estrogen metabolism,hsa00340:Histidine metabolism,hsa00350:Tyrosine metabolism,hsa00450:Selenoamino acid metabolism,	IPR013216:Methyltransferase type 11,	chain:Uncharacterized methyltransferase WBSCR22,splice variant,			PIRSF016329:PIRSF016329,
34606_s_at	activating transcription factor 7	Homo sapiens				GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046983~protein dimerization activity,	SM00338:BRLZ,SM00355:ZnF_C2H2,		activator,alternative splicing,complete proteome,DNA binding,dna-binding,leucine zipper,metal-binding,nucleus,phosphoprotein,Transcription,transcription regulation,zinc,zinc-finger,		IPR004827:Basic-leucine zipper (bZIP) transcription factor,IPR007087:Zinc finger, C2H2-type,IPR011616:bZIP transcription factor, bZIP-1,IPR015880:Zinc finger, C2H2-like,IPR016378:Transcription factor, cyclic AMP-dependent,IPR020003:ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain, active site,	chain:Cyclic AMP-dependent transcription factor ATF-7,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,splice variant,zinc finger region:C2H2-type,		GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,	PIRSF003153:ATF2_CRE-BP1,PIRSF003153:cyclic AMP-dependent transcription factor, CRE-BP1 type,
40317_at	amiloride-sensitive cation channel 1, neuronal	Homo sapiens		GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,		GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005272~sodium channel activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,			alternative splicing,cell membrane,complete proteome,disulfide bond,glycoprotein,ion transport,ionic channel,membrane,polymorphism,Sodium,sodium channel,Sodium transport,transmembrane,transport,	hsa04742:Taste transduction,	IPR001873:Na+ channel, amiloride-sensitive,IPR004724:Epithelial sodium channel,	chain:Amiloride-sensitive cation channel 1, neuronal,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007422~peripheral nervous system development,GO:0015672~monovalent inorganic cation transport,GO:0019226~transmission of nerve impulse,GO:0030001~metal ion transport,GO:0050877~neurological system process,	
37953_s_at	amiloride-sensitive cation channel 2, neuronal	Homo sapiens		GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,		GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005272~sodium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,			alternative splicing,calcium,calcium transport,cell membrane,complete proteome,disulfide bond,glycoprotein,ion transport,ionic channel,membrane,phosphoprotein,Sodium,sodium channel,Sodium transport,transmembrane,transport,		IPR001873:Na+ channel, amiloride-sensitive,IPR004724:Epithelial sodium channel,	chain:Amiloride-sensitive cation channel 2, neuronal,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006816~calcium ion transport,GO:0009268~response to pH,GO:0009628~response to abiotic stimulus,GO:0015672~monovalent inorganic cation transport,GO:0015674~di-, tri-valent inorganic cation transport,GO:0030001~metal ion transport,	
37983_at	angiotensin II receptor, type 1	Homo sapiens		GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,	h_ace2Pathway:Angiotensin-converting enzyme 2 regulates heart function,h_At1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,	GO:0001595~angiotensin receptor activity,GO:0001653~peptide receptor activity,GO:0004947~bradykinin receptor activity,GO:0004950~chemokine receptor activity,GO:0008047~enzyme activator activity,GO:0008528~peptide receptor activity, G-protein coupled,GO:0010698~acetyltransferase activator activity,GO:0016494~C-X-C chemokine receptor activity,GO:0019955~cytokine binding,GO:0019956~chemokine binding,GO:0019958~C-X-C chemokine binding,GO:0031711~bradykinin receptor binding,GO:0042277~peptide binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,			3d-structure,cell membrane,complete proteome,disease mutation,disulfide bond,G protein-coupled receptor,g-protein coupled receptor,glycoprotein,hormone receptor,lipoprotein,membrane,palmitate,phosphoprotein,polymorphism,receptor,transducer,transmembrane,transmembrane protein,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04270:Vascular smooth muscle contraction,hsa04614:Renin-angiotensin system,	IPR000190:AT1 angiotensin II receptor,IPR000248:Angiotensin II receptor,IPR000276:7TM GPCR, rhodopsin-like,IPR017452:GPCR, rhodopsin-like superfamily,	chain:Type-1 angiotensin II receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,	Hypertension, essential,Renal tubular dysgenesis,	GO:0001558~regulation of cell growth,GO:0001655~urogenital system development,GO:0001822~kidney development,GO:0001990~regulation of systemic arterial blood pressure by hormone,GO:0002016~regulation of blood volume by renin-angiotensin,GO:0002018~renin-angiotensin regulation of aldosterone production,GO:0002034~regulation of blood vessel size by renin-angiotensin,GO:0003013~circulatory system process,GO:0003014~renal system process,GO:0003018~vascular process in circulatory system,GO:0003044~regulation of systemic arterial blood pressure mediated by a chemical signal,GO:0003071~renal system process involved in regulation of systemic arterial blood pressure,GO:0003072~renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,GO:0003073~regulation of systemic arterial blood pressure,GO:0003078~regulation of natriuresis,GO:0003081~regulation of systemic arterial blood pressure by renin-angiotensin,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007200~activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger,GO:0007202~activation of phospholipase C activity,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0007242~intracellular signaling cascade,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010743~regulation of foam cell differentiation,GO:0010744~positive regulation of foam cell differentiation,GO:0010863~positive regulation of phospholipase C activity,GO:0010872~regulation of cholesterol esterification,GO:0010873~positive regulation of cholesterol esterification,GO:0019216~regulation of lipid metabolic process,GO:0019218~regulation of steroid metabolic process,GO:0019229~regulation of vasoconstriction,GO:0019722~calcium-mediated signaling,GO:0019725~cellular homeostasis,GO:0019932~second-messenger-mediated signaling,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0031349~positive regulation of defense response,GO:0032101~regulation of response to external stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032429~regulation of phospholipase A2 activity,GO:0032430~positive regulation of phospholipase A2 activity,GO:0032844~regulation of homeostatic process,GO:0033860~regulation of NAD(P)H oxidase activity,GO:0033864~positive regulation of NAD(P)H oxidase activity,GO:0034367~macromolecular complex remodeling,GO:0034368~protein-lipid complex remodeling,GO:0034369~plasma lipoprotein particle remodeling,GO:0034374~low-density lipoprotein particle remodeling,GO:0035150~regulation of tube size,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0042312~regulation of vasodilation,GO:0042592~homeostatic process,GO:0043085~positive regulation of catalytic activity,GO:0043933~macromolecular complex subunit organization,GO:0044057~regulation of system process,GO:0044062~regulation of excretion,GO:0044093~positive regulation of molecular function,GO:0045597~positive regulation of cell differentiation,GO:0045834~positive regulation of lipid metabolic process,GO:0045940~positive regulation of steroid metabolic process,GO:0048015~phosphoinositide-mediated signaling,GO:0048584~positive regulation of response to stimulus,GO:0048878~chemical homeostasis,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0050801~ion homeostasis,GO:0050880~regulation of blood vessel size,GO:0050886~endocrine process,GO:0051046~regulation of secretion,GO:0051094~positive regulation of developmental process,GO:0051247~positive regulation of protein metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051341~regulation of oxidoreductase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051353~positive regulation of oxidoreductase activity,GO:0051480~cytosolic calcium ion homeostasis,GO:0051482~elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating),GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,	PIRSF038557:angiotensin II receptor,PIRSF501034:angiotensin II receptor 1,PIRSF800006:rhodopsin-like G protein-coupled receptors,
37954_at	annexin A8-like 2	Homo sapiens				GO:0005509~calcium ion binding,GO:0005543~phospholipid binding,GO:0005544~calcium-dependent phospholipid binding,GO:0008289~lipid binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,	SM00335:ANX,		3d-structure,alternative splicing,annexin,blood coagulation,calcium,calcium binding,calcium/phospholipid-binding,complete proteome,duplication,endonexin fold,phospholipid binding,polymorphism,repeat,		IPR001464:Annexin,IPR009115:Annexin, type VIII,IPR018252:Annexin repeat, conserved site,IPR018502:Annexin repeat,	chain:Annexin A8,chain:Annexin A8-like protein 2,helix,repeat:Annexin 1,repeat:Annexin 2,repeat:Annexin 3,repeat:Annexin 4,sequence conflict,sequence variant,splice variant,strand,turn,		GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0009611~response to wounding,GO:0042060~wound healing,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,	PIRSF002359:annexin I,
34636_at	arachidonate 15-lipoxygenase	Homo sapiens		GO:0005829~cytosol,		GO:0005506~iron ion binding,GO:0016165~lipoxygenase activity,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0016801~hydrolase activity, acting on ether bonds,GO:0016803~ether hydrolase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0047977~hepoxilin-epoxide hydrolase activity,GO:0050473~arachidonate 15-lipoxygenase activity,	SM00308:LH2,		3d-structure,complete proteome,cytoplasm,dioxygenase,direct protein sequencing,fatty acid oxidation,iron,leukotriene biosynthesis,metal-binding,metalloprotein,oxidoreductase,polymorphism,	hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,	IPR000907:Lipoxygenase,IPR001024:Lipoxygenase, LH2,IPR001885:Lipoxygenase, mammalian,IPR013819:Lipoxygenase, C-terminal,	chain:Arachidonate 15-lipoxygenase,domain:Lipoxygenase,domain:PLAT,metal ion-binding site:Iron; catalytic,metal ion-binding site:Iron; via carboxylate; catalytic,mutagenesis site,sequence conflict,sequence variant,		GO:0000038~very-long-chain fatty acid metabolic process,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006636~unsaturated fatty acid biosynthetic process,GO:0006690~icosanoid metabolic process,GO:0006691~leukotriene metabolic process,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0008610~lipid biosynthetic process,GO:0009611~response to wounding,GO:0016053~organic acid biosynthetic process,GO:0019370~leukotriene biosynthetic process,GO:0030282~bone mineralization,GO:0031214~biomineral formation,GO:0033559~unsaturated fatty acid metabolic process,GO:0043449~cellular alkene metabolic process,GO:0043450~alkene biosynthetic process,GO:0046394~carboxylic acid biosynthetic process,GO:0046456~icosanoid biosynthetic process,GO:0055114~oxidation reduction,GO:0060348~bone development,	PIRSF000316:arachidonate 5-lipoxygenase,
35648_at	autism susceptibility candidate 2	Homo sapiens							alternative splicing,chromosomal rearrangement,complete proteome,phosphoprotein,polymorphism,			chain:Autism susceptibility gene 2 protein,compositionally biased region:His-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,			
33963_at	azurocidin 1	Homo sapiens		GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005764~lysosome,GO:0005766~primary lysosome,GO:0005773~vacuole,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042582~azurophil granule,		GO:0001871~pattern binding,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0015643~toxin binding,GO:0017171~serine hydrolase activity,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,	SM00020:Tryp_SPc,		3d-structure,antibiotic,Antimicrobial,chemotaxis,complete proteome,direct protein sequencing,disulfide bond,glycoprotein,heparin-binding,inflammation,polymorphism,Serine protease homolog,signal,		IPR001254:Peptidase S1 and S6, chymotrypsin/Hap,IPR001314:Peptidase S1A, chymotrypsin,IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site,	chain:Azurocidin,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); partial,helix,mutagenesis site,region of interest:Hydrophobic,region of interest:Possesses antibiotic activity,sequence conflict,sequence variant,signal peptide,strand,turn,		GO:0001774~microglial cell activation,GO:0001775~cell activation,GO:0001817~regulation of cytokine production,GO:0002274~myeloid leukocyte activation,GO:0003013~circulatory system process,GO:0003018~vascular process in circulatory system,GO:0006508~proteolysis,GO:0006916~anti-apoptosis,GO:0006928~cell motion,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007205~activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0008015~blood circulation,GO:0008347~glial cell migration,GO:0009611~response to wounding,GO:0009617~response to bacterium,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010941~regulation of cell death,GO:0016477~cell migration,GO:0019220~regulation of phosphate metabolic process,GO:0030100~regulation of endocytosis,GO:0030155~regulation of cell adhesion,GO:0030595~leukocyte chemotaxis,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032101~regulation of response to external stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032147~activation of protein kinase activity,GO:0032642~regulation of chemokine production,GO:0032644~regulation of fractalkine production,GO:0032651~regulation of interleukin-1 beta production,GO:0032652~regulation of interleukin-1 production,GO:0032680~regulation of tumor necrosis factor production,GO:0033674~positive regulation of kinase activity,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042035~regulation of cytokine biosynthetic process,GO:0042063~gliogenesis,GO:0042108~positive regulation of cytokine biosynthetic process,GO:0042116~macrophage activation,GO:0042117~monocyte activation,GO:0042325~regulation of phosphorylation,GO:0042330~taxis,GO:0042534~regulation of tumor necrosis factor biosynthetic process,GO:0042535~positive regulation of tumor necrosis factor biosynthetic process,GO:0042742~defense response to bacterium,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043114~regulation of vascular permeability,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045073~regulation of chemokine biosynthetic process,GO:0045080~positive regulation of chemokine biosynthetic process,GO:0045123~cellular extravasation,GO:0045321~leukocyte activation,GO:0045346~regulation of MHC class II biosynthetic process,GO:0045348~positive regulation of MHC class II biosynthetic process,GO:0045360~regulation of interleukin-1 biosynthetic process,GO:0045362~positive regulation of interleukin-1 biosynthetic process,GO:0045785~positive regulation of cell adhesion,GO:0045807~positive regulation of endocytosis,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0048246~macrophage chemotaxis,GO:0048520~positive regulation of behavior,GO:0048584~positive regulation of response to stimulus,GO:0048870~cell motility,GO:0050722~regulation of interleukin-1 beta biosynthetic process,GO:0050725~positive regulation of interleukin-1 beta biosynthetic process,GO:0050752~regulation of fractalkine biosynthetic process,GO:0050754~positive regulation of fractalkine biosynthetic process,GO:0050764~regulation of phagocytosis,GO:0050766~positive regulation of phagocytosis,GO:0050795~regulation of behavior,GO:0050829~defense response to Gram-negative bacterium,GO:0050900~leukocyte migration,GO:0050920~regulation of chemotaxis,GO:0050921~positive regulation of chemotaxis,GO:0050926~regulation of positive chemotaxis,GO:0050927~positive regulation of positive chemotaxis,GO:0050930~induction of positive chemotaxis,GO:0051050~positive regulation of transport,GO:0051130~positive regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051674~localization of cell,GO:0060326~cell chemotaxis,GO:0060548~negative regulation of cell death,GO:0060627~regulation of vesicle-mediated transport,	PIRSF001135:trypsin,
40790_at	basic helix-loop-helix family, member e40	Homo sapiens				GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,	SM00353:HLH,SM00511:ORANGE,		complete proteome,dna-binding,nucleus,phosphoprotein,Transcription,transcription regulation,ubl conjugation,	hsa04710:Circadian rhythm,	IPR001092:Basic helix-loop-helix dimerisation region bHLH,IPR003650:Orange,IPR011598:Helix-loop-helix DNA-binding,IPR018352:Orange subgroup,	chain:Class E basic helix-loop-helix protein 40,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Orange,modified residue,		GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0009649~entrainment of circadian clock,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031644~regulation of neurological system process,GO:0042752~regulation of circadian rhythm,GO:0044057~regulation of system process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048167~regulation of synaptic plasticity,GO:0048168~regulation of neuronal synaptic plasticity,GO:0050804~regulation of synaptic transmission,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051969~regulation of transmission of nerve impulse,	PIRSF027808:PIRSF027808,
38201_at	branched chain aminotransferase 1, cytosolic	Homo sapiens		GO:0005829~cytosol,		GO:0004084~branched-chain-amino-acid transaminase activity,GO:0008483~transaminase activity,GO:0016769~transferase activity, transferring nitrogenous groups,GO:0042802~identical protein binding,			3d-structure,acetylation,amino-acid biosynthesis,Aminotransferase,branched-chain amino acid biosynthesis,complete proteome,cytoplasm,polymorphism,pyridoxal phosphate,transferase,	hsa00280:Valine, leucine and isoleucine degradation,hsa00290:Valine, leucine and isoleucine biosynthesis,hsa00770:Pantothenate and CoA biosynthesis,	IPR001544:Aminotransferase, class IV,IPR005786:Branched-chain amino acid aminotransferase II,IPR018300:Aminotransferase, class IV, conserved site,	chain:Branched-chain-amino-acid aminotransferase, cytosolic,helix,modified residue,sequence conflict,sequence variant,strand,turn,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0008652~cellular amino acid biosynthetic process,GO:0009063~cellular amino acid catabolic process,GO:0009081~branched chain family amino acid metabolic process,GO:0009082~branched chain family amino acid biosynthetic process,GO:0009083~branched chain family amino acid catabolic process,GO:0009309~amine biosynthetic process,GO:0009310~amine catabolic process,GO:0016053~organic acid biosynthetic process,GO:0016054~organic acid catabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0044271~nitrogen compound biosynthetic process,GO:0046394~carboxylic acid biosynthetic process,GO:0046395~carboxylic acid catabolic process,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,	PIRSF006468:BCAT1,PIRSF006468:branched-chain amino acid aminotransferase, BCAT1 type,
39094_at	bromodomain containing 4	Homo sapiens		GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,		GO:0003677~DNA binding,	SM00297:BROMO,		3d-structure,acetylation,alternative splicing,bromodomain,chromosomal rearrangement,complete proteome,nucleus,phosphoprotein,polymorphism,repeat,		IPR001487:Bromodomain,IPR018359:Bromodomain, conserved site,	chain:Bromodomain-containing protein 4,compositionally biased region:Lys-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gln,compositionally biased region:Poly-His,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,domain:Bromo 1,domain:Bromo 2,helix,modified residue,sequence variant,site:Breakpoint for translocation to form BDR4-NUT fusion protein,splice variant,turn,		GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0043388~positive regulation of DNA binding,GO:0044093~positive regulation of molecular function,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051101~regulation of DNA binding,	
1786_at	c-mer proto-oncogene tyrosine kinase	Homo sapiens		GO:0000267~cell fraction,GO:0001750~photoreceptor outer segment,GO:0005625~soluble fraction,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005929~cilium,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031513~nonmotile primary cilium,GO:0042995~cell projection,GO:0044459~plasma membrane part,		GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,	SM00060:FN3,SM00219:TyrKc,SM00409:IG,		3d-structure,atp-binding,complete proteome,disease mutation,disulfide bond,glycoprotein,Immunoglobulin domain,kinase,membrane,nucleotide-binding,phosphoprotein,polymorphism,Proto-oncogene,receptor,repeat,retinitis pigmentosa,sensory transduction,signal,transferase,transmembrane,tyrosine-protein kinase,vision,		IPR000719:Protein kinase, core,IPR001245:Tyrosine protein kinase,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like,IPR008266:Tyrosine protein kinase, active site,IPR008957:Fibronectin, type III-like fold,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase Mer,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,	Retinitis pigmentosa, MERTK-related,Retinitis pigmentosa-38,	GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006897~endocytosis,GO:0006909~phagocytosis,GO:0007166~cell surface receptor linked signal transduction,GO:0007267~cell-cell signaling,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0010324~membrane invagination,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,	PIRSF000629:tyrosine-protein kinase receptor TYRO3/UFO/MER type,PIRSF500787:proto-oncogene tyrosine-protein kinase MER,
37172_at	carboxypeptidase B2 (plasma)	Homo sapiens		GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,		GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0008233~peptidase activity,GO:0008235~metalloexopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008238~exopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,	SM00631:Zn_pept,		3d-structure,alternative splicing,carboxypeptidase,complete proteome,direct protein sequencing,disulfide bond,glycoprotein,hydrolase,metal-binding,metallo-carboxypeptidase,metalloprotease,polymorphism,Protease,Secreted,signal,zinc,zymogen,	hsa04610:Complement and coagulation cascades,	IPR000834:Peptidase M14, carboxypeptidase A,IPR003146:Proteinase inhibitor, carboxypeptidase propeptide,	active site:Nucleophile,chain:Carboxypeptidase B2,disulfide bond,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); partial,helix,metal ion-binding site:Zinc,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,		GO:0006508~proteolysis,GO:0030193~regulation of blood coagulation,GO:0030195~negative regulation of blood coagulation,GO:0032101~regulation of response to external stimulus,GO:0042730~fibrinolysis,GO:0050818~regulation of coagulation,GO:0050819~negative regulation of coagulation,GO:0051241~negative regulation of multicellular organismal process,	PIRSF001128:carboxypeptidase,
32469_at	carcinoembryonic antigen-related cell adhesion molecule 3	Homo sapiens		GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,			SM00409:IG,		alternative splicing,complete proteome,glycoprotein,Immunoglobulin domain,membrane,phosphoprotein,polymorphism,signal,transmembrane,transmembrane protein,		IPR003599:Immunoglobulin subtype,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	chain:Carcinoembryonic antigen-related cell adhesion molecule 3,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,			
33530_at	carcinoembryonic antigen-related cell adhesion molecule 8	Homo sapiens		GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,			SM00409:IG,		3d-structure,cell membrane,complete proteome,disulfide bond,glycoprotein,gpi-anchor,Immunoglobulin domain,lipoprotein,membrane,phosphatidylinositol linkage,polymorphism,repeat,signal,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	chain:Carcinoembryonic antigen-related cell adhesion molecule 8,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated aspartate,propeptide:Removed in mature form,sequence variant,signal peptide,strand,turn,		GO:0006955~immune response,	
37105_at679_at	cathepsin G	Homo sapiens		GO:0005886~plasma membrane,GO:0009986~cell surface,		GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,	SM00020:Tryp_SPc,		3d-structure,antibiotic,Antimicrobial,complete proteome,direct protein sequencing,disulfide bond,glycoprotein,hydrolase,lysosome,polymorphism,Protease,Serine protease,serine proteinase,signal,zymogen,	hsa04080:Neuroactive ligand-receptor interaction,hsa04142:Lysosome,hsa04614:Renin-angiotensin system,hsa05322:Systemic lupus erythematosus,	IPR001254:Peptidase S1 and S6, chymotrypsin/Hap,IPR001314:Peptidase S1A, chymotrypsin,IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site,	active site:Charge relay system,chain:Cathepsin G,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence variant,signal peptide,strand,turn,		GO:0006508~proteolysis,GO:0006952~defense response,GO:0006955~immune response,GO:0009617~response to bacterium,GO:0042742~defense response to bacterium,	PIRSF001135:trypsin,
36421_at	cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)	Homo sapiens		GO:0005654~nucleoplasm,GO:0008023~transcription elongation factor complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0016593~Cdc73/Paf1 complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,					acetylation,cell cycle,complete proteome,direct protein sequencing,disease mutation,nucleus,phosphoprotein,Transcription,tumor suppressor,		IPR007852:RNA polymerase II accessory factor, Cdc73,	chain:Parafibromin,compositionally biased region:Poly-Ile,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,	Hyperparathyroidism, familial primary,Hyperparathyroidism-jaw tumor syndrome,Parathyroid adenoma with cystic changes,Parathyroid carcinoma,	GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006513~protein monoubiquitination,GO:0007049~cell cycle,GO:0010390~histone monoubiquitination,GO:0016567~protein ubiquitination,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016574~histone ubiquitination,GO:0032446~protein modification by small protein conjugation,GO:0033523~histone H2B ubiquitination,GO:0051276~chromosome organization,GO:0070647~protein modification by small protein conjugation or removal,	PIRSF037563:PIRSF037563,
37454_at	chemokine (C-C motif) ligand 13	Homo sapiens	109.Chemokine_families,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,		GO:0005125~cytokine activity,GO:0008009~chemokine activity,GO:0042379~chemokine receptor binding,	SM00199:SCY,		3d-structure,chemotaxis,complete proteome,cytokine,direct protein sequencing,disulfide bond,inflammatory response,polymorphism,Pyrrolidone carboxylic acid,Secreted,signal,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04621:NOD-like receptor signaling pathway,	IPR000827:Small chemokine, C-C group, conserved site,IPR001811:Small chemokine, interleukin-8-like,	chain:C-C motif chemokine 13, long chain,chain:C-C motif chemokine 13, medium chain,chain:C-C motif chemokine 13, short chain,disulfide bond,helix,modified residue,sequence conflict,sequence variant,signal peptide,strand,		GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007267~cell-cell signaling,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0009611~response to wounding,GO:0019725~cellular homeostasis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0042330~taxis,GO:0042592~homeostatic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,	PIRSF001950:small inducible chemokine, C/CC types,PIRSF500572:small inducible cytokine, A2 type,
36703_at	chemokine (C-C motif) ligand 25	Homo sapiens		GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005625~soluble fraction,GO:0044421~extracellular region part,		GO:0005125~cytokine activity,GO:0005179~hormone activity,GO:0008009~chemokine activity,GO:0042379~chemokine receptor binding,	SM00199:SCY,		alternative splicing,chemotaxis,complete proteome,cytokine,disulfide bond,inflammatory response,polymorphism,Secreted,signal,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04672:Intestinal immune network for IgA production,	IPR000827:Small chemokine, C-C group, conserved site,IPR001811:Small chemokine, interleukin-8-like,	chain:C-C motif chemokine 25,disulfide bond,sequence variant,signal peptide,splice variant,		GO:0006928~cell motion,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0009611~response to wounding,GO:0016477~cell migration,GO:0042330~taxis,GO:0048870~cell motility,GO:0050900~leukocyte migration,GO:0051674~localization of cell,	PIRSF001950:small inducible chemokine, C/CC types,
1403_s_at	chemokine (C-C motif) ligand 5	Homo sapiens	109.Chemokine_families,18.Cytokine_astocytes,22.Cytokine-chemokine_CNS,33.GProt-coupled_Rec_T_Cell_med_Inflamm,34.Chemokines_in_EAE,	GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005625~soluble fraction,GO:0044421~extracellular region part,	h_eosinophilsPathway:The Role of Eosinophils in the Chemokine Network of Allergy,	GO:0005125~cytokine activity,GO:0008009~chemokine activity,GO:0042056~chemoattractant activity,GO:0042379~chemokine receptor binding,	SM00199:SCY,		3d-structure,chemotaxis,complete proteome,cytokine,direct protein sequencing,disulfide bond,glycoprotein,immediate-early protein,inflammation,inflammatory response,polymorphism,Secreted,signal,T-cell,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa05020:Prion diseases,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,	IPR000827:Small chemokine, C-C group, conserved site,IPR001811:Small chemokine, interleukin-8-like,	chain:C-C motif chemokine 5,chain:RANTES(3-68),chain:RANTES(4-68),disulfide bond,glycosylation site:O-linked (GalNAc...); partial,helix,sequence conflict,sequence variant,signal peptide,site:Cleavage; by DPP4,site:Susceptible to oxidation,strand,	HIV-1 disease, delayed progression of,HIV-1 disease, rapid progression of,	GO:0002237~response to molecule of bacterial origin,GO:0002544~chronic inflammatory response,GO:0002673~regulation of acute inflammatory response,GO:0002675~positive regulation of acute inflammatory response,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006887~exocytosis,GO:0006928~cell motion,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006968~cellular defense response,GO:0006979~response to oxidative stress,GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007267~cell-cell signaling,GO:0007568~aging,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0009611~response to wounding,GO:0009615~response to virus,GO:0009617~response to bacterium,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0016192~vesicle-mediated transport,GO:0016477~cell migration,GO:0019725~cellular homeostasis,GO:0022610~biological adhesion,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030595~leukocyte chemotaxis,GO:0031349~positive regulation of defense response,GO:0031620~regulation of fever,GO:0031622~positive regulation of fever,GO:0031650~regulation of heat generation,GO:0031652~positive regulation of heat generation,GO:0031960~response to corticosteroid stimulus,GO:0032101~regulation of response to external stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032496~response to lipopolysaccharide,GO:0032844~regulation of homeostatic process,GO:0032846~positive regulation of homeostatic process,GO:0032868~response to insulin stimulus,GO:0032940~secretion by cell,GO:0034097~response to cytokine stimulus,GO:0034612~response to tumor necrosis factor,GO:0042330~taxis,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0043434~response to peptide hormone stimulus,GO:0045069~regulation of viral genome replication,GO:0045071~negative regulation of viral genome replication,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045672~positive regulation of osteoclast differentiation,GO:0046903~secretion,GO:0048247~lymphocyte chemotaxis,GO:0048525~negative regulation of viral reproduction,GO:0048545~response to steroid hormone stimulus,GO:0048584~positive regulation of response to stimulus,GO:0048870~cell motility,GO:0048878~chemical homeostasis,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0050792~regulation of viral reproduction,GO:0050801~ion homeostasis,GO:0050900~leukocyte migration,GO:0051094~positive regulation of developmental process,GO:0051240~positive regulation of multicellular organismal process,GO:0051384~response to glucocorticoid stimulus,GO:0051674~localization of cell,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060326~cell chemotaxis,	PIRSF001950:small inducible chemokine, C/CC types,PIRSF500570:small inducible cytokine A5,
37061_at	chitinase 1 (chitotriosidase)	Homo sapiens		GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005773~vacuole,GO:0044421~extracellular region part,		GO:0001871~pattern binding,GO:0004568~chitinase activity,GO:0008061~chitin binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0043167~ion binding,GO:0043169~cation binding,	SM00494:ChtBD2,SM00636:Glyco_18,		3d-structure,alternative splicing,carbohydrate metabolism,Chitin degradation,Chitin-binding,complete proteome,direct protein sequencing,disulfide bond,glycosidase,hydrolase,lysosome,polymorphism,polysaccharide degradation,Secreted,signal,	hsa00520:Amino sugar and nucleotide sugar metabolism,	IPR001223:Glycoside hydrolase, family 18, catalytic domain,IPR001579:Glycoside hydrolase, chitinase active site,IPR002557:Chitin binding protein, peritrophin-A,IPR011583:Chitinase II,IPR013781:Glycoside hydrolase, subgroup, catalytic core,	active site:Proton donor,chain:Chitotriosidase-1,disulfide bond,domain:Chitin-binding type-2,helix,sequence variant,signal peptide,splice variant,strand,turn,	Chitotriosidase deficiency,	GO:0000272~polysaccharide catabolic process,GO:0005976~polysaccharide metabolic process,GO:0006022~aminoglycan metabolic process,GO:0006026~aminoglycan catabolic process,GO:0006030~chitin metabolic process,GO:0006032~chitin catabolic process,GO:0006955~immune response,GO:0009057~macromolecule catabolic process,GO:0009617~response to bacterium,GO:0016052~carbohydrate catabolic process,	PIRSF001061:chitinase-like protein,
32010_at	chromosome 22 open reading frame 33	Homo sapiens							alternative splicing,complete proteome,			chain:Protein EAN57,splice variant,			
38482_at	claudin 7	Homo sapiens		GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~tight junction,GO:0016021~integral to membrane,GO:0016327~apicolateral plasma membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0043296~apical junction complex,GO:0044459~plasma membrane part,GO:0070160~occluding junction,		GO:0005198~structural molecule activity,GO:0042802~identical protein binding,			alternative splicing,cell junction,cell membrane,complete proteome,membrane,polymorphism,Tight junction,transmembrane,	hsa04514:Cell adhesion molecules (CAMs),hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,	IPR003552:Claudin-7,IPR004031:PMP-22/EMP/MP20/Claudin,IPR006187:Claudin,IPR017974:Claudin, conserved site,	chain:Claudin-7,region of interest:Interactions with TJP1, TJP2 and TJP3,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0007155~cell adhesion,GO:0016337~cell-cell adhesion,GO:0016338~calcium-independent cell-cell adhesion,GO:0022610~biological adhesion,	
35169_at	collagen, type XVI, alpha 1	Homo sapiens		GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005593~FACIT collagen,GO:0005597~collagen type XVI,GO:0030934~anchoring collagen,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,		GO:0005178~integrin binding,GO:0005198~structural molecule activity,GO:0032403~protein complex binding,	SM00210:TSPN,		alternative splicing,cell adhesion,cell binding,coiled coil,collagen,complete proteome,direct protein sequencing,extracellular matrix,glycoprotein,hydroxylation,hydroxylysine,hydroxyproline,polymorphism,repeat,Secreted,signal,trimer,triple helix,		IPR003129:Laminin G, thrombospondin-type, N-terminal,IPR008160:Collagen triple helix repeat,	chain:Collagen alpha-1(XVI) chain,domain:TSP N-terminal,glycosylation site:N-linked (GlcNAc...),region of interest:Nonhelical region 1 (NC1),region of interest:Nonhelical region 10 (NC10),region of interest:Nonhelical region 2 (NC2),region of interest:Nonhelical region 3 (NC3),region of interest:Nonhelical region 4 (NC4),region of interest:Nonhelical region 5 (NC5),region of interest:Nonhelical region 6 (NC6),region of interest:Nonhelical region 7 (NC7),region of interest:Nonhelical region 8 (NC8),region of interest:Nonhelical region 9 (NC9),region of interest:Triple-helical region 1 (COL1) with 2 imperfections,region of interest:Triple-helical region 2 (COL2) with 2 imperfections,region of interest:Triple-helical region 3 (COL3),region of interest:Triple-helical region 4 (COL4) with 2 imperfections,region of interest:Triple-helical region 5 (COL5) with 3 imperfections,region of interest:Triple-helical region 6 (COL6) with 1 imperfection,region of interest:Triple-helical region 7 (COL7) with 1 imperfection,region of interest:Triple-helical region 8 (COL8) with 1 imperfection,region of interest:Triple-helical region 9 (COL9) with 3 imperfections,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,		GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0007565~female pregnancy,GO:0022610~biological adhesion,	PIRSF002258:collagen alpha 1(IV) chain,
32250_at	complement factor H	Homo sapiens		GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,			SM00032:CCP,		3d-structure,age-related macular degeneration,alternative splicing,complement alternate pathway,complete proteome,direct protein sequencing,disease mutation,disulfide bond,glycoprotein,immune response,innate immunity,polymorphism,repeat,Secreted,signal,sushi,	hsa04610:Complement and coagulation cascades,	IPR000436:Sushi/SCR/CCP,IPR016060:Complement control module,	chain:Complement factor H,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 11,domain:Sushi 12,domain:Sushi 13,domain:Sushi 14,domain:Sushi 15,domain:Sushi 16,domain:Sushi 17,domain:Sushi 18,domain:Sushi 19,domain:Sushi 2,domain:Sushi 20,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,site:Not glycosylated,splice variant,strand,turn,	Basal laminar drusen,Complement factor H deficiency,Complement factor H polymorphism in age-related macular degeneration,Factor H and factor H-like 1,Hemolytic-uremic syndrome,Macular degeneration, age-related, 4,Membranoproliferative glomerulonephritis with CFH deficiency,Myocardial infarction, susceptibility to,	GO:0002252~immune effector process,GO:0002253~activation of immune response,GO:0002526~acute inflammatory response,GO:0002541~activation of plasma proteins involved in acute inflammatory response,GO:0002684~positive regulation of immune system process,GO:0006508~proteolysis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0006959~humoral immune response,GO:0009611~response to wounding,GO:0016485~protein processing,GO:0045087~innate immune response,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,GO:0051604~protein maturation,GO:0051605~protein maturation by peptide bond cleavage,	PIRSF002482:complement factor H,
36317_at	coronin, actin binding protein, 2A	Homo sapiens		GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,		GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,	SM00320:WD40,		actin-binding,coiled coil,complete proteome,polymorphism,repeat,wd repeat,		IPR001680:WD40 repeat,IPR008147:Glutamine synthetase, beta-Grasp,IPR015048:Region of unknown function DUF1899,IPR015049:Region of unknown function DUF1900,IPR015505:Coronin,IPR015943:WD40/YVTN repeat-like,IPR017986:WD40 repeat, region,IPR019775:WD40 repeat, conserved site,IPR019781:WD40 repeat, subgroup,IPR019782:WD40 repeat 2,	chain:Coronin-2A,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,sequence conflict,sequence variant,		GO:0007242~intracellular signaling cascade,	
1983_at	cyclin D2	Homo sapiens		GO:0000307~cyclin-dependent protein kinase holoenzyme complex,	h_cellcyclePathway:Cyclins and Cell Cycle Regulation,	GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,	SM00385:CYCLIN,		cell cycle,cell cycle control,cell division,complete proteome,cyclin,polymorphism,	hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04310:Wnt signaling pathway,hsa04510:Focal adhesion,hsa04630:Jak-STAT signaling pathway,	IPR004367:Cyclin, C-terminal,IPR006670:Cyclin,IPR006671:Cyclin, N-terminal,IPR013763:Cyclin-related,IPR014400:Cyclin, A/B/D/E,IPR015451:Cyclin D,	chain:G1/S-specific cyclin-D2,sequence conflict,sequence variant,		GO:0000079~regulation of cyclin-dependent protein kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0001541~ovarian follicle development,GO:0001889~liver development,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0003006~reproductive developmental process,GO:0007049~cell cycle,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0007548~sex differentiation,GO:0008284~positive regulation of cell proliferation,GO:0008406~gonad development,GO:0008585~female gonad development,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0014070~response to organic cyclic substance,GO:0019220~regulation of phosphate metabolic process,GO:0019953~sexual reproduction,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0022602~ovulation cycle process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032355~response to estradiol stimulus,GO:0032504~multicellular organism reproduction,GO:0032868~response to insulin stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0033574~response to testosterone stimulus,GO:0033674~positive regulation of kinase activity,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042698~ovulation cycle,GO:0043085~positive regulation of catalytic activity,GO:0043434~response to peptide hormone stimulus,GO:0043549~regulation of kinase activity,GO:0043627~response to estrogen stimulus,GO:0044093~positive regulation of molecular function,GO:0045137~development of primary sexual characteristics,GO:0045471~response to ethanol,GO:0045664~regulation of neuron differentiation,GO:0045737~positive regulation of cyclin-dependent protein kinase activity,GO:0045787~positive regulation of cell cycle,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045937~positive regulation of phosphate metabolic process,GO:0046545~development of primary female sexual characteristics,GO:0046660~female sex differentiation,GO:0048232~male gamete generation,GO:0048511~rhythmic process,GO:0048545~response to steroid hormone stimulus,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050767~regulation of neurogenesis,GO:0051174~regulation of phosphorus metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051301~cell division,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051591~response to cAMP,GO:0051726~regulation of cell cycle,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,	PIRSF001771:cyclin, A/B/D/E types,PIRSF001771:Cyclin_A_B_D_E,
34453_at	cytochrome P450, family 2, subfamily B, polypeptide 7 pseudogene 1	Homo sapiens				GO:0005506~iron ion binding,GO:0009055~electron carrier activity,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0020037~heme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,			heme,iron,metal-binding,Monooxygenase,oxidoreductase,		IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR008068:Cytochrome P450, E-class, group I, CYP2B-like,IPR017973:Cytochrome P450, C-terminal region,			GO:0055114~oxidation reduction,	
38229_at	cytochrome P450, family 3, subfamily A, polypeptide 5	Homo sapiens		GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005792~microsome,GO:0012505~endomembrane system,GO:0019898~extrinsic to membrane,GO:0031090~organelle membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0042598~vesicular fraction,GO:0044432~endoplasmic reticulum part,		GO:0005506~iron ion binding,GO:0009055~electron carrier activity,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,GO:0070330~aromatase activity,		Secondary metabolites biosynthesis, transport, and catabolism,	chromoprotein,complete proteome,electron transfer,endoplasmic reticulum,heme,iron,membrane,metal-binding,metalloprotein,microsome,Monooxygenase,oxidoreductase,polymorphism,transmembrane protein,	hsa00140:Steroid hormone biosynthesis,hsa00591:Linoleic acid metabolism,hsa00830:Retinol metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism,hsa00983:Drug metabolism,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR002402:Cytochrome P450, E-class, group II,IPR002403:Cytochrome P450, E-class, group IV,IPR008072:Cytochrome P450, E-class, CYP3A,IPR017972:Cytochrome P450, conserved site,IPR017973:Cytochrome P450, C-terminal region,	chain:Cytochrome P450 3A5,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,	Hypertension, salt-sensitive essential, susceptibility to,	GO:0008202~steroid metabolic process,GO:0055114~oxidation reduction,	PIRSF000051:cytochrome P450 CYP3A5,
1391_s_at	cytochrome P450, family 4, subfamily A, polypeptide 11	Homo sapiens		GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005792~microsome,GO:0012505~endomembrane system,GO:0019898~extrinsic to membrane,GO:0031090~organelle membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0042598~vesicular fraction,GO:0044432~endoplasmic reticulum part,	h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	GO:0005506~iron ion binding,GO:0009055~electron carrier activity,GO:0016713~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,GO:0018685~alkane 1-monooxygenase activity,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,		Secondary metabolites biosynthesis, transport, and catabolism,	alternative splicing,chromoprotein,complete proteome,direct protein sequencing,electron transfer,endoplasmic reticulum,fatty acid oxidation,heme,iron,membrane,metal-binding,metalloprotein,microsome,Monooxygenase,oxidoreductase,polymorphism,transmembrane protein,	hsa00071:Fatty acid metabolism,hsa00590:Arachidonic acid metabolism,hsa00830:Retinol metabolism,hsa03320:PPAR signaling pathway,hsa04270:Vascular smooth muscle contraction,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR017972:Cytochrome P450, conserved site,IPR017973:Cytochrome P450, C-terminal region,	binding site:Heme (covalent; via 1 link),chain:Cytochrome P450 4A11,compositionally biased region:Poly-Leu,metal ion-binding site:Iron (heme axial ligand),mutagenesis site,sequence conflict,sequence variant,splice variant,		GO:0006631~fatty acid metabolic process,GO:0055114~oxidation reduction,	PIRSF000050:cytochrome P450 CYP4B1,
31793_at31506_s_at	defensin, alpha 1	Homo sapiens		GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,			SM00048:DEFSN,		3d-structure,antibiotic,Antimicrobial,Antiviral defense,complete proteome,defensin,direct protein sequencing,disulfide bond,fungicide,homodimer,phosphoprotein,Secreted,signal,		IPR002366:Defensin propeptide,IPR006080:Mammalian defensin,IPR006081:Alpha defensin,IPR016327:Alpha-defensin,	chain:HP 1-56,disulfide bond,modified residue,peptide:Neutrophil defensin 1,peptide:Neutrophil defensin 2,signal peptide,strand,		GO:0001906~cell killing,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006955~immune response,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0009615~response to virus,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0031640~killing of cells of another organism,GO:0042330~taxis,GO:0042742~defense response to bacterium,GO:0050832~defense response to fungus,	PIRSF001875:alpha-defensin,
34546_at	defensin, alpha 4, corticostatin	Homo sapiens		GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,			SM00048:DEFSN,		3d-structure,antibiotic,Antimicrobial,complete proteome,defensin,direct protein sequencing,disulfide bond,fungicide,homodimer,polymorphism,Secreted,signal,		IPR002366:Defensin propeptide,IPR006080:Mammalian defensin,IPR006081:Alpha defensin,IPR016327:Alpha-defensin,	disulfide bond,peptide:Neutrophil defensin 4,sequence variant,signal peptide,strand,		GO:0001906~cell killing,GO:0006952~defense response,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0031640~killing of cells of another organism,GO:0042742~defense response to bacterium,GO:0050832~defense response to fungus,	PIRSF001875:alpha-defensin,
34623_at	defensin, alpha 5, Paneth cell-specific	Homo sapiens		GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,			SM00048:DEFSN,		3d-structure,antibiotic,Antimicrobial,complete proteome,defensin,disulfide bond,fungicide,homodimer,polymorphism,Secreted,signal,		IPR002366:Defensin propeptide,IPR006080:Mammalian defensin,IPR006081:Alpha defensin,IPR016327:Alpha-defensin,	disulfide bond,peptide:Defensin-5,sequence variant,signal peptide,strand,		GO:0001906~cell killing,GO:0006952~defense response,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0031640~killing of cells of another organism,GO:0042742~defense response to bacterium,GO:0050832~defense response to fungus,	PIRSF001875:alpha-defensin,
40186_at	dual specificity phosphatase 9	Homo sapiens		GO:0005783~endoplasmic reticulum,	h_dspPathway:Regulation of MAP Kinase Pathways Through Dual Specificity Phosphatases,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0033549~MAP kinase phosphatase activity,	SM00195:DSPc,SM00450:RHOD,		3d-structure,complete proteome,cytoplasm,hydrolase,protein phosphatase,	hsa04010:MAPK signaling pathway,	IPR000340:Dual specificity phosphatase, catalytic domain,IPR000340:Protein-tyrosine phosphatase, dual specificity,IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region,IPR000387:Protein-tyrosine phosphatase,IPR001763:Rhodanese-like,IPR008343:MAP kinase phosphatase,IPR014393:Dual specificity protein phosphatase (MAP kinase phosphatase),IPR016130:Protein-tyrosine phosphatase, active site,	active site:Phosphocysteine intermediate,chain:Dual specificity protein phosphatase 9,domain:Rhodanese,domain:Tyrosine-protein phosphatase,helix,strand,turn,		GO:0000165~MAPKKK cascade,GO:0000188~inactivation of MAPK activity,GO:0006469~negative regulation of protein kinase activity,GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0016311~dephosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0031098~stress-activated protein kinase signaling pathway,GO:0033554~cellular response to stress,GO:0033673~negative regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043086~negative regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,	PIRSF000939:dual specificity protein phosphatase (MAP kinase phosphatase),PIRSF000939:MAPK_Ptase,
34972_s_at	dynein, axonemal, heavy chain 17	Homo sapiens		GO:0005856~cytoskeleton,GO:0005858~axonemal dynein complex,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0005929~cilium,GO:0005930~axoneme,GO:0015630~microtubule cytoskeleton,GO:0030286~dynein complex,GO:0035085~cilium axoneme,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044441~cilium part,GO:0044447~axoneme part,GO:0044463~cell projection part,		GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,			alternative splicing,atp-binding,cell projection,cilium,coiled coil,complete proteome,cytoplasm,cytoskeleton,dynein,leucine-rich repeat,microtubule,motor protein,nucleotide-binding,polymorphism,repeat,tpr repeat,		IPR004273:Dynein heavy chain,IPR011704:ATPase associated with various cellular activities, AAA-5,IPR013594:Dynein heavy chain, N-terminal region 1,IPR013602:Dynein heavy chain, N-terminal region 2,	chain:Dynein heavy chain 17, axonemal,nucleotide phosphate-binding region:ATP,region of interest:AAA 1,region of interest:AAA 2,region of interest:AAA 3,region of interest:AAA 4,region of interest:AAA 5,region of interest:AAA 6,region of interest:Stalk,region of interest:Stem,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,sequence variant,splice variant,		GO:0001539~ciliary or flagellar motility,GO:0006928~cell motion,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0048870~cell motility,GO:0051674~localization of cell,	PIRSF002308:dynein heavy chain, ciliary,
37096_at	elastase, neutrophil expressed	Homo sapiens		GO:0005576~extracellular region,GO:0009986~cell surface,		GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0008367~bacterial binding,GO:0017171~serine hydrolase activity,GO:0019955~cytokine binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,	SM00020:Tryp_SPc,		3d-structure,complete proteome,direct protein sequencing,disease mutation,disulfide bond,glycoprotein,hydrolase,polymorphism,Protease,Serine protease,signal,zymogen,	hsa05322:Systemic lupus erythematosus,	IPR001254:Peptidase S1 and S6, chymotrypsin/Hap,IPR001314:Peptidase S1A, chymotrypsin,IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site,	active site:Charge relay system,chain:Neutrophil elastase,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,strand,turn,	Hematopoiesis, cyclic,Neutropenia, congenital,	GO:0001817~regulation of cytokine production,GO:0006508~proteolysis,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006897~endocytosis,GO:0006909~phagocytosis,GO:0006928~cell motion,GO:0008284~positive regulation of cell proliferation,GO:0009057~macromolecule catabolic process,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010324~membrane invagination,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016477~cell migration,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030163~protein catabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031348~negative regulation of defense response,GO:0032101~regulation of response to external stimulus,GO:0032102~negative regulation of response to external stimulus,GO:0032642~regulation of chemokine production,GO:0032677~regulation of interleukin-8 production,GO:0033674~positive regulation of kinase activity,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0042035~regulation of cytokine biosynthetic process,GO:0042036~negative regulation of cytokine biosynthetic process,GO:0042108~positive regulation of cytokine biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042592~homeostatic process,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045073~regulation of chemokine biosynthetic process,GO:0045079~negative regulation of chemokine biosynthetic process,GO:0045414~regulation of interleukin-8 biosynthetic process,GO:0045415~negative regulation of interleukin-8 biosynthetic process,GO:0045416~positive regulation of interleukin-8 biosynthetic process,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0048521~negative regulation of behavior,GO:0048585~negative regulation of response to stimulus,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048870~cell motility,GO:0048878~chemical homeostasis,GO:0050727~regulation of inflammatory response,GO:0050728~negative regulation of inflammatory response,GO:0050795~regulation of behavior,GO:0050801~ion homeostasis,GO:0050900~leukocyte migration,GO:0050920~regulation of chemotaxis,GO:0050922~negative regulation of chemotaxis,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051674~localization of cell,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,	
31621_s_at	elastin	Homo sapiens		GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,		GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0030023~extracellular matrix constituent conferring elasticity,GO:0050840~extracellular matrix binding,			alternative splicing,complete proteome,disulfide bond,extracellular matrix,hydroxylation,polymorphism,repeat,Secreted,signal,williams-beuren syndrome,		IPR003979:Tropoelastin,IPR004036:Endonuclease III, conserved site-2,	chain:Elastin,compositionally biased region:Ala-rich,compositionally biased region:Poly-Ala,disulfide bond,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,	Cutis laxa, AD,Supravalvar aortic stenosis,Williams-Beuren syndrome,	GO:0003013~circulatory system process,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007585~respiratory gaseous exchange,GO:0008015~blood circulation,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008283~cell proliferation,GO:0014706~striated muscle tissue development,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030198~extracellular matrix organization,GO:0030832~regulation of actin filament length,GO:0030833~regulation of actin filament polymerization,GO:0032271~regulation of protein polymerization,GO:0032535~regulation of cellular component size,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0043062~extracellular structure organization,GO:0043149~stress fiber formation,GO:0043254~regulation of protein complex assembly,GO:0044087~regulation of cellular component biogenesis,GO:0051017~actin filament bundle formation,GO:0051493~regulation of cytoskeleton organization,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,	
34249_at	epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)	Homo sapiens		GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005844~polysome,GO:0005886~plasma membrane,GO:0030529~ribonucleoprotein complex,		GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0030246~carbohydrate binding,			alternative splicing,carbohydrate metabolism,cell membrane,complete proteome,cytoplasm,disease mutation,endoplasmic reticulum,epilepsy,glycogen metabolism,hydrolase,membrane,nucleus,polymorphism,protein phosphatase,		IPR000340:Dual specificity phosphatase, catalytic domain,IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region,IPR002044:Glycoside hydrolase, carbohydrate-binding,IPR016130:Protein-tyrosine phosphatase, active site,	chain:Laforin,domain:CBM20,domain:Tyrosine-protein phosphatase,mutagenesis site,sequence conflict,sequence variant,splice variant,	Epilepsy, myoclonic, Lafora type,	GO:0005976~polysaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006073~cellular glucan metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006112~energy reserve metabolic process,GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007610~behavior,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016311~dephosphorylation,GO:0019318~hexose metabolic process,GO:0044042~glucan metabolic process,GO:0044264~cellular polysaccharide metabolic process,	
1855_at	fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog)	Homo sapiens		GO:0005576~extracellular region,GO:0005794~Golgi apparatus,		GO:0008083~growth factor activity,	SM00442:FGF,		complete proteome,disease mutation,glycoprotein,growth factor,mitogen,Proto-oncogene,signal,	hsa04010:MAPK signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05218:Melanoma,	IPR002209:Heparin-binding growth factor/Fibroblast growth factor,IPR002348:Interleukin 1/heparin-binding growth factor,	chain:INT-2 proto-oncogene protein,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,	A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs),Deafness, congenital with inner ear agenesis, microtia, and microdontia,	GO:0001708~cell fate specification,GO:0001759~induction of an organ,GO:0002520~immune system development,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007267~cell-cell signaling,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0031128~developmental induction,GO:0045165~cell fate commitment,GO:0045168~cell-cell signaling involved in cell fate specification,GO:0048534~hemopoietic or lymphoid organ development,GO:0048538~thymus development,GO:0051302~regulation of cell division,GO:0051781~positive regulation of cell division,	PIRSF001783:fibroblast growth factor,
32279_at	glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)	Homo sapiens		GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0009898~internal side of plasma membrane,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030054~cell junction,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0030424~axon,GO:0030659~cytoplasmic vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030665~clathrin coated vesicle membrane,GO:0030672~synaptic vesicle membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0044433~cytoplasmic vesicle part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,		GO:0004351~glutamate decarboxylase activity,GO:0016831~carboxy-lyase activity,GO:0019842~vitamin binding,GO:0030170~pyridoxal phosphate binding,GO:0048037~cofactor binding,GO:0070279~vitamin B6 binding,		Amino acid transport and metabolism,	3d-structure,carbon-carbon lyase,carboxy-lyase,cell junction,cell membrane,complete proteome,cytoplasm,cytoplasmic vesicle,decarboxylase,golgi apparatus,lipoprotein,lyase,membrane,Neurotransmitter biosynthesis,palmitate,phosphoprotein,polymorphism,pyridoxal phosphate,synapse,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa00410:beta-Alanine metabolism,hsa00430:Taurine and hypotaurine metabolism,hsa00650:Butanoate metabolism,hsa04940:Type I diabetes mellitus,	IPR002129:Pyridoxal phosphate-dependent decarboxylase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,	binding site:Substrate,chain:Glutamate decarboxylase 2,helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,region of interest:Substrate binding,sequence variant,strand,turn,		GO:0001505~regulation of neurotransmitter levels,GO:0006105~succinate metabolic process,GO:0006536~glutamate metabolic process,GO:0006538~glutamate catabolic process,GO:0006540~glutamate decarboxylation to succinate,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0009063~cellular amino acid catabolic process,GO:0009064~glutamine family amino acid metabolic process,GO:0009065~glutamine family amino acid catabolic process,GO:0009310~amine catabolic process,GO:0016054~organic acid catabolic process,GO:0019226~transmission of nerve impulse,GO:0042133~neurotransmitter metabolic process,GO:0042136~neurotransmitter biosynthetic process,GO:0043648~dicarboxylic acid metabolic process,GO:0046395~carboxylic acid catabolic process,GO:0050877~neurological system process,	PIRSF001333:glutamate decarboxylase,
38236_at	glutamate receptor, ionotropic, N-methyl D-aspartate 2A	Homo sapiens		GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008328~ionotropic glutamate receptor complex,GO:0014069~postsynaptic density,GO:0016021~integral to membrane,GO:0017146~N-methyl-D-aspartate selective glutamate receptor complex,GO:0019717~synaptosome,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043235~receptor complex,GO:0044430~cytoskeletal part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,		GO:0000287~magnesium ion binding,GO:0004970~ionotropic glutamate receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0008066~glutamate receptor activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016595~glutamate binding,GO:0016597~amino acid binding,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0031406~carboxylic acid binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043176~amine binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0050839~cell adhesion molecule binding,	SM00079:PBPe,		calcium,cell junction,cell membrane,complete proteome,glycoprotein,ion transport,ionic channel,magnesium,membrane,phosphoprotein,polymorphism,postsynaptic cell membrane,receptor,signal,synapse,transmembrane,transport,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04720:Long-term potentiation,hsa05010:Alzheimer's disease,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05322:Systemic lupus erythematosus,	IPR001320:Ionotropic glutamate receptor,IPR001508:NMDA receptor,IPR001828:Extracellular ligand-binding receptor,IPR015683:Glutamate receptor-related,IPR018884:Glutamate [NMDA] receptor, epsilon subunit, C-terminal,IPR019594:Glutamate receptor, L-glutamate/glycine-binding,	binding site:Glutamate,binding site:Glutamate; via amide nitrogen,chain:Glutamate [NMDA] receptor subunit epsilon-1,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Glutamate binding,sequence variant,short sequence motif:PDZ-binding,signal peptide,site:Functional determinant of NMDA receptors,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0001508~regulation of action potential,GO:0001964~startle response,GO:0001975~response to amphetamine,GO:0006575~cellular amino acid derivative metabolic process,GO:0006576~biogenic amine metabolic process,GO:0006584~catecholamine metabolic process,GO:0006586~indolalkylamine metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006873~cellular ion homeostasis,GO:0007166~cell surface receptor linked signal transduction,GO:0007215~glutamate signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007600~sensory perception,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007613~memory,GO:0007632~visual behavior,GO:0008104~protein localization,GO:0008542~visual learning,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009611~response to wounding,GO:0009628~response to abiotic stimulus,GO:0009712~catechol metabolic process,GO:0009719~response to endogenous stimulus,GO:0009894~regulation of catabolic process,GO:0009895~negative regulation of catabolic process,GO:0010033~response to organic substance,GO:0010243~response to organic nitrogen,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0014075~response to amine stimulus,GO:0015674~di-, tri-valent inorganic cation transport,GO:0018958~phenol metabolic process,GO:0019226~transmission of nerve impulse,GO:0019233~sensory perception of pain,GO:0019725~cellular homeostasis,GO:0030001~metal ion transport,GO:0030431~sleep,GO:0031644~regulation of neurological system process,GO:0033058~directional locomotion,GO:0034311~diol metabolic process,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0042176~regulation of protein catabolic process,GO:0042177~negative regulation of protein catabolic process,GO:0042391~regulation of membrane potential,GO:0042417~dopamine metabolic process,GO:0042428~serotonin metabolic process,GO:0042430~indole and derivative metabolic process,GO:0042434~indole derivative metabolic process,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0044057~regulation of system process,GO:0045471~response to ethanol,GO:0048167~regulation of synaptic plasticity,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048511~rhythmic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050804~regulation of synaptic transmission,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050905~neuromuscular process,GO:0051248~negative regulation of protein metabolic process,GO:0051899~membrane depolarization,GO:0051930~regulation of sensory perception of pain,GO:0051931~regulation of sensory perception,GO:0051969~regulation of transmission of nerve impulse,GO:0055082~cellular chemical homeostasis,GO:0060078~regulation of postsynaptic membrane potential,GO:0060079~regulation of excitatory postsynaptic membrane potential,	PIRSF002440:N-methyl-D-aspartate receptor 2A,
36479_at	growth arrest-specific 8	Homo sapiens		GO:0005794~Golgi apparatus,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005929~cilium,GO:0005932~microtubule basal body,GO:0009434~microtubule-based flagellum,GO:0015630~microtubule cytoskeleton,GO:0019861~flagellum,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044463~cell projection part,					cell projection,cilium,coiled coil,complete proteome,cytoplasm,cytoskeleton,flagellum,golgi apparatus,microtubule,polymorphism,			chain:Growth arrest-specific protein 8,region of interest:Microtubule-binding,region of interest:Regulates microtubule-binding,sequence variant,		GO:0006928~cell motion,GO:0008285~negative regulation of cell proliferation,GO:0030317~sperm motility,GO:0042127~regulation of cell proliferation,GO:0048870~cell motility,GO:0051674~localization of cell,	
1890_at	growth differentiation factor 15	Homo sapiens		GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,		GO:0005125~cytokine activity,GO:0008083~growth factor activity,	SM00204:TGFB,		cleavage on pair of basic residues,complete proteome,cytokine,disulfide bond,glycoprotein,growth factor,polymorphism,Secreted,signal,		IPR001839:Transforming growth factor beta,IPR017948:Transforming growth factor beta, conserved site,	chain:Growth/differentiation factor 15,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,		GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007267~cell-cell signaling,	
919_at	guanine nucleotide binding protein (G protein) alpha 12	Homo sapiens		GO:0005886~plasma membrane,GO:0005903~brush border,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0042995~cell projection,	h_akap13Pathway:Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0050780~dopamine receptor binding,			complete proteome,gtp-binding,lipoprotein,membrane,nucleotide-binding,palmitate,phosphoprotein,polymorphism,transducer,	hsa04010:MAPK signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,	IPR000469:G-protein alpha subunit, group 12,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,	chain:Guanine nucleotide-binding protein subunit alpha-12,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,	Many sequence variants affecting diversity of adult human height,	GO:0001701~in utero embryonic development,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007266~Rho protein signal transduction,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0008360~regulation of cell shape,GO:0009611~response to wounding,GO:0009792~embryonic development ending in birth or egg hatching,GO:0022604~regulation of cell morphogenesis,GO:0030326~embryonic limb morphogenesis,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0042060~wound healing,GO:0042733~embryonic digit morphogenesis,GO:0043009~chordate embryonic development,GO:0048598~embryonic morphogenesis,GO:0048736~appendage development,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,GO:0060173~limb development,	PIRSF002400:GTP-binding regulatory protein Gs alpha chain,
37905_r_at	guanine nucleotide binding protein-like 1	Homo sapiens		GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,		GO:0000166~nucleotide binding,GO:0005198~structural molecule activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,		General function prediction only,	alternative splicing,complete proteome,GTP binding,gtp-binding,nucleotide binding,nucleotide-binding,P-loop,phosphoprotein,		IPR002917:GTP-binding protein, HSR1-related,	chain:Guanine nucleotide-binding protein-like 1,compositionally biased region:Asp/Glu-rich (highly acidic),modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,splice variant,		GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002456~T cell mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0006955~immune response,GO:0006974~response to DNA damage stimulus,GO:0033554~cellular response to stress,	
31525_s_at	hemoglobin, alpha 2; hemoglobin, alpha 1	Homo sapiens		GO:0005829~cytosol,GO:0005833~hemoglobin complex,GO:0005840~ribosome,GO:0015935~small ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~ribonucleoprotein complex,GO:0033279~ribosomal subunit,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044445~cytosolic part,		GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,			3d-structure,acetylation,blood,chromoprotein,complete proteome,direct protein sequencing,disease mutation,erythrocyte,glycation,glycoprotein,heme,heterotetramer,iron,metal-binding,metalloprotein,opioid peptide,oxygen carrier,oxygen transport,phosphoprotein,polymorphism,transport,		IPR000971:Globin, subset,IPR002338:Haemoglobin, alpha,IPR002339:Haemoglobin, pi,IPR012292:Globin,IPR018331:Haemoglobin alpha chain,	chain:Hemoglobin subunit alpha,glycosylation site:N-linked (Glc) (glycation),helix,metal ion-binding site:Iron (heme distal ligand),metal ion-binding site:Iron (heme proximal ligand),modified residue,sequence conflict,sequence variant,site:Not glycated,turn,	Erythremias, alpha-,Erythrocytosis,Heinz body anemia,Heinz body anemias, alpha-,Hemoglobin H disease,Hypochromic microcytic anemia,Methemoglobinemias, alpha-,Thalassemia, alpha-,Thalassemias, alpha-,	GO:0015669~gas transport,GO:0015671~oxygen transport,	PIRSF036518:globin,PIRSF500045:hemoglobin, vertebrate type,
31687_f_at	hemoglobin, beta	Homo sapiens		GO:0005829~cytosol,GO:0005833~hemoglobin complex,GO:0044445~cytosolic part,	h_ahspPathway:Hemoglobin's Chaperone,	GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0030492~hemoglobin binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,			3d-structure,acetylation,blocked amino end,blood,chromoprotein,complete proteome,congenital dyserythropoietic anemia,direct protein sequencing,disease mutation,erythrocyte,glycation,glycoprotein,heme,hereditary hemolytic anemia,heterotetramer,homotetramer,hypotensive agent,iron,metal-binding,metalloprotein,opioid peptide,oxygen carrier,oxygen transport,phosphoprotein,polymorphism,pyruvate,s-nitrosylation,transport,vasoactive,		IPR000971:Globin, subset,IPR002337:Haemoglobin, beta,IPR012292:Globin,	binding site:2,3-bisphosphoglycerate,binding site:2,3-bisphosphoglycerate; via amino nitrogen,chain:Hemoglobin subunit beta,glycosylation site:N-linked (Glc) (glycation),glycosylation site:N-linked (Glc) (glycation); in Hb A1c,helix,metal ion-binding site:Iron (heme distal ligand),metal ion-binding site:Iron (heme proximal ligand),modified residue,peptide:LVV-hemorphin-7,sequence conflict,sequence variant,site:Aspirin-acetylated lysine,site:Not glycated,site:Susceptible to oxidation; associated with variant Atlanta, variant non-spherocytic haemolytic anemia and variant Christchurch,turn,	A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15,Erythremias, beta-,Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia,Heinz body anemias, beta-,Hereditary persistence of fetal hemoglobin,HPFH, deletion type,Methemoglobinemias, beta-,Sickle cell anemia,Thalassemia-beta, dominant inclusion-body,Thalassemias, beta-,	GO:0003013~circulatory system process,GO:0003018~vascular process in circulatory system,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0009891~positive regulation of biosynthetic process,GO:0015669~gas transport,GO:0015671~oxygen transport,GO:0030185~nitric oxide transport,GO:0031328~positive regulation of cellular biosynthetic process,GO:0035150~regulation of tube size,GO:0045428~regulation of nitric oxide biosynthetic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0050880~regulation of blood vessel size,GO:0051173~positive regulation of nitrogen compound metabolic process,	PIRSF036518:globin,PIRSF500045:hemoglobin, vertebrate type,
33516_at	hemoglobin, delta	Homo sapiens		GO:0005829~cytosol,GO:0005833~hemoglobin complex,GO:0044445~cytosolic part,		GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,			3d-structure,acetylation,blood,chromoprotein,complete proteome,direct protein sequencing,erythrocyte,heme,heterotetramer,iron,metal-binding,metalloprotein,oxygen carrier,oxygen transport,phosphoprotein,polymorphism,transport,		IPR000971:Globin, subset,IPR002337:Haemoglobin, beta,IPR012292:Globin,	chain:Hemoglobin subunit delta,helix,metal ion-binding site:Iron (heme distal ligand),metal ion-binding site:Iron (heme proximal ligand),modified residue,sequence variant,turn,	Thalassemia due to Hb Lepore,Thalassemia, delta-,	GO:0015669~gas transport,GO:0015671~oxygen transport,	PIRSF036518:globin,PIRSF500045:hemoglobin, vertebrate type,
40735_at	histidine ammonia-lyase	Homo sapiens		GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005829~cytosol,		GO:0004397~histidine ammonia-lyase activity,GO:0016211~ammonia ligase activity,GO:0016840~carbon-nitrogen lyase activity,GO:0016841~ammonia-lyase activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016880~acid-ammonia (or amide) ligase activity,			ammonia-lyase,carbon-nitrogen lyase,complete proteome,cytoplasm,disease mutation,histidine catabolism,histidine metabolism,lyase,Phenylpropanoid metabolism,phosphoprotein,polymorphism,	hsa00340:Histidine metabolism,hsa00910:Nitrogen metabolism,	IPR001106:Phenylalanine/histidine ammonia-lyase,IPR005921:Histidine ammonia-lyase,	chain:Histidine ammonia-lyase,cross-link:5-imidazolinone (Ala-Gly),modified residue,sequence variant,	Histidinemia,	GO:0006547~histidine metabolic process,GO:0006548~histidine catabolic process,GO:0009063~cellular amino acid catabolic process,GO:0009075~histidine family amino acid metabolic process,GO:0009077~histidine family amino acid catabolic process,GO:0009310~amine catabolic process,GO:0016054~organic acid catabolic process,GO:0046395~carboxylic acid catabolic process,GO:0046700~heterocycle catabolic process,	
35566_f_at	immunoglobulin heavy constant gamma 1 (G1m marker); immunoglobulin heavy constant mu; immunoglobulin heavy variable 3-7; immunoglobulin heavy constant gamma 3 (G3m marker); immunoglobulin heavy variable 3-11 (gene/pseudogene); immunoglobulin heavy variable 4-31; immunoglobulin heavy locus	Homo sapiens	78.B_Cell_Development,79.B_cell_Activation,	GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,		GO:0003823~antigen binding,	SM00406:IGv,SM00407:IGc1,		3d-structure,alternative splicing,cell membrane,chromosomal rearrangement,complete proteome,direct protein sequencing,disulfide bond,duplication,glycoprotein,heterotetramer,immunoglobulin,immunoglobulin c region,Immunoglobulin domain,membrane,membrane protein,polymorphism,pyroglutamic acid,Pyrrolidone carboxylic acid,receptor,repeat,Secreted,signal,transmembrane,		IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003596:Immunoglobulin V-set, subgroup,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR018062:Helix-turn-helix, AraC type, subdomain 2,	chain:anti-RhD monoclonal T125 gamma1 heavy chain,chain:Ig gamma-1 chain C region,chain:Ig gamma-3 chain C region,chain:Ig mu chain C region,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,region of interest:CH1,region of interest:CH2,region of interest:CH3,region of interest:CH4,region of interest:Hinge,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,	Agammaglobulinemia,	GO:0006955~immune response,	
35915_at	inhibin, beta C	Homo sapiens		GO:0005576~extracellular region,		GO:0005160~transforming growth factor beta receptor binding,GO:0005179~hormone activity,GO:0008083~growth factor activity,	SM00204:TGFB,		cleavage on pair of basic residues,complete proteome,disulfide bond,glycoprotein,growth factor,hormone,polymorphism,Secreted,signal,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,	IPR001318:Inhibin, beta C subunit,IPR001839:Transforming growth factor beta,IPR015615:Transforming growth factor-beta-related,IPR017948:Transforming growth factor beta, conserved site,	chain:Inhibin beta C chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,			PIRSF037268:activin/inhibin, beta subunit,PIRSF500818:activin/inhibin, beta C subunit,PIRSF800009:TGF-beta-like cysteine-knot cytokine,
38926_at	integrin, beta 5	Homo sapiens		GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008305~integrin complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0043235~receptor complex,GO:0044459~plasma membrane part,			SM00181:EGF,SM00187:INB,SM00327:VWA,SM00423:PSI,		cell adhesion,complete proteome,cytoskeleton,disulfide bond,duplication,extracellular matrix,glycoprotein,heterodimer,integrin,membrane,polymorphism,receptor,repeat,signal,transmembrane,transmembrane protein,	hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04810:Regulation of actin cytoskeleton,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	IPR001169:Integrin beta subunit, C-terminal,IPR002035:von Willebrand factor, type A,IPR002369:Integrin beta subunit, N-terminal,IPR003659:Plexin/semaphorin/integrin,IPR006210:EGF-like,IPR012012:Integrin beta subunit, subgroup,IPR012896:Integrin beta subunit, tail,IPR013032:EGF-like region, conserved site,IPR013111:EGF, extracellular,IPR014836:Integrin beta subunit, cytoplasmic,IPR015435:Integrin beta-3 subunit, C-terminal,IPR015812:Integrin beta subunit,	chain:Integrin beta-5,disulfide bond,domain:PSI,domain:VWFA,glycosylation site:N-linked (GlcNAc...),region of interest:Cysteine-rich tandem repeats,repeat:I,repeat:II,repeat:III,repeat:IV,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0022610~biological adhesion,GO:0031589~cell-substrate adhesion,	PIRSF002512:integrin, beta subunit,PIRSF002512:Integrin_B,
38674_at	kelch-like 9 (Drosophila)	Homo sapiens					SM00225:BTB,SM00612:Kelch,		complete proteome,kelch repeat,phosphoprotein,repeat,ubl conjugation pathway,	hsa04120:Ubiquitin mediated proteolysis,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR013069:BTB/POZ,IPR013089:Kelch related,IPR015915:Kelch-type beta propeller,IPR017096:Kelch-like protein, gigaxonin,	chain:Kelch-like protein 9,domain:BACK,domain:BTB,modified residue,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,		GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,	PIRSF037037:kelch-like protein, gigaxonin type,PIRSF037037:Kelch-like_protein_gigaxonin,
34012_at	keratin 34	Homo sapiens		GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045111~intermediate filament cytoskeleton,		GO:0005198~structural molecule activity,			coiled coil,complete proteome,Intermediate filament,keratin,polymorphism,		IPR001664:Intermediate filament protein,IPR002957:Keratin, type I,IPR016044:Filament,IPR018039:Intermediate filament protein, conserved site,	chain:Keratin, type I cuticular Ha4,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Linker 1,region of interest:Linker 12,region of interest:Rod,region of interest:Tail,sequence conflict,sequence variant,site:Stutter,		GO:0007398~ectoderm development,GO:0008544~epidermis development,	PIRSF002282:cytoskeletal keratin,
31987_at	kin of IRRE like (Drosophila)	Homo sapiens		GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,			SM00408:IGc2,SM00409:IG,		alternative splicing,cell membrane,complete proteome,disulfide bond,glycoprotein,Immunoglobulin domain,membrane,phosphoprotein,polymorphism,repeat,signal,transmembrane,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,	chain:Kin of IRRE-like protein 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0007588~excretion,GO:0046903~secretion,	
35367_at	lectin, galactoside-binding, soluble, 3	Homo sapiens		GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,		GO:0005529~sugar binding,GO:0019863~IgE binding,GO:0019865~immunoglobulin binding,GO:0030246~carbohydrate binding,GO:0032403~protein complex binding,	SM00276:GLECT,		3d-structure,acetylation,complete proteome,differentiation,disulfide bond,ige-binding protein,Lectin,nucleus,phosphoprotein,polymorphism,repeat,		IPR001079:Galectin, carbohydrate recognition domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015534:Galectin-3,	chain:Galectin-3,disulfide bond,domain:Galectin,helix,modified residue,region of interest:8 X 9 AA tandem repeats of Y-P-G-X(3)-P- G-A,region of interest:Beta-galactoside binding,repeat:1,repeat:2,repeat:3,repeat:4; approximate,repeat:5,repeat:6; approximate,repeat:7; approximate,repeat:8; approximate,sequence conflict,sequence variant,strand,		GO:0001501~skeletal system development,GO:0030198~extracellular matrix organization,GO:0043062~extracellular structure organization,	PIRSF037626:galectin 3,
36436_at	leukocyte cell-derived chemotaxin 2	Homo sapiens		GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,					chemotaxis,complete proteome,cytoplasm,polymorphism,Secreted,signal,		IPR008663:Leukocyte cell-derived chemotaxin 2,IPR016047:Peptidase M23,IPR017381:Leukocyte cell-derived chemotaxin 2, chordata,	chain:Leukocyte cell-derived chemotaxin-2,sequence variant,signal peptide,		GO:0001501~skeletal system development,GO:0006935~chemotaxis,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0030178~negative regulation of Wnt receptor signaling pathway,GO:0042330~taxis,	PIRSF038085:LECT3,
32073_at	lysine (K)-specific demethylase 4A	Homo sapiens		GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,		GO:0005506~iron ion binding,GO:0008270~zinc ion binding,GO:0016564~transcription repressor activity,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0030528~transcription regulator activity,GO:0032451~demethylase activity,GO:0032452~histone demethylase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051864~histone demethylase activity (H3-K36 specific),	SM00249:PHD,SM00333:TUDOR,SM00545:JmjN,SM00558:JmjC,	General function prediction only,	3d-structure,chromatin regulator,complete proteome,dioxygenase,host-virus interaction,iron,metal-binding,nucleus,oxidoreductase,phosphoprotein,polymorphism,repeat,Transcription,transcription regulation,zinc,zinc-finger,		IPR001965:Zinc finger, PHD-type,IPR002999:Tudor domain,IPR003347:Transcription factor jumonji/aspartyl beta-hydroxylase,IPR003349:Transcription factor jumonji, JmjN,IPR013129:Transcription factor jumonji,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	binding site:Alpha-ketoglutarate,binding site:Histone H3-K4Me3,chain:Lysine-specific demethylase 4A,domain:JmjC,domain:JmjN,domain:Tudor 1,domain:Tudor 2,helix,metal ion-binding site:Iron; catalytic,metal ion-binding site:Zinc,modified residue,mutagenesis site,region of interest:Interaction with NCOR1,sequence variant,strand,turn,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,		GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006482~protein amino acid demethylation,GO:0006730~one-carbon metabolic process,GO:0008214~protein amino acid dealkylation,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016577~histone demethylation,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0055114~oxidation reduction,	
37408_at	mannose receptor, C type 2	Homo sapiens		GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,		GO:0005509~calcium ion binding,GO:0005529~sugar binding,GO:0030246~carbohydrate binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,	SM00034:CLECT,SM00059:FN2,SM00458:RICIN,		calcium,complete proteome,direct protein sequencing,disulfide bond,Endocytosis,glycoprotein,Lectin,membrane,phosphoprotein,polymorphism,receptor,repeat,signal,transmembrane,		IPR000562:Type II fibronectin, collagen-binding,IPR000772:Ricin B lectin,IPR001304:C-type lectin,IPR002353:Type II antifreeze protein,IPR016186:C-type lectin-like,IPR018378:C-type lectin, conserved site,	chain:C-type mannose receptor 2,disulfide bond,domain:C-type lectin 1,domain:C-type lectin 2,domain:C-type lectin 3,domain:C-type lectin 4,domain:C-type lectin 5,domain:C-type lectin 6,domain:C-type lectin 7,domain:C-type lectin 8,domain:Fibronectin type-II,domain:Ricin B-type lectin,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0006897~endocytosis,GO:0010324~membrane invagination,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,	PIRSF002427:mannose receptor,
34577_at	melanoma antigen family A, 9; melanoma antigen family A, 9B	Homo sapiens							complete proteome,tumor antigen,		IPR002190:MAGE protein,	chain:Melanoma-associated antigen 9,compositionally biased region:Poly-Glu,domain:MAGE,sequence conflict,			PIRSF005491:tumor associated protein MAGE,
38945_at	metal-regulatory transcription factor 1	Homo sapiens				GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0042156~zinc-mediated transcriptional activator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,	SM00355:ZnF_C2H2,	General function prediction only,Transcription / Cell division and chromosome partitioning,	activator,complete proteome,dna-binding,metal-binding,nucleus,repeat,Transcription,transcription regulation,zinc,zinc-finger,		IPR007087:Zinc finger, C2H2-type,IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding,IPR015880:Zinc finger, C2H2-like,	chain:Metal regulatory transcription factor 1,compositionally biased region:Pro-rich,sequence conflict,short sequence motif:Nuclear localization signal,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,		GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006979~response to oxidative stress,GO:0009891~positive regulation of biosynthetic process,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046686~response to cadmium ion,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,	
31576_at	mevalonate kinase	Homo sapiens		GO:0005777~peroxisome,GO:0042579~microbody,		GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004496~mevalonate kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,			3d-structure,ATP,atp-binding,cataract,Cholesterol biosynthesis,complete proteome,cytoplasm,disease mutation,isoprenoid biosynthesis,kinase,lipid synthesis,nucleotide-binding,peroxisome,phosphotransferase,polymorphism,Steroid biosynthesis,sterol biosynthesis,transferase,	hsa00900:Terpenoid backbone biosynthesis,	IPR006203:GHMP kinase, ATP-binding, conserved site,IPR006204:GHMP kinase,IPR006205:Mevalonate kinase,IPR006206:Mevalonate and galactokinase,IPR013750:GHMP kinase, C-terminal,IPR014721:Ribosomal protein S5 domain 2-type fold,	binding site:ATP,chain:Mevalonate kinase,helix,nucleotide phosphate-binding region:ATP,sequence variant,strand,turn,	Common variants at 30 loci contribute to polygenic dyslipidemia,Hyper-IgD syndrome,Mevalonic aciduria,Mevalonicaciduria,Newly identified loci that influence lipid concentrations and risk of coronary artery disease,	GO:0006694~steroid biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0006720~isoprenoid metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0008299~isoprenoid biosynthetic process,GO:0008610~lipid biosynthetic process,GO:0016125~sterol metabolic process,GO:0016126~sterol biosynthetic process,GO:0016310~phosphorylation,	PIRSF000546:mevalonate kinase/phosphomevalonate kinase,PIRSF500058:mevalonate kinase,
33246_at	mitogen-activated protein kinase 13	Homo sapiens		GO:0000267~cell fraction,GO:0005625~soluble fraction,	h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004707~MAP kinase activity,GO:0005524~ATP binding,GO:0016909~SAP kinase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,	SM00220:S_TKc,		3d-structure,atp-binding,cell cycle,complete proteome,kinase,nucleotide-binding,phosphoprotein,phosphotransferase,polymorphism,serine/threonine-protein kinase,transferase,	hsa04010:MAPK signaling pathway,hsa04370:VEGF signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04912:GnRH signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05120:Epithelial cell signaling in Helicobacter pylori infection,	IPR000719:Protein kinase, core,IPR002290:Serine/threonine protein kinase,IPR003527:MAP kinase, conserved site,IPR008271:Serine/threonine protein kinase, active site,IPR008352:MAP kinase, p38,IPR017441:Protein kinase, ATP binding site,IPR017442:Serine/threonine protein kinase-related,	active site:Proton acceptor,binding site:ATP,chain:Mitogen-activated protein kinase 13,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:TXY,strand,turn,		GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007049~cell cycle,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0016310~phosphorylation,	PIRSF000564:kinase-related transforming protein,
41280_r_at	mitogen-activated protein kinase 8 interacting protein 1	Homo sapiens		GO:0005829~cytosol,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0048471~perinuclear region of cytoplasm,		GO:0004857~enzyme inhibitor activity,GO:0004860~protein kinase inhibitor activity,GO:0005078~MAP-kinase scaffold activity,GO:0005198~structural molecule activity,GO:0008092~cytoskeletal protein binding,GO:0008432~JUN kinase binding,GO:0019207~kinase regulator activity,GO:0019210~kinase inhibitor activity,GO:0019887~protein kinase regulator activity,GO:0019894~kinesin binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030159~receptor signaling complex scaffold activity,GO:0031434~mitogen-activated protein kinase kinase binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0032947~protein complex scaffold,	SM00326:SH3,SM00462:PTB,		3d-structure,complete proteome,cytoplasm,diabetes mellitus,disease mutation,kinase,nucleus,phosphoprotein,polymorphism,repeat,sh3 domain,ubl conjugation,	hsa04010:MAPK signaling pathway,	IPR001452:Src homology-3 domain,IPR006020:Phosphotyrosine interaction region,IPR011993:Pleckstrin homology-type,	chain:C-jun-amino-terminal kinase-interacting protein 1,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,domain:PID,domain:SH3,modified residue,mutagenesis site,region of interest:JNK-binding domain (JBD),region of interest:Minimal inhibitory domain (MID),sequence variant,short sequence motif:D-box 1,short sequence motif:D-box 2,	Diabetes mellitus, noninsulin-dependent,	GO:0000165~MAPKKK cascade,GO:0001932~regulation of protein amino acid phosphorylation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006468~protein amino acid phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006916~anti-apoptosis,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0007258~JUN phosphorylation,GO:0009968~negative regulation of signal transduction,GO:0010627~regulation of protein kinase cascade,GO:0010648~negative regulation of cell communication,GO:0010741~negative regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0031098~stress-activated protein kinase signaling pathway,GO:0031399~regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0033554~cellular response to stress,GO:0033673~negative regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043086~negative regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043408~regulation of MAPKKK cascade,GO:0043409~negative regulation of MAPKKK cascade,GO:0043506~regulation of JUN kinase activity,GO:0043508~negative regulation of JUN kinase activity,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0045449~regulation of transcription,GO:0045859~regulation of protein kinase activity,GO:0046328~regulation of JNK cascade,GO:0046329~negative regulation of JNK cascade,GO:0048585~negative regulation of response to stimulus,GO:0051174~regulation of phosphorus metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0060548~negative regulation of cell death,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0070303~negative regulation of stress-activated protein kinase signaling pathway,GO:0080135~regulation of cellular response to stress,	
33284_at	myeloperoxidase	Homo sapiens		GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005773~vacuole,GO:0044421~extracellular region part,		GO:0003682~chromatin binding,GO:0004601~peroxidase activity,GO:0005506~iron ion binding,GO:0005509~calcium ion binding,GO:0016209~antioxidant activity,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0020037~heme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,			3d-structure,alternative splicing,calcium,chromoprotein,complete proteome,direct protein sequencing,disease mutation,disulfide bond,glycoprotein,heme,hydrogen peroxide,iron,lysosome,metal-binding,metalloprotein,oxidation,oxidoreductase,peroxidase,polymorphism,signal,		IPR002007:Haem peroxidase, animal,IPR019791:Haem peroxidase, animal, subgroup,IPR019793:Peroxidases heam-ligand binding site,IPR019794:Peroxidase, active site,	active site:Proton acceptor,binding site:Heme (covalent; via 3 links),chain:84 kDa myeloperoxidase,chain:89 kDa myeloperoxidase,chain:Myeloperoxidase,chain:Myeloperoxidase heavy chain,chain:Myeloperoxidase light chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,metal ion-binding site:Iron (heme axial ligand),modified residue,sequence conflict,sequence variant,signal peptide,site:Transition state stabilizer,splice variant,strand,turn,	Alzheimer disease, susceptibility to,Lung cancer, protection against, in smokers,Myeloperoxidase deficiency,	GO:0000302~response to reactive oxygen species,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0006916~anti-apoptosis,GO:0006952~defense response,GO:0006979~response to oxidative stress,GO:0010035~response to inorganic substance,GO:0010941~regulation of cell death,GO:0033554~cellular response to stress,GO:0034367~macromolecular complex remodeling,GO:0034368~protein-lipid complex remodeling,GO:0034369~plasma lipoprotein particle remodeling,GO:0034374~low-density lipoprotein particle remodeling,GO:0034599~cellular response to oxidative stress,GO:0034614~cellular response to reactive oxygen species,GO:0042542~response to hydrogen peroxide,GO:0042743~hydrogen peroxide metabolic process,GO:0042744~hydrogen peroxide catabolic process,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043933~macromolecular complex subunit organization,GO:0055114~oxidation reduction,GO:0060548~negative regulation of cell death,GO:0070301~cellular response to hydrogen peroxide,	PIRSF000299:myeloperoxidase,
37711_at	myocyte enhancer factor 2C	Homo sapiens		GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,	h_alkPathway:ALK in cardiac myocytes,h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),	GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,	SM00432:MADS,	Transcription,	acetylation,activator,alternative splicing,Apoptosis,brain,complete proteome,developmental protein,differentiation,DNA binding,dna-binding,isopeptide bond,neurogenesis,nucleus,phosphoprotein,skeletal muscle,Transcription,transcription factor,transcription regulation,ubl conjugation,	hsa04010:MAPK signaling pathway,	IPR002100:Transcription factor, MADS-box,	chain:Myocyte-specific enhancer factor 2C,compositionally biased region:Lys-rich (basic),compositionally biased region:Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Mef2-type,domain:MADS-box,modified residue,mutagenesis site,region of interest:Beta domain,region of interest:Transcription repressor,site:Cleavage,splice variant,	Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0007517~muscle organ development,GO:0008219~cell death,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043193~positive regulation of gene-specific transcription,GO:0045449~regulation of transcription,GO:0045884~regulation of survival gene product expression,GO:0045885~positive regulation of survival gene product expression,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060548~negative regulation of cell death,	
35038_at	myosin binding protein C, cardiac	Homo sapiens		GO:0005856~cytoskeleton,GO:0005859~muscle myosin complex,GO:0005863~striated muscle thick filament,GO:0014705~C zone,GO:0015629~actin cytoskeleton,GO:0016459~myosin complex,GO:0016460~myosin II complex,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0031672~A band,GO:0032982~myosin filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043292~contractile fiber,GO:0044430~cytoskeletal part,GO:0044449~contractile fiber part,		GO:0001671~ATPase activator activity,GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0008047~enzyme activator activity,GO:0008092~cytoskeletal protein binding,GO:0008307~structural constituent of muscle,GO:0017022~myosin binding,GO:0031432~titin binding,GO:0032036~myosin heavy chain binding,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0060590~ATPase regulator activity,	SM00060:FN3,SM00408:IGc2,SM00409:IG,		3d-structure,actin-binding,cardiac muscle,Cardiomyopathy,cell adhesion,complete proteome,disease mutation,heart,Immunoglobulin domain,muscle protein,phosphoprotein,polymorphism,repeat,thick filament,	hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05414:Dilated cardiomyopathy,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like,IPR008957:Fibronectin, type III-like fold,IPR013098:Immunoglobulin I-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	chain:Myosin-binding protein C, cardiac-type,compositionally biased region:Pro-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,helix,modified residue,sequence conflict,sequence variant,strand,turn,	?Cardiomyopathy, dilated,Cardiomyopathy, familial hypertrophic, 4,	GO:0003007~heart morphogenesis,GO:0003012~muscle system process,GO:0003013~circulatory system process,GO:0003015~heart process,GO:0006936~muscle contraction,GO:0006937~regulation of muscle contraction,GO:0006941~striated muscle contraction,GO:0006942~regulation of striated muscle contraction,GO:0007155~cell adhesion,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0008015~blood circulation,GO:0014706~striated muscle tissue development,GO:0022610~biological adhesion,GO:0032386~regulation of intracellular transport,GO:0032781~positive regulation of ATPase activity,GO:0032970~regulation of actin filament-based process,GO:0032971~regulation of muscle filament sliding,GO:0043085~positive regulation of catalytic activity,GO:0043462~regulation of ATPase activity,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0048729~tissue morphogenesis,GO:0048738~cardiac muscle tissue development,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0055008~cardiac muscle tissue morphogenesis,GO:0055010~ventricular cardiac muscle morphogenesis,GO:0060047~heart contraction,GO:0060048~cardiac muscle contraction,GO:0060341~regulation of cellular localization,GO:0060415~muscle tissue morphogenesis,GO:0060537~muscle tissue development,	
37968_at	natural cytotoxicity triggering receptor 3	Homo sapiens		GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,			SM00409:IG,		alternative splicing,cell membrane,complete proteome,disulfide bond,glycoprotein,Immunoglobulin domain,membrane,polymorphism,receptor,signal,transmembrane,	hsa04650:Natural killer cell mediated cytotoxicity,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	chain:Natural cytotoxicity triggering receptor 3,disulfide bond,domain:Ig-like,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,	Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity,Malaria, mild, susceptibility to,	GO:0001910~regulation of leukocyte mediated cytotoxicity,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0002684~positive regulation of immune system process,GO:0002697~regulation of immune effector process,GO:0002699~positive regulation of immune effector process,GO:0002703~regulation of leukocyte mediated immunity,GO:0002705~positive regulation of leukocyte mediated immunity,GO:0002706~regulation of lymphocyte mediated immunity,GO:0002708~positive regulation of lymphocyte mediated immunity,GO:0002715~regulation of natural killer cell mediated immunity,GO:0002717~positive regulation of natural killer cell mediated immunity,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0008037~cell recognition,GO:0009611~response to wounding,GO:0031341~regulation of cell killing,GO:0031343~positive regulation of cell killing,GO:0031349~positive regulation of defense response,GO:0042269~regulation of natural killer cell mediated cytotoxicity,GO:0045088~regulation of innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,	PIRSF038040:Natural cytotoxicity triggering receptor 3,
34233_i_at	natural killer-tumor recognition sequence	Homo sapiens		GO:0019898~extrinsic to membrane,		GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0008144~drug binding,GO:0016018~cyclosporin A binding,GO:0016859~cis-trans isomerase activity,GO:0042277~peptide binding,			3d-structure,alternative splicing,complete proteome,Cyclosporin,Isomerase,isopeptide bond,lymphocyte,membrane,phosphoprotein,polymorphism,repeat,Rotamase,ubl conjugation,		IPR002130:Peptidyl-prolyl cis-trans isomerase, cyclophilin-type,	chain:NK-tumor recognition protein,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Arg/Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:PPIase cyclophilin-type,helix,modified residue,region of interest:Arg/Ser tandem repeat-rich,sequence variant,strand,turn,		GO:0006457~protein folding,	
1112_g_at	neural cell adhesion molecule 1	Homo sapiens		GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0030424~axon,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0044459~plasma membrane part,	h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,		SM00060:FN3,SM00408:IGc2,		3d-structure,alternative splicing,cell adhesion,cell membrane,complete proteome,disulfide bond,duplication,glycoprotein,gpi-anchor,heparin binding,Immunoglobulin domain,lipoprotein,membrane,membrane protein,phosphatidylinositol linkage,phosphoprotein,polymorphism,repeat,Secreted,sialoglycoprotein,signal,skeletal muscle,transmembrane,	hsa04514:Cell adhesion molecules (CAMs),hsa05020:Prion diseases,	IPR003598:Immunoglobulin subtype 2,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like,IPR008957:Fibronectin, type III-like fold,IPR009138:Neural cell adhesion,IPR013098:Immunoglobulin I-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	chain:Neural cell adhesion molecule 1,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010647~positive regulation of cell communication,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0034109~homotypic cell-cell adhesion,GO:0050848~regulation of calcium-mediated signaling,GO:0050850~positive regulation of calcium-mediated signaling,	PIRSF002507:cell adhesion molecule, NCAM/Fasciclin-2 types,PIRSF501037:neural cell adhesion molecule,
32717_at	neuralized homolog (Drosophila)	Homo sapiens		GO:0005886~plasma membrane,GO:0048471~perinuclear region of cytoplasm,		GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,	SM00184:RING,SM00588:NEUZ,		alternative splicing,complete proteome,cytoplasm,metal-binding,repeat,zinc,zinc-finger,		IPR001841:Zinc finger, RING-type,IPR006573:NEUZ,IPR017907:Zinc finger, RING-type, conserved site,	chain:Neuralized-like protein 1A,domain:NHR 1,domain:NHR 2,sequence conflict,splice variant,zinc finger region:RING-type,		GO:0000226~microtubule cytoskeleton organization,GO:0001578~microtubule bundle formation,GO:0003006~reproductive developmental process,GO:0006928~cell motion,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007288~sperm axoneme assembly,GO:0007595~lactation,GO:0009296~flagellum assembly,GO:0010927~cellular component assembly involved in morphogenesis,GO:0019953~sexual reproduction,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0030317~sperm motility,GO:0030879~mammary gland development,GO:0032504~multicellular organism reproduction,GO:0032989~cellular component morphogenesis,GO:0035082~axoneme assembly,GO:0035084~flagellar axoneme assembly,GO:0043064~flagellum organization,GO:0048232~male gamete generation,GO:0048515~spermatid differentiation,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0048732~gland development,GO:0048870~cell motility,GO:0051674~localization of cell,	
35091_at35090_g_at	neuregulin 2	Homo sapiens		GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,	h_agrPathway:Agrin in Postsynaptic Differentiation,h_erbB4pathway:g-Secretase mediated ErbB4 Signaling Pathway ,	GO:0008083~growth factor activity,	SM00181:EGF,SM00408:IGc2,		alternative splicing,cell membrane,complete proteome,disulfide bond,egf-like domain,glycoprotein,growth factor,Immunoglobulin domain,membrane,phosphoprotein,Secreted,transmembrane,	hsa04012:ErbB signaling pathway,	IPR000742:EGF-like, type 3,IPR002154:Neuregulin 1-related, C-terminal,IPR003598:Immunoglobulin subtype 2,IPR006209:EGF,IPR006210:EGF-like,IPR007110:Immunoglobulin-like,IPR013032:EGF-like region, conserved site,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,	chain:Neuregulin-2,chain:Pro-neuregulin-2, membrane-bound isoform,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Ser/Thr-rich,disulfide bond,domain:EGF-like,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),modified residue,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,			PIRSF036337:pro-neuregulin-2,
38604_at	neuropeptide Y	Homo sapiens		GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,		GO:0005179~hormone activity,GO:0005184~neuropeptide hormone activity,GO:0005246~calcium channel regulator activity,GO:0016247~channel regulator activity,GO:0031841~neuropeptide Y receptor binding,	SM00309:PAH,		3d-structure,amidation,cleavage on pair of basic residues,complete proteome,neuropeptide,polymorphism,Secreted,signal,	hsa04920:Adipocytokine signaling pathway,	IPR001955:Pancreatic hormone,IPR001955:Pancreatic hormone-like,	helix,modified residue,peptide:C-flanking peptide of NPY,peptide:Neuropeptide Y,sequence conflict,sequence variant,signal peptide,strand,		GO:0003013~circulatory system process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,GO:0007218~neuropeptide signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007586~digestion,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007610~behavior,GO:0007631~feeding behavior,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0008283~cell proliferation,GO:0008343~adult feeding behavior,GO:0009991~response to extracellular stimulus,GO:0015674~di-, tri-valent inorganic cation transport,GO:0019226~transmission of nerve impulse,GO:0019932~second-messenger-mediated signaling,GO:0019935~cyclic-nucleotide-mediated signaling,GO:0030001~metal ion transport,GO:0030534~adult behavior,GO:0031667~response to nutrient levels,GO:0032095~regulation of response to food,GO:0032097~positive regulation of response to food,GO:0032098~regulation of appetite,GO:0032100~positive regulation of appetite,GO:0032101~regulation of response to external stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032104~regulation of response to extracellular stimulus,GO:0032106~positive regulation of response to extracellular stimulus,GO:0032107~regulation of response to nutrient levels,GO:0032109~positive regulation of response to nutrient levels,GO:0045776~negative regulation of blood pressure,GO:0048015~phosphoinositide-mediated signaling,GO:0048584~positive regulation of response to stimulus,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050909~sensory perception of taste,	PIRSF001845:pancreatic hormone,
1355_g_at	neurotrophic tyrosine kinase, receptor, type 2	Homo sapiens		GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016021~integral to membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0033267~axon part,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043195~terminal button,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043679~nerve terminal,GO:0044430~cytoskeletal part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045202~synapse,GO:0048786~presynaptic active zone,GO:0060076~excitatory synapse,		GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005030~neurotrophin receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0019838~growth factor binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043121~neurotrophin binding,GO:0048403~brain-derived neurotrophic factor binding,	SM00013:LRRNT,SM00082:LRRCT,SM00219:TyrKc,SM00408:IGc2,		3d-structure,alternative splicing,ATP,atp-binding,autophosphorylation,complete proteome,developmental protein,differentiation,disulfide bond,glycoprotein,growth factor receptor,Immunoglobulin domain,kinase,leucine-rich repeat,membrane,neurogenesis,nucleotide-binding,phosphoprotein,phosphotransferase,polymorphism,receptor,repeat,signal,tandem repeat,transferase,transmembrane,transmembrane protein,tyrosine-protein kinase,tyrosine-specific protein kinase,	hsa04010:MAPK signaling pathway,hsa04722:Neurotrophin signaling pathway,	IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal,IPR000483:Cysteine-rich flanking region, C-terminal,IPR000719:Protein kinase, core,IPR001245:Tyrosine protein kinase,IPR001611:Leucine-rich repeat,IPR002011:Receptor tyrosine kinase, class II, conserved site,IPR003598:Immunoglobulin subtype 2,IPR007110:Immunoglobulin-like,IPR008266:Tyrosine protein kinase, active site,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,	active site:Proton acceptor,binding site:ATP,chain:BDNF/NT-3 growth factors receptor,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,repeat:LRR 1,repeat:LRR 2,sequence variant,signal peptide,site:Interaction with PLC-gamma-1,site:Interaction with SHC1,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,	Obesity, hyperphagia, and developmental delay,	GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001654~eye development,GO:0001754~eye photoreceptor cell differentiation,GO:0001944~vasculature development,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0006140~regulation of nucleotide metabolic process,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007267~cell-cell signaling,GO:0007423~sensory organ development,GO:0007610~behavior,GO:0007631~feeding behavior,GO:0010647~positive regulation of cell communication,GO:0010975~regulation of neuron projection development,GO:0014047~glutamate secretion,GO:0016310~phosphorylation,GO:0030182~neuron differentiation,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030814~regulation of cAMP metabolic process,GO:0030817~regulation of cAMP biosynthetic process,GO:0031279~regulation of cyclase activity,GO:0031281~positive regulation of cyclase activity,GO:0031344~regulation of cell projection organization,GO:0031547~brain-derived neurotrophic factor receptor signaling pathway,GO:0031644~regulation of neurological system process,GO:0031646~positive regulation of neurological system process,GO:0032940~secretion by cell,GO:0042461~photoreceptor cell development,GO:0042462~eye photoreceptor cell development,GO:0042490~mechanoreceptor differentiation,GO:0043085~positive regulation of catalytic activity,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0045664~regulation of neuron differentiation,GO:0045761~regulation of adenylate cyclase activity,GO:0045762~positive regulation of adenylate cyclase activity,GO:0046530~photoreceptor cell differentiation,GO:0046548~retinal rod cell development,GO:0046777~protein amino acid autophosphorylation,GO:0046903~secretion,GO:0046928~regulation of neurotransmitter secretion,GO:0048514~blood vessel morphogenesis,GO:0048592~eye morphogenesis,GO:0048666~neuron development,GO:0050767~regulation of neurogenesis,GO:0050773~regulation of dendrite development,GO:0050804~regulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0051046~regulation of secretion,GO:0051240~positive regulation of multicellular organismal process,GO:0051339~regulation of lyase activity,GO:0051349~positive regulation of lyase activity,GO:0051588~regulation of neurotransmitter transport,GO:0051960~regulation of nervous system development,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0051969~regulation of transmission of nerve impulse,GO:0051971~positive regulation of transmission of nerve impulse,GO:0060284~regulation of cell development,GO:0060341~regulation of cellular localization,	PIRSF000623:tyrosine-protein kinase, BDNF/NT/NGF receptor type,
1419_g_at	nitric oxide synthase 2, inducible	Homo sapiens	8.MonocytesIFNF_IL4,	GO:0005777~peroxisome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005938~cell cortex,GO:0030863~cortical cytoskeleton,GO:0042579~microbody,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044448~cell cortex part,GO:0048471~perinuclear region of cytoplasm,	h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004517~nitric-oxide synthase activity,GO:0005506~iron ion binding,GO:0005509~calcium ion binding,GO:0005516~calmodulin binding,GO:0008270~zinc ion binding,GO:0008603~cAMP-dependent protein kinase regulator activity,GO:0009055~electron carrier activity,GO:0010181~FMN binding,GO:0016597~amino acid binding,GO:0017076~purine nucleotide binding,GO:0019207~kinase regulator activity,GO:0019887~protein kinase regulator activity,GO:0020037~heme binding,GO:0030554~adenyl nucleotide binding,GO:0031406~carboxylic acid binding,GO:0034617~tetrahydrobiopterin binding,GO:0034618~arginine binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043176~amine binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,GO:0046983~protein dimerization activity,GO:0048037~cofactor binding,GO:0050660~FAD binding,GO:0050661~NADP or NADPH binding,GO:0050662~coenzyme binding,		Inorganic ion transport and metabolism,	3d-structure,alternative splicing,calcium,calmodulin-binding,complete proteome,FAD,fmn,heme,iron,metal-binding,nadp,oxidoreductase,phosphoprotein,polymorphism,zinc,	hsa00330:Arginine and proline metabolism,hsa04020:Calcium signaling pathway,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	IPR001094:Flavodoxin-like,IPR001433:Oxidoreductase FAD/NAD(P)-binding,IPR001709:Flavoprotein pyridine nucleotide cytochrome reductase,IPR003097:FAD-binding, type 1,IPR004030:Nitric oxide synthase, oxygenase region,IPR008254:Flavodoxin/nitric oxide synthase,IPR012144:Nitric-oxide synthase,IPR017927:Ferredoxin reductase-type FAD-binding domain,	chain:Nitric oxide synthase, inducible,domain:FAD-binding FR-type,domain:Flavodoxin-like,helix,metal ion-binding site:Iron (heme axial ligand),metal ion-binding site:Zinc,modified residue,nucleotide phosphate-binding region:FAD,nucleotide phosphate-binding region:FMN,nucleotide phosphate-binding region:NADP,region of interest:Calmodulin-binding,sequence conflict,sequence variant,splice variant,strand,turn,	Hypertension, susceptibility to,Malaria, resistance to,	GO:0001568~blood vessel development,GO:0001666~response to hypoxia,GO:0001910~regulation of leukocyte mediated cytotoxicity,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0001935~endothelial cell proliferation,GO:0001944~vasculature development,GO:0001974~blood vessel remodeling,GO:0002227~innate immune response in mucosa,GO:0002251~organ or tissue specific immune response,GO:0002385~mucosal immune response,GO:0002684~positive regulation of immune system process,GO:0002697~regulation of immune effector process,GO:0002699~positive regulation of immune effector process,GO:0002791~regulation of peptide secretion,GO:0003013~circulatory system process,GO:0006525~arginine metabolic process,GO:0006527~arginine catabolic process,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0006801~superoxide metabolic process,GO:0006809~nitric oxide biosynthetic process,GO:0006952~defense response,GO:0006955~immune response,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,GO:0007199~G-protein signaling, coupled to cGMP nucleotide second messenger,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0008015~blood circulation,GO:0008016~regulation of heart contraction,GO:0008217~regulation of blood pressure,GO:0008283~cell proliferation,GO:0009063~cellular amino acid catabolic process,GO:0009064~glutamine family amino acid metabolic process,GO:0009065~glutamine family amino acid catabolic process,GO:0009310~amine catabolic process,GO:0009617~response to bacterium,GO:0016054~organic acid catabolic process,GO:0019932~second-messenger-mediated signaling,GO:0019934~cGMP-mediated signaling,GO:0019935~cyclic-nucleotide-mediated signaling,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0031341~regulation of cell killing,GO:0031343~positive regulation of cell killing,GO:0042127~regulation of cell proliferation,GO:0042742~defense response to bacterium,GO:0043457~regulation of cellular respiration,GO:0043467~regulation of generation of precursor metabolites and energy,GO:0043900~regulation of multi-organism process,GO:0043902~positive regulation of multi-organism process,GO:0044057~regulation of system process,GO:0044271~nitrogen compound biosynthetic process,GO:0045087~innate immune response,GO:0046209~nitric oxide metabolic process,GO:0046395~carboxylic acid catabolic process,GO:0046883~regulation of hormone secretion,GO:0048384~retinoic acid receptor signaling pathway,GO:0048514~blood vessel morphogenesis,GO:0048771~tissue remodeling,GO:0050796~regulation of insulin secretion,GO:0050829~defense response to Gram-negative bacterium,GO:0051046~regulation of secretion,GO:0051709~regulation of killing of cells of another organism,GO:0051712~positive regulation of killing of cells of another organism,GO:0055114~oxidation reduction,GO:0060341~regulation of cellular localization,GO:0070482~response to oxygen levels,	PIRSF000333:nitric-oxide synthase, inducible,PIRSF000333:NOS,
34720_at	nuclear factor I/B	Homo sapiens		GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,		GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043566~structure-specific DNA binding,	SM00523:DWA,		activator,alternative splicing,complete proteome,dna replication,dna-binding,nucleus,phosphoprotein,Transcription,transcription regulation,		IPR000647:CTF transcription factor/nuclear factor 1,IPR003619:MAD homology 1, Dwarfin-type,IPR019548:CTF transcription factor/nuclear factor 1, N-terminal,IPR019739:CTF transcription factor/nuclear factor 1, conserved site,	chain:Nuclear factor 1 B-type,DNA-binding region:CTF/NF-I,modified residue,sequence conflict,splice variant,		GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008285~negative regulation of cell proliferation,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0030900~forebrain development,GO:0030902~hindbrain development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0035295~tube development,GO:0042127~regulation of cell proliferation,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060541~respiratory system development,	PIRSF018476:nuclear factor 1,
40271_at	nucleoporin 93kDa	Homo sapiens		GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0046930~pore complex,					acetylation,complete proteome,mRNA transport,nuclear pore complex,nucleus,phosphoprotein,polymorphism,protein transport,translocation,transport,		IPR007231:Nucleoporin interacting component Nup93/Nic96,	chain:Nuclear pore complex protein Nup93,modified residue,sequence variant,		GO:0006403~RNA localization,GO:0008104~protein localization,GO:0015031~protein transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0045184~establishment of protein localization,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051236~establishment of RNA localization,GO:0055085~transmembrane transport,	
34539_at	olfactory receptor, family 7, subfamily E, member 35 pseudogene	Homo sapiens		GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,		GO:0004984~olfactory receptor activity,			receptor,		IPR000276:7TM GPCR, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like superfamily,			GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,	
35903_at	oligodendrocyte myelin glycoprotein	Homo sapiens		GO:0005886~plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,			SM00013:LRRNT,SM00369:LRR_TYP,	Function unknown,	blocked carboxyl end,cell adhesion,cell membrane,complete proteome,direct protein sequencing,glycoprotein,gpi-anchor,leucine-rich repeat,lipoprotein,membrane,phosphatidylinositol linkage,phosphoprotein,polymorphism,repeat,signal,tandem repeat,		IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,	chain:Oligodendrocyte-myelin glycoprotein,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8; truncated,repeat:Ser/Thr-rich,sequence variant,signal peptide,		GO:0007155~cell adhesion,GO:0010721~negative regulation of cell development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010975~regulation of neuron projection development,GO:0022604~regulation of cell morphogenesis,GO:0022610~biological adhesion,GO:0031344~regulation of cell projection organization,GO:0031345~negative regulation of cell projection organization,GO:0045596~negative regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0050770~regulation of axonogenesis,GO:0050771~negative regulation of axonogenesis,GO:0051129~negative regulation of cellular component organization,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,	
36696_at	phosphatidylinositol glycan anchor biosynthesis, class C	Homo sapiens		GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044432~endoplasmic reticulum part,		GO:0008375~acetylglucosaminyltransferase activity,GO:0017176~phosphatidylinositol N-acetylglucosaminyltransferase activity,			complete proteome,endoplasmic reticulum,glycosyltransferase,gpi-anchor biosynthesis,membrane,polymorphism,transferase,transmembrane,	hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,	IPR009450:Phosphatidylinositol N-acetylglucosaminyltransferase,	chain:Phosphatidylinositol N- acetylglucosaminyltransferase subunit C,sequence variant,transmembrane region,		GO:0006497~protein amino acid lipidation,GO:0006505~GPI anchor metabolic process,GO:0006506~GPI anchor biosynthetic process,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0008610~lipid biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0016254~preassembly of GPI anchor in ER membrane,GO:0019637~organophosphate metabolic process,GO:0030384~phosphoinositide metabolic process,GO:0042157~lipoprotein metabolic process,GO:0042158~lipoprotein biosynthetic process,GO:0045017~glycerolipid biosynthetic process,GO:0046474~glycerophospholipid biosynthetic process,GO:0046486~glycerolipid metabolic process,GO:0046489~phosphoinositide biosynthetic process,	PIRSF016104:GPI2,
32418_at	phosphodiesterase 1C, calmodulin-dependent 70kDa	Homo sapiens		GO:0005829~cytosol,		GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004117~calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,GO:0005516~calmodulin binding,GO:0008081~phosphoric diester hydrolase activity,GO:0016208~AMP binding,GO:0017076~purine nucleotide binding,GO:0030551~cyclic nucleotide binding,GO:0030552~cAMP binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,	SM00471:HDc,		3d-structure,alternative splicing,calmodulin-binding,camp,cGMP,complete proteome,hydrolase,metal-binding,phosphoprotein,	hsa00230:Purine metabolism,hsa04020:Calcium signaling pathway,hsa04740:Olfactory transduction,	IPR002073:3'5'-cyclic nucleotide phosphodiesterase,IPR003607:Metal-dependent phosphohydrolase, HD region,IPR013706:3'5'-cyclic nucleotide phosphodiesterase N-terminal,	active site:Proton donor,chain:Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C,helix,metal ion-binding site:Divalent metal cation 1,metal ion-binding site:Divalent metal cation 2,modified residue,region of interest:Catalytic,splice variant,strand,turn,		GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0050877~neurological system process,GO:0050890~cognition,	
35373_at	phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	Homo sapiens	104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,2.Cytokine_Receptors,37.Akt-PKB_Effector_of_P13K_in_Vivo,63.LAT_couples_T-cell_receptor,	GO:0005829~cytosol,GO:0005942~phosphoinositide 3-kinase complex,GO:0005943~1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex,GO:0044445~cytosolic part,	h_aktPathway:AKT Signaling Pathway,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_crebPathway:Transcription factor CREB and its extracellular signals,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_egfPathway:EGF Signaling Pathway,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_igf1mtorpathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_mTORPathway:mTOR Signaling Pathway,h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_RacCycDPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_trkaPathway:Trka Receptor Signaling Pathway,	GO:0005158~insulin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005543~phospholipid binding,GO:0005545~phosphatidylinositol binding,GO:0008289~lipid binding,GO:0017046~peptide hormone binding,GO:0019207~kinase regulator activity,GO:0019899~enzyme binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0032403~protein complex binding,GO:0035014~phosphoinositide 3-kinase regulator activity,GO:0035091~phosphoinositide binding,GO:0042277~peptide binding,GO:0042562~hormone binding,GO:0043125~ErbB-3 class receptor binding,GO:0043559~insulin binding,GO:0043560~insulin receptor substrate binding,	SM00252:SH2,SM00324:RhoGAP,SM00326:SH3,	Cell division and chromosome partitioning,	3d-structure,acetylation,alternative splicing,complete proteome,disease mutation,host-virus interaction,phosphoprotein,phosphotransferase,polymorphism,repeat,SH2 domain,sh3 domain,ubl conjugation,	hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04150:mTOR signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04930:Type II diabetes mellitus,hsa04960:Aldosterone-regulated sodium reabsorption,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,	IPR000198:RhoGAP,IPR000980:SH2 motif,IPR001452:Src homology-3 domain,IPR001720:PI3 kinase, P85 regulatory subunit,	chain:Phosphatidylinositol 3-kinase regulatory subunit alpha,domain:Rho-GAP,domain:SH2 1,domain:SH2 2,domain:SH3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,		GO:0001775~cell activation,GO:0001952~regulation of cell-matrix adhesion,GO:0001953~negative regulation of cell-matrix adhesion,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007162~negative regulation of cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0008286~insulin receptor signaling pathway,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0010810~regulation of cell-substrate adhesion,GO:0010812~negative regulation of cell-substrate adhesion,GO:0010827~regulation of glucose transport,GO:0010828~positive regulation of glucose transport,GO:0014065~phosphoinositide 3-kinase cascade,GO:0016310~phosphorylation,GO:0019637~organophosphate metabolic process,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030155~regulation of cell adhesion,GO:0030183~B cell differentiation,GO:0030258~lipid modification,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030384~phosphoinositide metabolic process,GO:0032868~response to insulin stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0032880~regulation of protein localization,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042113~B cell activation,GO:0043434~response to peptide hormone stimulus,GO:0045321~leukocyte activation,GO:0046324~regulation of glucose import,GO:0046326~positive regulation of glucose import,GO:0046486~glycerolipid metabolic process,GO:0046649~lymphocyte activation,GO:0046834~lipid phosphorylation,GO:0046854~phosphoinositide phosphorylation,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048534~hemopoietic or lymphoid organ development,GO:0051050~positive regulation of transport,GO:0051130~positive regulation of cellular component organization,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0060396~growth hormone receptor signaling pathway,GO:0060416~response to growth hormone stimulus,GO:0070201~regulation of establishment of protein localization,GO:0090003~regulation of establishment of protein localization to plasma membrane,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,	PIRSF038271:phosphatidylinositol 3-kinase, regulatory subunit, p85 type,
40959_at	pleckstrin homology domain containing, family G (with RhoGef domain) member 3	Homo sapiens				GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,	SM00233:PH,SM00325:RhoGEF,		alternative splicing,complete proteome,phosphoprotein,polymorphism,		IPR000219:Dbl homology (DH) domain,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR001849:Pleckstrin homology,IPR011993:Pleckstrin homology-type,	chain:Pleckstrin homology domain-containing family G member 3,compositionally biased region:Poly-Glu,compositionally biased region:Ser-rich,domain:DH,domain:PH,modified residue,sequence conflict,sequence variant,splice variant,		GO:0035023~regulation of Rho protein signal transduction,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,	
35956_s_at	pregnancy specific beta-1-glycoprotein 7; pregnancy specific beta-1-glycoprotein 8; pregnancy specific beta-1-glycoprotein 4	Homo sapiens		GO:0005576~extracellular region,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,			SM00408:IGc2,SM00409:IG,		alternative splicing,complete proteome,disulfide bond,duplication,glycoprotein,Immunoglobulin domain,plasma,polymorphism,Pregnancy,repeat,Secreted,signal,tandem repeat,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like,IPR013106:Immunoglobulin V-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	chain:Pregnancy-specific beta-1-glycoprotein 4,chain:Pregnancy-specific beta-1-glycoprotein 8,chain:Putative pregnancy-specific beta-1- glycoprotein 7,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,		GO:0006952~defense response,GO:0007565~female pregnancy,	
38948_at	protein phosphatase 1, regulatory (inhibitor) subunit 3D	Homo sapiens				GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0016791~phosphatase activity,			carbohydrate metabolism,complete proteome,glycogen metabolism,phosphoprotein,	hsa04910:Insulin signaling pathway,	IPR005036:Putative phosphatase regulatory subunit,IPR017434:Protein phosphatase 1, glycogen targeting subunit, Metazoa.,	chain:Protein phosphatase 1 regulatory subunit 3D,domain:CBM21,modified residue,short sequence motif:PP1-binding motif,		GO:0005976~polysaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006073~cellular glucan metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006112~energy reserve metabolic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0019318~hexose metabolic process,GO:0044042~glucan metabolic process,GO:0044264~cellular polysaccharide metabolic process,	PIRSF038207:PP1_GT_animal,PIRSF038207:protein phosphatase 1, glycogen targeting subunit, animal type,
38646_s_at	regenerating islet-derived 1 alpha; regenerating islet-derived 1 pseudogene	Homo sapiens				GO:0005529~sugar binding,GO:0008083~growth factor activity,GO:0030246~carbohydrate binding,	SM00034:CLECT,		3d-structure,alzheimer disease,complete proteome,direct protein sequencing,disulfide bond,down syndrome,glycoprotein,Lectin,pancreas,pyroglutamic acid,Pyrrolidone carboxylic acid,signal,		IPR001304:C-type lectin,IPR003990:Pancreatitis-associated protein,IPR016186:C-type lectin-like,IPR018378:C-type lectin, conserved site,	chain:Lithostathine-1-alpha,disulfide bond,domain:C-type lectin,glycosylation site:O-linked (GlcNAc...),helix,modified residue,sequence conflict,signal peptide,strand,		GO:0008284~positive regulation of cell proliferation,GO:0042127~regulation of cell proliferation,	PIRSF002422:tetranectin,
36766_at	ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)	Homo sapiens		GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005764~lysosome,GO:0005773~vacuole,		GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0004522~pancreatic ribonuclease activity,GO:0004540~ribonuclease activity,GO:0016892~endoribonuclease activity, producing 3'-phosphomonoesters,GO:0016894~endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,	SM00092:RNAse_Pc,		3d-structure,chemotaxis,complete proteome,direct protein sequencing,disulfide bond,Endonuclease,glycoprotein,hydrolase,lysosome,neurotoxin,nitration,nuclease,polymorphism,signal,		IPR001427:Pancreatic ribonuclease,	active site:Proton acceptor,active site:Proton donor,chain:Non-secretory ribonuclease,disulfide bond,glycosylation site:C-linked (Man),glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Substrate binding,sequence conflict,sequence variant,signal peptide,strand,turn,		GO:0006401~RNA catabolic process,GO:0006935~chemotaxis,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0009057~macromolecule catabolic process,GO:0042330~taxis,GO:0044265~cellular macromolecule catabolic process,	PIRSF001015:pyrimidine-specific ribonuclease/angiogenin,
33979_at	ribonuclease, RNase A family, 3 (eosinophil cationic protein)	Homo sapiens		GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005625~soluble fraction,		GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0004522~pancreatic ribonuclease activity,GO:0004540~ribonuclease activity,GO:0016892~endoribonuclease activity, producing 3'-phosphomonoesters,GO:0016894~endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,	SM00092:RNAse_Pc,		3d-structure,antibiotic,Antimicrobial,complete proteome,direct protein sequencing,disulfide bond,Endonuclease,glycoprotein,hydrolase,nitration,nuclease,polymorphism,signal,	hsa05310:Asthma,	IPR001427:Pancreatic ribonuclease,	active site:Proton acceptor,active site:Proton donor,chain:Eosinophil cationic protein,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Substrate binding,sequence variant,signal peptide,strand,		GO:0006401~RNA catabolic process,GO:0006952~defense response,GO:0009057~macromolecule catabolic process,GO:0009617~response to bacterium,GO:0042742~defense response to bacterium,GO:0044265~cellular macromolecule catabolic process,	
39187_at	runt-related transcription factor 2	Homo sapiens		GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,		GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0005524~ATP binding,GO:0016563~transcription activator activity,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,			alternative splicing,complete proteome,disease mutation,dna-binding,nucleus,phosphoprotein,polymorphism,Transcription,transcription regulation,		IPR000040:Acute myeloid leukemia 1 protein (AML 1)/Runt,IPR012346:p53 and RUNT-type transcription factor, DNA-binding,IPR013524:Acute myeloid leukemia 1 (AML 1)/Runt,IPR013711:Runx inhibition,IPR016554:Transcription factor, Runt-related, RUNX,	chain:Runt-related transcription factor 2,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Pro/Ser/Thr-rich,domain:Runt,region of interest:Interaction with MYST3,region of interest:Interaction with MYST4,sequence conflict,sequence variant,splice variant,	Cleidocranial dysplasia,Dental anomalies, isolated,Many sequence variants affecting diversity of adult human height,	GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001649~osteoblast differentiation,GO:0001958~endochondral ossification,GO:0002051~osteoblast fate commitment,GO:0002062~chondrocyte differentiation,GO:0002063~chondrocyte development,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0008589~regulation of smoothened signaling pathway,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0016481~negative regulation of transcription,GO:0021700~developmental maturation,GO:0030278~regulation of ossification,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032330~regulation of chondrocyte differentiation,GO:0032332~positive regulation of chondrocyte differentiation,GO:0040036~regulation of fibroblast growth factor receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042481~regulation of odontogenesis,GO:0042487~regulation of odontogenesis of dentine-containing tooth,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045778~positive regulation of ossification,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048705~skeletal system morphogenesis,GO:0051094~positive regulation of developmental process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051216~cartilage development,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060348~bone development,GO:0060349~bone morphogenesis,GO:0060350~endochondral bone morphogenesis,	PIRSF009374:runt-related transcription factor RUNX,PIRSF009374:TF_Runt-rel_RUNX,
36328_at	sex hormone-binding globulin	Homo sapiens		GO:0005576~extracellular region,		GO:0005496~steroid binding,GO:0005497~androgen binding,GO:0008289~lipid binding,GO:0042562~hormone binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,	SM00282:LamG,		3d-structure,alternative splicing,complete proteome,direct protein sequencing,disulfide bond,glycoprotein,homodimer,lipid-binding,plasma,polymorphism,repeat,Secreted,signal,steroid binding,steroid-binding,		IPR001791:Laminin G,IPR012679:Laminin G, subdomain 1,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,	chain:Sex hormone-binding globulin,disulfide bond,domain:Laminin G-like 1,domain:Laminin G-like 2,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); when associated with variant N-356,glycosylation site:O-linked (GalNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,	A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs),	GO:0003006~reproductive developmental process,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0007285~primary spermatocyte growth,GO:0008361~regulation of cell size,GO:0009914~hormone transport,GO:0010817~regulation of hormone levels,GO:0016049~cell growth,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0032535~regulation of cellular component size,GO:0040007~growth,GO:0048232~male gamete generation,GO:0048588~developmental cell growth,GO:0048589~developmental growth,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,	PIRSF002538:sex steroid-binding protein,
33077_at	sidekick homolog 1, cell adhesion molecule (chicken); hypothetical LOC730351	Homo sapiens		GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,			SM00060:FN3,SM00408:IGc2,SM00409:IG,		alternative splicing,cell adhesion,complete proteome,disulfide bond,glycoprotein,Immunoglobulin domain,membrane,polymorphism,repeat,signal,transmembrane,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR003962:Fibronectin, type III subdomain,IPR007110:Immunoglobulin-like,IPR008957:Fibronectin, type III-like fold,IPR013098:Immunoglobulin I-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	chain:Protein sidekick-1,compositionally biased region:Pro-rich,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 10,domain:Fibronectin type-III 11,domain:Fibronectin type-III 12,domain:Fibronectin type-III 13,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0007155~cell adhesion,GO:0022610~biological adhesion,	
39511_at	similar to Afadin (Protein AF-6); myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4	Homo sapiens		GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0030054~cell junction,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,		GO:0008022~protein C-terminus binding,	SM00228:PDZ,SM00240:FHA,SM00314:RA,		3d-structure,alternative splicing,cell adhesion,cell junction,chromosomal rearrangement,coiled coil,complete proteome,phosphoprotein,Proto-oncogene,repeat,	hsa04520:Adherens junction,hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,	IPR000159:Ras-association,IPR000253:Forkhead-associated,IPR001478:PDZ/DHR/GLGF,IPR002710:Dilute,IPR018444:Dil domain,	chain:Afadin,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Glu/Lys-rich,compositionally biased region:Pro-rich,domain:Dilute,domain:FHA,domain:PDZ,domain:Ras-associating 1,domain:Ras-associating 2,helix,modified residue,sequence conflict,site:Breakpoint for translocation to form MLL- MLLT4,splice variant,strand,		GO:0007155~cell adhesion,GO:0007267~cell-cell signaling,GO:0022610~biological adhesion,	
36234_at	similar to eukaryotic translation initiation factor 4A; small nucleolar RNA, H/ACA box 67; eukaryotic translation initiation factor 4A, isoform 1	Homo sapiens		GO:0005829~cytosol,GO:0016281~eukaryotic translation initiation factor 4F complex,	h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_iresPathway:Internal Ribosome entry pathway,h_mTORPathway:mTOR Signaling Pathway,	GO:0000166~nucleotide binding,GO:0000339~RNA cap binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003743~translation initiation factor activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008135~translation factor activity, nucleic acid binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0070035~purine NTP-dependent helicase activity,	SM00487:DEXDc,SM00490:HELICc,		3d-structure,acetylation,ATP,atp-binding,complete proteome,helicase,hydrolase,Initiation factor,nucleotide binding,nucleotide-binding,P-loop,phosphoprotein,protein biosynthesis,RNA binding,rna-binding,		IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:DNA/RNA helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:DEAD-like helicase, N-terminal,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR014021:Helicase, superfamily 1 and 2, ATP-binding,	chain:Eukaryotic initiation factor 4A-I,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,short sequence motif:DEAD box,short sequence motif:Q motif,strand,turn,		GO:0006412~translation,	PIRSF003023:translation initiation factor eIF-4A,
31512_at	similar to hCG26659; immunoglobulin kappa constant; similar to Ig kappa chain V-I region HK102 precursor	Homo sapiens		GO:0005576~extracellular region,		GO:0003823~antigen binding,	SM00406:IGv,SM00407:IGc1,		3d-structure,complete proteome,direct protein sequencing,disulfide bond,heterotetramer,immunoglobulin,immunoglobulin c region,Immunoglobulin domain,immunoglobulin v region,signal,		IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003596:Immunoglobulin V-set, subgroup,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	chain:anti-RhD monoclonal T125 kappa light chain,chain:Ig kappa chain C region,chain:Ig kappa chain V-I region HK101,chain:Ig kappa chain V-I region Walker,disulfide bond,domain:Ig-like,helix,region of interest:Complementarity-determining-1,region of interest:Complementarity-determining-2,region of interest:Complementarity-determining-3,region of interest:Framework-1,region of interest:Framework-2,region of interest:Framework-3,region of interest:Framework-4,sequence conflict,sequence variant,signal peptide,strand,turn,	Kappa light chain deficiency,	GO:0006955~immune response,	PIRSF001974:immunoglobulin V region,
41489_at	similar to transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila); transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)	Homo sapiens		GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,	h_wntPathway:WNT Signaling Pathway,	GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,	SM00320:WD40,		3d-structure,complete proteome,direct protein sequencing,nucleus,phosphoprotein,repeat,repressor,Transcription,transcription regulation,wd repeat,wnt signaling pathway,		IPR001680:WD40 repeat,IPR005617:Groucho/TLE, N-terminal Q-rich region,IPR009146:Groucho/transducin-like enhancer,IPR015943:WD40/YVTN repeat-like,IPR017986:WD40 repeat, region,IPR019775:WD40 repeat, conserved site,IPR019781:WD40 repeat, subgroup,IPR019782:WD40 repeat 2,	chain:Transducin-like enhancer protein 1,compositionally biased region:Gln-rich,compositionally biased region:Gly/Pro-rich,compositionally biased region:Pro/Ser-rich,modified residue,mutagenesis site,region of interest:CCN domain,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence conflict,short sequence motif:Nuclear localization signal,strand,turn,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007166~cell surface receptor linked signal transduction,GO:0009890~negative regulation of biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0016055~Wnt receptor signaling pathway,GO:0016481~negative regulation of transcription,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0030178~negative regulation of Wnt receptor signaling pathway,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,	
37097_at	solute carrier family 17 (sodium phosphate), member 1	Homo sapiens		GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,		GO:0008509~anion transmembrane transporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0015114~phosphate transmembrane transporter activity,GO:0015293~symporter activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,			alternative splicing,complete proteome,glycoprotein,ion transport,membrane,polymorphism,Sodium,Sodium transport,Symport,transmembrane,transport,		IPR004745:Na-dependent inorganic phosphate cotransporter,IPR011701:Major facilitator superfamily MFS-1,	chain:Sodium-dependent phosphate transport protein 1,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,transmembrane region,	Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels,	GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006817~phosphate transport,GO:0006820~anion transport,GO:0015672~monovalent inorganic cation transport,GO:0015698~inorganic anion transport,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,	
34436_at	solute carrier family 17 (sodium phosphate), member 3	Homo sapiens		GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,		GO:0005436~sodium:phosphate symporter activity,GO:0008509~anion transmembrane transporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0015114~phosphate transmembrane transporter activity,GO:0015293~symporter activity,GO:0015294~solute:cation symporter activity,GO:0015296~anion:cation symporter activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,			complete proteome,endoplasmic reticulum,glycoprotein,ion transport,membrane,phosphoprotein,polymorphism,Sodium,Sodium transport,Symport,transmembrane,transport,		IPR011701:Major facilitator superfamily MFS-1,IPR017373:Sodium-dependent phosphate transport protein 4 , predicted,	chain:Sodium-dependent phosphate transport protein 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,transmembrane region,	Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study,	GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,	PIRSF038072:Na(+)/PI_cotransporter4_prd,
32084_at	solute carrier family 22 (organic cation/carnitine transporter), member 5	Homo sapiens		GO:0005886~plasma membrane,GO:0005903~brush border,GO:0016021~integral to membrane,GO:0016324~apical plasma membrane,GO:0031224~intrinsic to membrane,GO:0031253~cell projection membrane,GO:0031526~brush border membrane,GO:0042995~cell projection,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045177~apical part of cell,		GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005275~amine transmembrane transporter activity,GO:0005524~ATP binding,GO:0015101~organic cation transmembrane transporter activity,GO:0015226~carnitine transporter activity,GO:0015238~drug transporter activity,GO:0015293~symporter activity,GO:0015651~quaternary ammonium group transmembrane transporter activity,GO:0017076~purine nucleotide binding,GO:0019904~protein domain specific binding,GO:0022890~inorganic cation transmembrane transporter activity,GO:0030165~PDZ domain binding,GO:0030554~adenyl nucleotide binding,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0051183~vitamin transporter activity,GO:0051184~cofactor transporter activity,			alternative splicing,atp-binding,complete proteome,disease mutation,glycoprotein,ion transport,membrane,nucleotide-binding,phosphoprotein,polymorphism,Sodium,Sodium transport,Symport,transmembrane,transport,		IPR004749:Organic cation transport protein,IPR005829:Sugar transporter, conserved site,IPR011701:Major facilitator superfamily MFS-1,	chain:Solute carrier family 22 member 5,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,	Carnitine deficiency, systemic primary,	GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006865~amino acid transport,GO:0009372~quorum sensing,GO:0015672~monovalent inorganic cation transport,GO:0015695~organic cation transport,GO:0015697~quaternary ammonium group transport,GO:0015837~amine transport,GO:0015838~betaine transport,GO:0015849~organic acid transport,GO:0015879~carnitine transport,GO:0015893~drug transport,GO:0030001~metal ion transport,GO:0032844~regulation of homeostatic process,GO:0032846~positive regulation of homeostatic process,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0044057~regulation of system process,GO:0044058~regulation of digestive system process,GO:0046942~carboxylic acid transport,GO:0048872~homeostasis of number of cells,GO:0048874~homeostasis of number of cells in a free-living population,GO:0051180~vitamin transport,GO:0051181~cofactor transport,GO:0051240~positive regulation of multicellular organismal process,GO:0052097~interspecies quorum sensing,GO:0052106~quorum sensing during interaction with host,GO:0055085~transmembrane transport,GO:0060456~positive regulation of digestive system process,GO:0060730~regulation of intestinal epithelial structure maintenance,GO:0060731~positive regulation of intestinal epithelial structure maintenance,GO:0070715~sodium-dependent organic cation transport,	
35121_at	solute carrier family 6 (neurotransmitter transporter, taurine), member 6	Homo sapiens		GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,		GO:0001761~beta-alanine transmembrane transporter activity,GO:0005275~amine transmembrane transporter activity,GO:0005326~neurotransmitter transporter activity,GO:0005328~neurotransmitter:sodium symporter activity,GO:0005343~organic acid:sodium symporter activity,GO:0005368~taurine transmembrane transporter activity,GO:0005369~taurine:sodium symporter activity,GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015175~neutral amino acid transmembrane transporter activity,GO:0015293~symporter activity,GO:0015294~solute:cation symporter activity,GO:0015370~solute:sodium symporter activity,GO:0030977~taurine binding,GO:0043176~amine binding,		General function prediction only,	complete proteome,glycoprotein,membrane,neurotransmitter transport,phosphoprotein,polymorphism,Symport,transmembrane,transmembrane protein,transport,		IPR000175:Sodium:neurotransmitter symporter,IPR002434:Sodium:neurotransmitter symporter, taurine,	chain:Sodium- and chloride-dependent taurine transporter,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0001762~beta-alanine transport,GO:0006836~neurotransmitter transport,GO:0006865~amino acid transport,GO:0015718~monocarboxylic acid transport,GO:0015734~taurine transport,GO:0015804~neutral amino acid transport,GO:0015837~amine transport,GO:0015849~organic acid transport,GO:0046942~carboxylic acid transport,	PIRSF002444:gamma-aminobutyric acid transporter,
35439_at	splicing factor 1	Homo sapiens		GO:0005681~spliceosome,GO:0005730~nucleolus,GO:0005840~ribosome,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,		GO:0003702~RNA polymerase II transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,	SM00322:KH,SM00343:ZnF_C2HC,	RNA processing and modification,	3d-structure,acetylation,alternative splicing,complete proteome,direct protein sequencing,metal-binding,mrna processing,mrna splicing,nucleus,phosphoprotein,polymorphism,repressor,rna-binding,Spliceosome,Transcription,transcription regulation,zinc,zinc-finger,		IPR001878:Zinc finger, CCHC-type,IPR004087:K Homology,IPR004088:K Homology, type 1,IPR018111:K Homology, type 1, subgroup,	chain:Splicing factor 1,compositionally biased region:Pro-rich,domain:KH,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,zinc finger region:CCHC-type,		GO:0000245~spliceosome assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000389~nuclear mRNA 3'-splice site recognition,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006376~mRNA splice site selection,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0007049~cell cycle,GO:0007530~sex determination,GO:0007548~sex differentiation,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0016071~mRNA metabolic process,GO:0019216~regulation of lipid metabolic process,GO:0019218~regulation of steroid metabolic process,GO:0022402~cell cycle process,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0030238~male sex determination,GO:0033327~Leydig cell differentiation,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0042127~regulation of cell proliferation,GO:0043933~macromolecular complex subunit organization,GO:0045137~development of primary sexual characteristics,GO:0045449~regulation of transcription,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0046890~regulation of lipid biosynthetic process,GO:0048608~reproductive structure development,GO:0048610~reproductive cellular process,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0050810~regulation of steroid biosynthetic process,GO:0065003~macromolecular complex assembly,	
38691_s_at	surfactant protein C	Homo sapiens		GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,			SM00019:SF_P,		alternative splicing,complete proteome,direct protein sequencing,disease mutation,gaseous exchange,lipoprotein,lung,palmitate,phosphoprotein,polymorphism,pulmonary surfactant,respiratory distress syndrome,Secreted,surface film,thiolester bond,		IPR001729:Surfactant-associated polypeptide,IPR007084:BRICHOS,IPR015091:Surfactant protein C, N-terminal propeptide,IPR018051:Surfactant-associated polypeptide, palmitoylation site,	chain:Pulmonary surfactant-associated protein C,domain:BRICHOS,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,sequence conflict,sequence variant,splice variant,	Pulmonary alveolar proteinosis,Pulmonary fibrosis, idiopathic, familial,Surfactant metabolism dysfunction, pulmonary, 2,Surfactant protein C deficiency,	GO:0007585~respiratory gaseous exchange,	PIRSF002432:pulmonary surfactant protein C,
38508_s_at	tenascin XB; tenascin XA pseudogene	Homo sapiens		GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005583~fibrillar collagen,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,		GO:0001871~pattern binding,GO:0005178~integrin binding,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0032403~protein complex binding,	SM00060:FN3,SM00181:EGF,SM00186:FBG,		3d-structure,alternative splicing,cell adhesion,coiled coil,complete proteome,direct protein sequencing,disulfide bond,egf-like domain,Ehlers-Danlos syndrome,extracellular matrix,glycoprotein,phosphoprotein,polymorphism,pseudogene,repeat,Secreted,signal,	hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,	IPR000742:EGF-like, type 3,IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular,IPR003961:Fibronectin, type III,IPR006210:EGF-like,IPR008957:Fibronectin, type III-like fold,IPR013032:EGF-like region, conserved site,IPR013111:EGF, extracellular,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,	chain:Putative tenascin-XA,chain:Tenascin-X,disulfide bond,domain:EGF-like 10,domain:EGF-like 11,domain:EGF-like 12,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 15,domain:EGF-like 16,domain:EGF-like 17,domain:EGF-like 18,domain:EGF-like 19,domain:EGF-like 1; incomplete,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:Fibrinogen C-terminal,domain:Fibronectin type-III 1,domain:Fibronectin type-III 10,domain:Fibronectin type-III 11,domain:Fibronectin type-III 12,domain:Fibronectin type-III 13,domain:Fibronectin type-III 14,domain:Fibronectin type-III 15,domain:Fibronectin type-III 16,domain:Fibronectin type-III 17,domain:Fibronectin type-III 18,domain:Fibronectin type-III 19,domain:Fibronectin type-III 2,domain:Fibronectin type-III 20,domain:Fibronectin type-III 21,domain:Fibronectin type-III 22,domain:Fibronectin type-III 23,domain:Fibronectin type-III 24,domain:Fibronectin type-III 25,domain:Fibronectin type-III 26,domain:Fibronectin type-III 27,domain:Fibronectin type-III 28,domain:Fibronectin type-III 29,domain:Fibronectin type-III 3,domain:Fibronectin type-III 30,domain:Fibronectin type-III 31,domain:Fibronectin type-III 32,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,strand,turn,	Ehlers-Danlos due to tenascin X deficiency,Ehlers-Danlos syndrome, hypermobility type,	GO:0007010~cytoskeleton organization,GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030198~extracellular matrix organization,GO:0032963~collagen metabolic process,GO:0043062~extracellular structure organization,GO:0044236~multicellular organismal metabolic process,GO:0044259~multicellular organismal macromolecule metabolic process,GO:0048251~elastic fiber assembly,	PIRSF002500:tenascin-X,
31715_at	testis expressed 28; testis expressed 28 pseudogene 1; testis expressed 28 pseudogene 2	Homo sapiens		GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,					coiled coil,complete proteome,membrane,transmembrane,		IPR017387:Testis-specific TEX28,IPR019394:Predicted transmembrane and coiled-coil 2 protein,	chain:Testis-specific protein TEX28,transmembrane region,			PIRSF038100:testis-specific protein TEX28,PIRSF038100:Testis-specific_TEX28,
39198_s_at	tetratricopeptide repeat domain 15	Homo sapiens					SM00028:TPR,		complete proteome,phosphoprotein,polymorphism,repeat,tpr repeat,		IPR001440:Tetratricopeptide TPR-1,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide region,IPR019734:Tetratricopeptide repeat,	chain:Tetratricopeptide repeat protein 15,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,sequence conflict,sequence variant,			
38816_at	transforming, acidic coiled-coil containing protein 2	Homo sapiens		GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,		GO:0019904~protein domain specific binding,GO:0035257~nuclear hormone receptor binding,GO:0051427~hormone receptor binding,			acetylation,alternative splicing,coiled coil,complete proteome,cytoplasm,cytoskeleton,nucleus,phosphoprotein,polymorphism,		IPR007707:Transforming acidic coiled-coil-containing,	chain:Transforming acidic coiled-coil- containing protein 2,compositionally biased region:Poly-Lys,compositionally biased region:Pro-rich,domain:SPAZ,modified residue,sequence conflict,sequence variant,splice variant,		GO:0000226~microtubule cytoskeleton organization,GO:0000279~M phase,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0008283~cell proliferation,GO:0021537~telencephalon development,GO:0021543~pallium development,GO:0021846~cell proliferation in forebrain,GO:0021987~cerebral cortex development,GO:0022027~interkinetic nuclear migration,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030900~forebrain development,GO:0030953~spindle astral microtubule organization,GO:0031122~cytoplasmic microtubule organization,GO:0032886~regulation of microtubule-based process,GO:0051640~organelle localization,GO:0051647~nucleus localization,	
37898_r_at	trefoil factor 3 (intestinal)	Homo sapiens		GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0032579~apical lamina of hyaline layer,GO:0033166~hyaline layer,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,	h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,		SM00018:PD,		3d-structure,complete proteome,direct protein sequencing,disulfide bond,extracellular matrix,intestine,Secreted,signal,		IPR000519:P-type trefoil,IPR017957:P-type trefoil, conserved site,IPR017994:P-type trefoil, chordata,	chain:Trefoil factor 3,disulfide bond,domain:P-type,helix,sequence conflict,signal peptide,strand,turn,		GO:0006952~defense response,GO:0007586~digestion,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0043434~response to peptide hormone stimulus,	PIRSF001853:trefoil factor, types 1 and 3,
36713_at	tripartite motif-containing 58	Homo sapiens				GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,	SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,		coiled coil,complete proteome,metal-binding,polymorphism,zinc,zinc-finger,		IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B302 (SPRY)-like,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR017907:Zinc finger, RING-type, conserved site,IPR018355:SPla/RYanodine receptor subgroup,IPR018957:Zinc finger, C3HC4 RING-type,	chain:Tripartite motif-containing protein 58,domain:B30.2/SPRY,sequence conflict,sequence variant,zinc finger region:B box-type,zinc finger region:RING-type,			
1331_s_at	tumor necrosis factor receptor superfamily, member 25	Homo sapiens		GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,	h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,	GO:0005031~tumor necrosis factor receptor activity,GO:0019955~cytokine binding,GO:0043120~tumor necrosis factor binding,	SM00005:DEATH,SM00208:TNFR,		alternative splicing,Apoptosis,cell membrane,complete proteome,disulfide bond,glycoprotein,membrane,polymorphism,receptor,repeat,Secreted,signal,transmembrane,	hsa04060:Cytokine-cytokine receptor interaction,	IPR000488:Death,IPR001368:TNFR/CD27/30/40/95 cysteine-rich region,IPR011029:DEATH-like,	chain:Tumor necrosis factor receptor superfamily member 25,disulfide bond,domain:Death,glycosylation site:N-linked (GlcNAc...),mutagenesis site,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,repeat:TNFR-Cys 4,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0007166~cell surface receptor linked signal transduction,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,	
1372_at	tumor necrosis factor, alpha-induced protein 6	Homo sapiens				GO:0001871~pattern binding,GO:0005539~glycosaminoglycan binding,GO:0005540~hyaluronic acid binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,	SM00042:CUB,SM00445:LINK,		3d-structure,cell adhesion,complete proteome,direct protein sequencing,disulfide bond,glycoprotein,phosphoprotein,polymorphism,signal,		IPR000538:Link,IPR000859:CUB,	chain:Tumor necrosis factor-inducible gene 6 protein,disulfide bond,domain:CUB,domain:Link,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence variant,signal peptide,strand,		GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007267~cell-cell signaling,GO:0009611~response to wounding,GO:0022610~biological adhesion,	
1974_s_at	tumor protein p53	Homo sapiens	1.RBphosphoE2F,152.altered_synaptic_signalling-neurodegenerative_disorders,157.14-3-3_Cell_Cycle,38.Cell_cycle_arrest_and_apoptosis_ceramide,94.E2F_transcriptional_activity_cell_cycle,99.NF-kB_activation,	GO:0000267~cell fraction,GO:0005626~insoluble fraction,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005667~transcription factor complex,GO:0005669~transcription factor TFIID complex,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016363~nuclear matrix,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0016604~nuclear body,GO:0016605~PML body,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034399~nuclear periphery,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_btg2Pathway:BTG family proteins and cell cycle regulation,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,h_plk3Pathway:Regulation of cell cycle progression by Plk3,h_pmlPathway:Regulation of transcriptional activity by PML,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_rnaPathway:Double Stranded RNA Induced Gene Expression,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_tertpathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,h_tidPathway:Chaperones modulate interferon Signaling Pathway,	GO:0000166~nucleotide binding,GO:0000739~DNA strand annealing activity,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0003700~transcription factor activity,GO:0005507~copper ion binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0010843~promoter binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0047485~protein N-terminus binding,GO:0051087~chaperone binding,			3d-structure,acetylation,activator,alternative splicing,Apoptosis,cell cycle,cell division control,complete proteome,cytoplasm,disease mutation,DNA binding,dna-binding,endoplasmic reticulum,glycoprotein,homotetramer,host-virus interaction,isopeptide bond,Li-Fraumeni syndrome,metal-binding,methylation,nucleus,phosphoprotein,polymorphism,Transcription,transcription regulation,tumor suppressor,ubl conjugation,zinc,	hsa04010:MAPK signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04310:Wnt signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05016:Huntington's disease,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,	IPR002117:p53 tumour antigen,IPR010991:p53, tetramerisation,IPR011615:p53, DNA-binding,IPR012346:p53 and RUNT-type transcription factor, DNA-binding,IPR013872:p53 transactivation domain,IPR015551:Cellular tumour antigen p53,	chain:Cellular tumor antigen p53,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,region of interest:Basic (repression of DNA-binding),region of interest:Interaction with AXIN1,region of interest:Interaction with CARM1,region of interest:Interaction with E4F1,region of interest:Interaction with HIPK1,region of interest:Interaction with HIPK2,region of interest:Interaction with HRMT1L2,region of interest:Interaction with USP7,region of interest:Interaction with WWOX,region of interest:Interacts with the 53BP2 SH3 domain,region of interest:Oligomerization,region of interest:Required for interaction with FBXO42,region of interest:Transcription activation (acidic),sequence variant,short sequence motif:Bipartite nuclear localization signal,short sequence motif:Nuclear export signal,short sequence motif:[KR]-[STA]-K motif,splice variant,strand,turn,	Adrenal cortical carcinoma,Breast cancer,Choroid plexus papilloma,Colorectal cancer,Hepatocellular carcinoma,Histiocytoma,Li-Fraumeni syndrome,Li-Fraumeni-like syndrome,Multiple malignancy syndrome,Nasopharyngeal carcinoma,Osteosarcoma,Pancreatic cancer,Thyroid carcinoma,	GO:0000060~protein import into nucleus, translocation,GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001558~regulation of cell growth,GO:0001701~in utero embryonic development,GO:0001775~cell activation,GO:0001836~release of cytochrome c from mitochondria,GO:0002263~cell activation during immune response,GO:0002285~lymphocyte activation during immune response,GO:0002286~T cell activation during immune response,GO:0002309~T cell proliferation during immune response,GO:0002326~B cell lineage commitment,GO:0002347~response to tumor cell,GO:0002360~T cell lineage commitment,GO:0002366~leukocyte activation during immune response,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0006259~DNA metabolic process,GO:0006275~regulation of DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006302~double-strand break repair,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006839~mitochondrial transport,GO:0006873~cellular ion homeostasis,GO:0006885~regulation of pH,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006919~activation of caspase activity,GO:0006955~immune response,GO:0006970~response to osmotic stress,GO:0006974~response to DNA damage stimulus,GO:0006983~ER overload response,GO:0006984~ER-nuclear signaling pathway,GO:0007005~mitochondrion organization,GO:0007006~mitochondrial membrane organization,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007093~mitotic cell cycle checkpoint,GO:0007242~intracellular signaling cascade,GO:0007346~regulation of mitotic cell cycle,GO:0007369~gastrulation,GO:0007406~negative regulation of neuroblast proliferation,GO:0007568~aging,GO:0007569~cell aging,GO:0008104~protein localization,GO:0008156~negative regulation of DNA replication,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0008629~induction of apoptosis by intracellular signals,GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis,GO:0008635~activation of caspase activity by cytochrome c,GO:0008637~apoptotic mitochondrial changes,GO:0009267~cellular response to starvation,GO:0009303~rRNA transcription,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009651~response to salt stress,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009991~response to extracellular stimulus,GO:0010165~response to X-ray,GO:0010212~response to ionizing radiation,GO:0010332~response to gamma radiation,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010721~negative regulation of cell development,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010952~positive regulation of peptidase activity,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016265~death,GO:0016481~negative regulation of transcription,GO:0017038~protein import,GO:0019725~cellular homeostasis,GO:0022402~cell cycle process,GO:0030003~cellular cation homeostasis,GO:0030004~cellular monovalent inorganic cation homeostasis,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0030308~negative regulation of cell growth,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030641~regulation of cellular pH,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031570~DNA integrity checkpoint,GO:0031571~G1 DNA damage checkpoint,GO:0031575~G1/S transition checkpoint,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0032535~regulation of cellular component size,GO:0032583~regulation of gene-specific transcription,GO:0032774~RNA biosynthetic process,GO:0032943~mononuclear cell proliferation,GO:0033077~T cell differentiation in the thymus,GO:0033365~protein localization in organelle,GO:0033554~cellular response to stress,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0034644~cellular response to UV,GO:0034976~response to endoplasmic reticulum stress,GO:0040008~regulation of growth,GO:0042098~T cell proliferation,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0042149~cellular response to glucose starvation,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0042594~response to starvation,GO:0042770~DNA damage response, signal transduction,GO:0042771~DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043193~positive regulation of gene-specific transcription,GO:0043280~positive regulation of caspase activity,GO:0043281~regulation of caspase activity,GO:0043523~regulation of neuron apoptosis,GO:0043525~positive regulation of neuron apoptosis,GO:0043933~macromolecular complex subunit organization,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0045165~cell fate commitment,GO:0045184~establishment of protein localization,GO:0045321~leukocyte activation,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045786~negative regulation of cell cycle,GO:0045792~negative regulation of cell size,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045926~negative regulation of growth,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0046902~regulation of mitochondrial membrane permeability,GO:0046907~intracellular transport,GO:0048145~regulation of fibroblast proliferation,GO:0048147~negative regulation of fibroblast proliferation,GO:0048534~hemopoietic or lymphoid organ development,GO:0048598~embryonic morphogenesis,GO:0048878~chemical homeostasis,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0050801~ion homeostasis,GO:0051052~regulation of DNA metabolic process,GO:0051053~negative regulation of DNA metabolic process,GO:0051095~regulation of helicase activity,GO:0051097~negative regulation of helicase activity,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051259~protein oligomerization,GO:0051262~protein tetramerization,GO:0051276~chromosome organization,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051346~negative regulation of hydrolase activity,GO:0051453~regulation of intracellular pH,GO:0051726~regulation of cell cycle,GO:0051960~regulation of nervous system development,GO:0052547~regulation of peptidase activity,GO:0052548~regulation of endopeptidase activity,GO:0055067~monovalent inorganic cation homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060284~regulation of cell development,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070661~leukocyte proliferation,GO:0070727~cellular macromolecule localization,	PIRSF002089:tumor suppressor p53,
34629_at	tumor protein p53 inducible protein 11	Homo sapiens												GO:0008285~negative regulation of cell proliferation,GO:0042127~regulation of cell proliferation,	
36378_at	uroplakin 1A	Homo sapiens		GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,		GO:0005529~sugar binding,GO:0030246~carbohydrate binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,GO:0048029~monosaccharide binding,			alternative splicing,complete proteome,disulfide bond,glycoprotein,membrane,polymorphism,transmembrane,		IPR000301:Tetraspanin, subgroup,IPR018499:Tetraspanin,	chain:Uroplakin-1a,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,		GO:0006461~protein complex assembly,GO:0030855~epithelial cell differentiation,GO:0043933~macromolecular complex subunit organization,GO:0051259~protein oligomerization,GO:0060429~epithelium development,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,	PIRSF005764:uroplakin,
1901_s_at	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)	Homo sapiens		GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0009925~basal plasma membrane,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031224~intrinsic to membrane,GO:0042995~cell projection,GO:0043209~myelin sheath,GO:0043219~lateral loop,GO:0043235~receptor complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0045177~apical part of cell,GO:0045178~basal part of cell,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0048471~perinuclear region of cytoplasm,	h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0001948~glycoprotein binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005006~epidermal growth factor receptor activity,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0017076~purine nucleotide binding,GO:0019838~growth factor binding,GO:0019899~enzyme binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0030554~adenyl nucleotide binding,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0043125~ErbB-3 class receptor binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0051879~Hsp90 protein binding,	SM00219:TyrKc,SM00261:FU,		3d-structure,ATP,atp-binding,autophosphorylation,complete proteome,disulfide bond,duplication,glycoprotein,kinase,membrane,nucleotide-binding,phosphoprotein,phosphotransferase,polymorphism,Proto-oncogene,receptor,signal,transferase,transforming protein,transmembrane,transmembrane protein,tyrosine-protein kinase,tyrosine-specific protein kinase,	hsa04012:ErbB signaling pathway,hsa04020:Calcium signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05219:Bladder cancer,hsa05223:Non-small cell lung cancer,	IPR000494:EGF receptor, L domain,IPR000719:Protein kinase, core,IPR001245:Tyrosine protein kinase,IPR004019:YLP motif,IPR006211:Furin-like cysteine rich region,IPR006212:Furin-like repeat,IPR008266:Tyrosine protein kinase, active site,IPR016245:Tyrosine protein kinase, receptor-type, EGF/ERB/XmrK,IPR017441:Protein kinase, ATP binding site,	active site:Proton acceptor,binding site:ATP,chain:Receptor tyrosine-protein kinase erbB-2,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with PIK3C2B,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,	Adenocarcinoma of lung, somatic,Gastric cancer, somatic,Glioblastoma, somatic,Ovarian cancer, somatic,	GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001508~regulation of action potential,GO:0001889~liver development,GO:0002683~negative regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006873~cellular ion homeostasis,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007272~ensheathment of neurons,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007422~peripheral nervous system development,GO:0007423~sensory organ development,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007528~neuromuscular junction development,GO:0008045~motor axon guidance,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008366~axon ensheathment,GO:0009611~response to wounding,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009967~positive regulation of signal transduction,GO:0010001~glial cell differentiation,GO:0010033~response to organic substance,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0014065~phosphoinositide 3-kinase cascade,GO:0014066~regulation of phosphoinositide 3-kinase cascade,GO:0014068~positive regulation of phosphoinositide 3-kinase cascade,GO:0014706~striated muscle tissue development,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0019220~regulation of phosphate metabolic process,GO:0019226~transmission of nerve impulse,GO:0019228~regulation of action potential in neuron,GO:0019725~cellular homeostasis,GO:0019932~second-messenger-mediated signaling,GO:0022602~ovulation cycle process,GO:0022612~gland morphogenesis,GO:0030030~cell projection organization,GO:0030155~regulation of cell adhesion,GO:0030182~neuron differentiation,GO:0030879~mammary gland development,GO:0031175~neuron projection development,GO:0032504~multicellular organism reproduction,GO:0032570~response to progesterone stimulus,GO:0032944~regulation of mononuclear cell proliferation,GO:0032945~negative regulation of mononuclear cell proliferation,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033081~regulation of T cell differentiation in the thymus,GO:0033083~regulation of immature T cell proliferation,GO:0033084~regulation of immature T cell proliferation in the thymus,GO:0033087~negative regulation of immature T cell proliferation,GO:0033088~negative regulation of immature T cell proliferation in the thymus,GO:0033674~positive regulation of kinase activity,GO:0042060~wound healing,GO:0042063~gliogenesis,GO:0042127~regulation of cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042130~negative regulation of T cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042391~regulation of membrane potential,GO:0042493~response to drug,GO:0042552~myelination,GO:0042592~homeostatic process,GO:0042692~muscle cell differentiation,GO:0042698~ovulation cycle,GO:0042981~regulation of apoptosis,GO:0043062~extracellular structure organization,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043408~regulation of MAPKKK cascade,GO:0043410~positive regulation of MAPKKK cascade,GO:0043549~regulation of kinase activity,GO:0043586~tongue development,GO:0044093~positive regulation of molecular function,GO:0045580~regulation of T cell differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045765~regulation of angiogenesis,GO:0045785~positive regulation of cell adhesion,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046777~protein amino acid autophosphorylation,GO:0048015~phosphoinositide-mediated signaling,GO:0048483~autonomic nervous system development,GO:0048485~sympathetic nervous system development,GO:0048511~rhythmic process,GO:0048545~response to steroid hormone stimulus,GO:0048609~reproductive process in a multicellular organism,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048678~response to axon injury,GO:0048732~gland development,GO:0048741~skeletal muscle fiber development,GO:0048747~muscle fiber development,GO:0048771~tissue remodeling,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048878~chemical homeostasis,GO:0050670~regulation of lymphocyte proliferation,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050801~ion homeostasis,GO:0050808~synapse organization,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050868~negative regulation of T cell activation,GO:0050877~neurological system process,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051146~striated muscle cell differentiation,GO:0051174~regulation of phosphorus metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0055001~muscle cell development,GO:0055002~striated muscle cell development,GO:0055082~cellular chemical homeostasis,GO:0060056~mammary gland involution,GO:0060206~estrous cycle phase,GO:0060209~estrus,GO:0060443~mammary gland morphogenesis,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0060548~negative regulation of cell death,GO:0070663~regulation of leukocyte proliferation,GO:0070664~negative regulation of leukocyte proliferation,	PIRSF000619:tyrosine-protein kinase, EGF receptor type,PIRSF000619:TyrPK_EGF-R,
33684_at	wingless-type MMTV integration site family, member 2B	Homo sapiens		GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,			SM00097:WNT1,		alternative splicing,complete proteome,developmental protein,extracellular matrix,glycoprotein,Secreted,signal,wnt signaling pathway,	hsa04310:Wnt signaling pathway,hsa04340:Hedgehog signaling pathway,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,	IPR005816:Secreted growth factor Wnt protein,IPR005817:Wnt superfamily,IPR009140:Wnt-2 protein,IPR018161:Secreted growth factor Wnt protein, conserved site,	chain:Protein Wnt-2b,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,		GO:0007166~cell surface receptor linked signal transduction,GO:0007223~Wnt receptor signaling pathway, calcium modulating pathway,GO:0016055~Wnt receptor signaling pathway,	PIRSF001784:int-1 transforming protein,
2090_i_at	wingless-type MMTV integration site family, member 6	Homo sapiens		GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,		GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,	SM00097:WNT1,		carcinogenesis,complete proteome,developmental protein,extracellular matrix,glycoprotein,Secreted,signal,wnt signaling pathway,	hsa04310:Wnt signaling pathway,hsa04340:Hedgehog signaling pathway,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,	IPR005816:Secreted growth factor Wnt protein,IPR005817:Wnt superfamily,IPR009143:Wnt-6 protein,IPR018161:Secreted growth factor Wnt protein, conserved site,	chain:Protein Wnt-6,glycosylation site:N-linked (GlcNAc...),signal peptide,		GO:0007166~cell surface receptor linked signal transduction,GO:0007223~Wnt receptor signaling pathway, calcium modulating pathway,GO:0007267~cell-cell signaling,GO:0016055~Wnt receptor signaling pathway,	PIRSF001784:int-1 transforming protein,
41113_at	zinc finger protein 500	Homo sapiens				GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,	SM00349:KRAB,SM00355:ZnF_C2H2,SM00431:SCAN,	General function prediction only,	complete proteome,dna-binding,metal-binding,nucleus,repeat,Transcription,transcription regulation,zinc,zinc-finger,		IPR001909:Krueppel-associated  box,IPR003309:Transcriptional regulator SCAN,IPR007087:Zinc finger, C2H2-type,IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding,IPR015880:Zinc finger, C2H2-like,	chain:Zinc finger protein 500,domain:KRAB,domain:SCAN box,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,		GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,	
